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Epidemiological trends in mental disorders are shown against a background governed by 
medical aid health policy. The study quantitatively analysed a dataset of mental disorders for 
South Africa’s leading medical aid scheme.  
South Africa’s leading medical aid scheme has been in operation for almost three decades. 
This degree of longevity allows for a reliable longitudinal analysis of diagnostic trends. 
Through consent of the Scheme, a database was provided, which lists mental disorder 
diagnoses over seven years from 2008 to mid-way through 2015. Data from this source were 
analysed and interpreted.  
Data fields provided and made use of from the raw medical scheme database are: Date of 
admission (Year, Month); Patient gender; Database population per year; Patient diagnosis 
(DEG Description); Total per DEG Description. 
Each diagnosis (mental disorder) is presented in the following ways: 
1. Bar charts showing the volume of specific mental illnesses each year.  
2. Bar charts showing fluctuations of occurrence of a specific mental illness over 
time.  
3. Frequency of specific mental illnesses over time, relative to the entire database 
population.  
4. Male:Female ratio per mental disorder.  
5. Female Outpatient vs. Inpatient volumes across each mental disorder and across 
all years (2008 – 2015).  
  
v  
6. Male Outpatient vs. Inpatient volumes across each mental disorder and across all 
years (2008 – 2015). 
7. Total number of patients per mental disorder across time (2008 – 2015). 
8. Frequency polygons showing the fluctuation of a selected mental disorder over 
time as compared to other selected mental disorders.  
It is found that there are changes in prevalence rates of mental disorders over time and that 
these fluctuations are attributed to an economic factor within medical aid scheme cost-driven 
policy.  
The effect of cost-driven policy is that members diagnosed with a mental disorder may not be 
granted provision of adequate treatment because diagnosis is in part, determined by economic 
structures. 
Costs for mental illness treatment programmes are curtailed by keeping patient numbers 
significantly low, by radically over-diagnosing certain mental illnesses treated with 
comparably cheaper pharmaceuticals or by drastically curbing time spent in a mental health 
facility.  
Some members of the medical aid scheme have been deliberately misdiagnosed. 
Alternatively, those, correctly diagnosed, do not receive the treatment required of such an 
illness. The scenario then is of thousands of mentally ill people, who are not treated 
effectively. 
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Chapter 1: Overview of mental illness 
An introduction to fluidity in psychopathology 
Those with a propensity for or a sufferer of a mental disorder 
are subject to the effects of a wide-reaching spectrum of 
influencing factors (Shrivastava, Johnston, & Bureau, 2012). 
These factors range from individual characteristics (such as 
intrusive thoughts, fluctuating emotions and erratic 
behaviours), to social, cultural, economic, genetic and 
environmental factors (such as working conditions, family 
and community support). 
Thomas Kuhn (1996) proposed the concept of a paradigm as 
an intellectual scaffolding that frames the context of a theory 
or hypothesis. Proponents of a paradigm are then guided 
subconsciously as to which questions to ask and which 
evidence to view as relevant. The underlying 
social/geographic/political/historical traditions of the 
scientists’ environment and the principles of the discipline 
itself contribute to forming the paradigm. The Theory of 
 
3  
Evolution by means of Natural Selection (Charles Darwin) is 
an example of a unifying paradigm in biological sciences. 
In contrast, Psychology as a discipline is not steered by a 
unifying paradigm, which allows a single methodological 
approach. Instead, there is a splintering of paradigms into 
trends or themes, and these are associated with application 
specific psychiatric theory and practice. Watson (1967) 
refers to this as a prescriptive trend, and since it is the nature 
of a trend, these prescriptive trends fluctuate, shift, combine, 
separate, and recombine (Watson, 1967). Functionalism, 
Behaviourism, Gestalt psychology and Psychoanalysis are 
examples of the prescriptions referred to by Watson (Marx & 
Hillix, 1963).  
Psychiatric theories evolve from a melting pot of doctors, 
patients and the society that surrounds them. Furthermore, 
psychiatric practice is made more complex because mental 
illnesses are often not static (Borch-Jacobsen, 2001). Static 
mental disorders are those with a purely 
 
4  
physiological/biological base and include tumoural, 
neurological, endocrine, toxic, or infectious illnesses. 
Examples of such illnesses would be epilepsy or Alzheimer’s 
disease.  
Biological disorders will present along a predictable 
continuum of symptoms. However, most mental disorders 
present as dynamic, with great variation in symptoms. This is 
because they do not have an exclusively genetic or 
biochemical basis (Barrett, 1996). Symptoms, such as 
auditory hallucination (classically associated with 
schizophrenia) did not appear until the end of the 18th 
century (Shorter, 1997; Hacking, 1999). Further examples of 
the dynamism of mental illness are that the average duration 
of schizophrenia is much shorter in the Third World than in 
industrialised countries (WHO, 1979) and that the symptoms 
of Chinese neurasthenia, correspond to severe depression, 
but do not respond to antidepressants (Kleinman, 1986). 
These examples show that it is critical to extend beyond the 
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framework of biological causes of mental illness and to 
integrate social and cultural contexts. (Benedict, 1934; Lévi-
Strauss, 1950; Devereux, 1956; Bastide, 1965; Kleinman, 
1988; Nathan, Stengers, & Andréa, 2000; Borch-Jacobsen, 
2001).  
An aspect of the symptoms of mental illness is the 
combination of a patient’s interaction with medical 
professionals and institutions (Borch-Jacobsen, 2001). 
Patients present with symptoms that align or misalign with 
an illness category, and then they may subconsciously reject, 
accept or adopt new behaviours that reinforce an illness 
category. A dynamic feedback loop between doctor and 
patient drives the evolution into a new psychopathological 
paradigm (Watzlawick, Beavin & Jackson, 1967; Bateson, 
1972; Hacking, 1999). This is because patients will tend to 
conform to the language of the medical professional and the 
society to which they belong, to expedite the treatment they 
so desperately need (Grivois, 1992). Barrett (1996), by way 
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of reinforcing this point, demonstrates how schizophrenic 
patients learn, during clinical interviews, to speak the 
doctor’s language.  
Hysteria for example, fell away as a diagnosis at the 
beginning of the 20th Century, because patients presented 
with new symptoms, such as catatonia or obsessional 
neurosis, through the trend initiated by medical professionals 
(Micale, 1993). Roudinesco (1999) questions whether this 
patient-doctor interplay is a factor in explaining the 
exponential increase in depressive disorders since the late 
1950s. Healy (1998) showed that the explosion in depressive 
disorder figures corresponded directly to the introduction of 
antidepressant medications. Such a correlation can be 
understood in the light of patients modelling their symptoms 
on the psychotropic medications that act on those very 
symptoms.  
An element of mental illness is the sum of symptoms 
developed between patients, medical professionals and 
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surrounding culture; therefore, it can be argued that the 
development of new psychiatric concepts and behaviours 
emerge from preconceptions, expectations and complex 
interactions (Bertolote, 2008). This creates a new mental 
illness paradigm common to the medical professional, patient 
and society (Borch-Jacobsen, 2001). Latour (1987) speaks of 
‘psychiatry in action’, which is the extension of the patient-
doctor interaction to other doctors and patients and to larger 
populations, resulting in the cementing of a psychiatric 
theory and the new symptoms that define it.  
What is mental health? 
There are numerous definitions for ‘mental health.’ At the 
simplest level, a definition for mental health is an absence of 
mental illness. A holistic definition is expressed by Mental 
Health Ireland (pg.31, 2009) to be “… a state of emotional 
and social wellbeing in which the individual can cope with 
the normal stresses of life and achieve his or her potential. It 
includes being able to work productively and contribute to 
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community life.”  
Those with sound mental health interact inclusively and 
equitably in ways that encourage personal wellbeing and the 
optimising of opportunities for development and the use of 
mental abilities. Mental health is not simply the absence of 
mental illness (Bertolote, 2008; Galderisi, Heinz, Kastrup, 
Beezhold & Sartorius, 2015). 
Mental Illness 
If, at a fundamental level, mental health is defined as the 
absence of a mental illness, then it follows that a mentally 
healthy individual does not have a psychiatric disorder 
(Sands, 1991; Galderisi et al., 2015). In contrast to 
behaviourist theory, the foundation of the DSM is that 
symptoms correspond with mental illness (Mayo Clinic, 
2007). The DSM details the symptoms and functional 
impairments that signify a specific mental illness. Examples 
of such symptoms of illness would include: 
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• Behaviours (e.g., repeated actions) 
• Feelings (e.g., apathy) 
• Thoughts (e.g., delusions) 
• Physiological responses (e.g., heart palpitations). 
Mental Disorder 
Mental Disorders are described as clinically significant 
behavioural or psychological patterns that cause distress, 
pain, disability and impairment to function (Sands, 1991; 
Schneiderman, Ironson & Siegel, 2005; DSM- IV Multi 
Axial System, 2007; Mayo Clinic, 2007). Furthermore, a 
mental disorder is also defined as a behavioural, 
psychological, or biological dysfunction that is not an 
expectable reaction to a particular event (Stein, Phillips, 
Bolton, Fulford, Sadler & Kendler, 2010). Morrison (1995) 
augments the description above, by adding the following 




• Mental disorders describe disease processes, not 
people.  
• There are not necessarily distinct boundaries 
between disorders. For example, the DSM-IV 
defines criteria for alcohol abuse and alcohol 
dependence, but in reality, alcohol users do not 
necessarily fit neatly into one of the two 
disorders.  
• There is no difference between a physical 
condition (such as diabetes) and a mental disorder 
(such as bipolar I disorder).  
• The DSM follows the medical model of illness, 
meaning that the DSM is a body of work derived 
from scientific studies of groups of patients 
presenting similarities in symptoms of their 
disease. 
• The DSM makes no assumptions as to the 
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aetiology (cause) of most disorders.  
According to Gaebel and Zielasek (2010), core mental 
disorders in the DSM, are categorised as either: 
1. Affective disorders,  
2. Neurodegenerative disorders, 
3. Personality disorders, 
4. Developmental disorders, or 
5. Disorders of addiction 
The DSM System 
Globally, the most commonly used diagnostic criteria 
manual for mental disorders, is the Diagnostic and Statistical 
Manual of Mental Disorders (DSM), developed and 
published by the American Psychiatric Association (1994). 
Pharmaceutical companies, policy makers, medical 
practitioners and medical aids in the area of mental health 
increasingly use the DSM (Brubeck, 1999). 
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The DSM and ICD systems 
The International Statistical Classification of Diseases and 
Related Health Problems, 10th edition, is referred to as the 
ICD-10. ICD-10 codes are alphanumeric labels assigned to 
every medical diagnosis and description of symptoms. The 
World Health Organisation (WHO) develops and monitors 
the classifications (Torrey, 2009).  
In South Africa, the Council for Medical Schemes and the 
National Department of Health have adopted the ICD-10 
diagnostic coding system in the public and private health 
sector. It is also the diagnostic coding standard adopted in 
1996, by the National Department of Health and the National 
Health Information System of South Africa (NHISSA) (The 
Board of Health Care Funders, 2007; Council for Medical 
Schemes, 2010).  
In South Africa, Medical aid schemes mandate a DSM 
diagnosis from a psychiatrist before authorising mental 
health treatment and services (Dittmer, 2011; Kriel, 2011; 
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Pridigeon, 2011). Discovery, Polmed, GEMS (Government 
Employees Medical Scheme) and Liberty medical aid 
schemes approve mental health admission only with a 
comprehensive DSM-IV report for all psychiatric and mental 
health related services (Discovery Health, 2009; Government 
Employees Medical Scheme, 2010; Liberty Medical Scheme, 
2010). Without this report, fees are deducted from the 
limited day-to-day benefits. 
Mental health practitioners also use ICD-10 codes when 
processing medical aid claims (Duncan, 2008). The DSM 
and the ICD systems developed around diagnostic codes, but 
practitioners use the ICD for invoicing purposes and refer to 
the DSM for diagnostic criteria (First, Rebello, Keeley, 
Bhargava, Dai, Kulygina, Matsumoto, Robles, Stona & 
Reed, 2018). 
Interestingly, and especially in South Africa, evidence shows 
that regarding mental disorders, medical practitioners prefer 
applying the DSM system because it is more comprehensive 
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than the ICD-10 coding system (Mezzich, 2002; Allers, 
2008; Collin, 2008), and is a diagnostic classification system, 
specifically designed for mental disorders. It comprises a list 
of mental disorders (each uniquely coded) but with detailed 
classification criteria (First et al., 2018). 
The DSM system is also the preferred clinical diagnostic 
guideline in South African private mental health hospitals 
(Clark, Cuthbert, Lewis-Fernández, Narrow, & Reed, 2017). 
According to the Hospital Association of South Africa 
(HASA) there are 247 private mental health hospitals 
totalling 30 334 beds. These private psychiatric hospitals 
have the same psychiatric admission and administration 
criteria, individualised for each of the 110 medical aid 
schemes, registered with the Council for Medical Schemes in 
2009 (Clark, 2011; Perry, Lawrence & Henderson, 2020).  
The history of the DSM 
The first edition of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-I) was published in 1952. There 
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have been six revisions since the first publication, with each 
subsequent publication, expanded to include additional 
disorders, all with the aim of defining and classifying mental 
disorders to improve diagnoses, treatment, and research 
(Brubeck, 1999; Houts, 2000): 
1. DSM-II (1968) 
2. DSM-III (1980) 
3. Revised DSM-III, DSM-III-R (1987) 
4. DSM-IV (1994)  
5. Revised DSM-IV-TR (2000) 
6. DSM-V (2013)  
In 1917, a ‘Committee on Statistics’ (referred to now as the 
American Psychiatric Association (APA)), together with the 
National Commission on Mental Hygiene, developed the 
first standard diagnostic classifications manual for mental 
hospitals called the ‘Statistical Manual for the Use of 
Institutions for the Insane’, and this listed 22 diagnoses 
(Brubeck, 1999; Houts, 2000). 
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The DSM-I listed 106 mental disorders, and the DSM-II 
expanded the list to include 182 disorders (Grob, 1991; 
Houts, 2000), with both documents not accentuating a clear 
distinction between ‘normality’ and ‘abnormality’ (Mayes & 
Horwitz, 2005; Wilson, 1993). The DSM-III listed 265 
diagnostic categories and was used globally. In 1987, the 
DSM-III-R was published as a revision of DSM-III and cited 
292 diagnoses (Burbeck, 1999; Houts, 2000). 
The DSM-IV (1994) listed 297 disorders and was significant 
in its inclusion of a ‘clinical significance criterion’ to almost 
half of its categories, which made it mandatory that 
symptoms cause ‘clinically significant distress or impairment 
in social, occupational, or other important areas of 





DSM-IV Multi-axial evaluation 
The DSM-IV incorporated a multi-axial evaluation approach, 
with five axes to record the bio-psycho-social assessment of 
each patient. Axis I for clinical syndromes; Axis II for 
personality disorders and mental retardation; Axis III for 
physical disorders and conditions; Axis IV for psychosocial 
stressors such as environmental problems and axis V for 
global assessment of patient functioning over the previous 
year (The American Psychiatric Association, 1994; 
Morrison, 1995; Brubeck, 1999; Houts, 2000).  
Axis I: Mental Disorders 
Axis I record mental diagnoses as a clinical syndrome, 
except for personality disorders and mental retardation (The 
American Psychiatric Association, 1994; Morrison, 1995; 
Brubeck, 1999; Ruocco, 2005). In most instances, a patient 
will suffer a minimum of one Axis I diagnosis, but many 
patients will have more than one. The primary diagnosis 
should be listed on Axis I (Hout, 2000).  
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Axis II: Personality Disorders and Mental Retardation 
Clinicians will be inclined to focus on an Axis I pathology 
and so the Axis II is necessary to ensure that personality 
disorders and mental retardation are not overlooked, and 
with some patients presenting with more than one Axis II 
diagnosis (Morrison, 1995). 
Common Axis II disorders include personality disorders such 
as paranoid personality disorder, schizoid personality 
disorder, schizotypal personality disorder, borderline 
personality disorder, antisocial personality disorder, 
narcissistic personality disorder, histrionic personality 
disorder, avoidant personality disorder, dependent 
personality disorder, obsessive-compulsive personality 
disorder, and mental retardation (Røysamb, Kendler, Tambs, 




Axis III: Physical Conditions and Disorders 
A physical illness may have a direct effect on the Axis I 
diagnosis of a patient and can impact the management of an 
Axis I or Axis II disorder (Morrison, 1995, Røysamb et al., 
2011). 
Axis IV: Psychosocial and Environmental Problems 
The role of Axis IV is to report any environmental or 
psychosocial event or condition that might affect the 
diagnosis or management of the patient (Morrison, 1995; 
Røysamb et al., 2011). The Axis I or Axis II disorder may 
have caused these problems, or they may be independent 
events. If the Axis IV identified variable occurred earlier, 
then it must have contributed to the development of the 
mental disorder.  
According to Morrison (1995), there are nine categories of 




1. Economic problems: Such as debt, poverty, 
inadequate welfare or child support. 
2. Housing problems: Such as homelessness, poor 
housing, and dangerous neighbourhoods. 
3. Problems with primary support group: Such as the 
death/illness of a relative, divorce/separation, 
physical or sexual abuse. 
4. Occupational problems: Such as stressful work 
conditions, change of job, dissatisfaction with job or 
unemployment. 
5. Educational problems: Such as academic challenges, 
illiteracy, or poor school environment. 
6. Problems related to the social environment: Such as 
racial or sexual discrimination, retirement, or social 
isolation. 
7. Problems related to the legal system or crime: Such 
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as incarceration or being a victim of crime. 
8. Other psychosocial problems: Such as exposure to 
war, and natural disasters. 
9. Problems with access to health care services: Such as 
no or insufficient health insurance or the 
unavailability of transportation to health care 
services. 
Axis V: Global Assessment of Functioning (GAF) 
The Global Assessment of Functioning (GAF) score is a 
numerical indication of a patient’s current and overall 
(occupational, psychological, and social) functioning, 
recorded as a number on a 100-point scale (Morrison, 1995; 
Saleebey, 2001; Røysamb et al., 2011). South African 
Employee Assessment companies apply the DSM- IV’s GAF 
Scale to determine if a patient could benefit from brief 
counselling (Keet, 2009). 
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DSM limitations and advantages 
There is no standard diagnostic test or measurement for 
mental illness. Nevertheless, it is human nature to attempt to 
categorise experience (Phares, 1992), and so, not surprising 
many mental health professionals emphasise psychiatric 
classification systems to the point where they become the 
basis of diagnosis rather than just a supporting tool (Anello, 
1989; Phares, 1992; Strong, 2007). The DSM has come 
under the scrutiny of criticism over the years. Below are 
some limitations: 
Limitations of the DSM 
1. The ever-expanding criteria of the DSM is indicative 
of the increasing medicalisation of human nature, 
driven by the influence of pharmaceutical companies 
on psychiatry (Cosgrove, Bursztajn, Kupfer, & 
Regier, 2006; Kupfer & Regier, 2009; Cosgrove, 
Bursztajn & Krimsky, 2009). One cannot ignore the 
potential for direct conflict of interest when half of 
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the authors who defined the DSM-IV have or 
previously had financial relationships in 
pharmaceutical companies (Kupfer & Regier, 2009). 
2. Frances (2009) is highly critical of the processes 
adopted in the implementation of the DSM-5, where 
he is almost dire in his predication of the risk of 
serious and dangerous unintended consequences such 
as new false ‘epidemics’. 
3. The extreme fragmentation of mental disorders could 
explain why patients are often given more than one 
diagnosis simultaneously and why, in some instances 
patients are diagnosed with comorbidity within an 
Axis (Saleebey, 2001; Gomes de Matos, Gomes de 
Matos, & Gomes de Matos, 2005; Corcoran & 
Walsh, 2011). This statement does not refute the fact 
that comorbidities do exist. 
4. The system needlessly captures human quirks and bad 
habits as mental disorders (Saleebey, 2001). Robbins 
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(2011) notes that under the new DSM-5 guidelines, 
some responses to grief are now definable as 
pathological disorders, instead of the archetypal 
human experiences they are (Allday, 2011). The 
essence of this criticism is aptly summarised by the 
British Psychological Society (June 2011 page 118) 
that states that “clients and the general public are 
negatively affected by the continued and continuous 
medicalisation of their natural and normal responses 
to their experiences ... which demand helping 
responses, but which do not reflect illnesses so much 
as normal individual variation.”  
5. The DSM-V needs greater cognisance of cultural and 
gender issues. This is vital, so as not to erroneously 
imply elevated psychopathology (Smart & Smart, 
1997; Ivey & Ivey, 1998; Saleebey, 2001; Reyneke, 
2008; Corcoran &Walsh, 2011). 
6. Professionals using the DSM without extensive 
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theoretical knowledge, adequate training and/or 
experience could be detrimental because many 
symptoms in the DSM overlap different disorders 
(Kendell & Jablensky, 2003; Corcoran & Walsh, 
2011).  
Huyssen (1999) states that criticisms about the DSM are 
abundant, although few of its critics doubt the necessity of a 
classification system. The manual must never replace 
extensive clinical assessment and diagnosis that can only 
result from the unique relationship between patient and 
professional (Kendell & Jablensky, 2003; Gomes de Matos 
et al., 2005; Corcoran & Walsh, 2011). 
Advantages of the DSM 
1. The proper use of the DSM can lead to improved 
treatment of individuals. Social workers in the field 
of mental health, for example, are responsible for 
making diagnostic decisions and they formulate their 
treatment plans according to the diagnosis. This is 
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reason enough to be familiar with the DSM (Brubeck, 
1999; Kutchins & Kirk, 1995; Corcoran & Walsh, 
2011; Smit, 2012). 
2. Professionals need to communicate with colleagues 
using a common language, regarding treatment and to 
this end, the DSM manual provides a common 
‘mental health vocabulary’ (Jampala, Zimmerman, 
Sierles & Taylor, 1992). 
3. The DSM system can serve as a comprehensive 
educational and training tool (Kutchins & Kirk, 1995; 
Smit, 2012).  
4. The DSM also provides a foundation upon which the 
effectiveness of counselling and treatment can be 




Categorical/Diagnostic Model vs Dimensional Model 
The overarching objective of the DSM is to deliver a 
standard language for defining psychopathology (Jampala et 
al., 1992). In creating this common language, what has 
resulted is a set of labels with definitions. On one end of the 
continuum, this creates a global standard of terms, but on the 
other end, a major flaw, is a lack of empirical evidence 
supporting every diagnosis.  
Debate continues over which model would better suit the 
application of the DSM, and more importantly, would better 
apply to sufferers of mental illness. The two models are 
either the Diagnostic/Categorical Model preferred by 
psychiatrists or the Dimensional Model preferred by 
psychologists (Potuzak, Ravichandran, Lewandowski, Ongür 
& Cohen, 2012). 
The Diagnostic Model adopts the diagnostic methodology of 
clinical medicine, but in so doing fails to include the 
complexities and subtleties of personality. The Dimensional 
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Model, in opposition, incorporates varied degrees of 
personality (Potuzak et al., 2012; Crocq, 2013).  
The Diagnostic Model adopts the concept that an illness is 
either present or not: The criteria for a mental illness are met 
and the illness is present, or not met, and no illness is 
present. This method is what governs diagnosis in the DSM 
and ICD-10 (Widiger & Trull, 2007). The advantage of this 
model is the predictive power it creates (First & Tasman, 
2004), because medical practitioners can theoretically expect 
similar behaviours and treatment results from patients who 
meet the set of criteria that defines a specific illness (Widiger 
& Trull, 2007).  
The disadvantage of this model is that although symptoms of 
a mental disorder may be present, these may not meet all the 
criteria for that disorder, and therefore according to the 
stringency of DSM, the diagnosis cannot be made (Ruscio, 
2008). In addition, there is scant research on treatments for 
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individuals who have only features or symptoms of a 
disorder (Cabassa & Baumann, 2013). 
On the opposite end of the spectrum, the Dimensional Model 
adopts the philosophy that disorders are a sum of a complex 
interaction between factors over time and take into account 
the unique characteristics of individual symptoms. This 
model makes allowances for co-morbidity not concurrent 
with the main personality type (Widiger & Trull, 2007; 
Potuzak et al., 2012). The main disadvantage of this 
approach is the lack of clear thresholds establishing whether 
the individual has a disorder or not. This is problematic for 
health insurance, where treatment for precise diagnoses is a 
prerequisite (Ruscio, 2008). 
The categorisation of personality disorders, for example, is 
more the result of observation than empirical study, making 
them largely inexact concepts, without clearly delineated 
boundaries. To emphasise this point, there is a call for the 
provision of empirical clinical data to evidence the linking of 
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personality and psychopathology in personality (Insel, 2013). 
For example, is it possible for two individuals with the same 
personality disorder diagnosis to have very different non-
overlapping symptoms (Cabassa & Baumann, 2013; 
Krueger, Hopwood, Wright & Markon, 2014)? 
Practitioners opposed to the diagnostic approach, advocate 
instead, that mental health be viewed from a completely 
different perspective. This perspective begins with 
acknowledging and accepting the overwhelming evidence 
that mental illness falls on a continuum with 'normal' 
experience. In addition, it is critical to acknowledge that 
psychosocial factors such as poverty, unemployment and 
trauma are evidence-based, contributing factors to mental 
illness. These practitioners are firm in their stance that 
diagnosing mental illnesses, should not be from rigid 
categories, but should begin instead, with the specific 
experiences, or symptoms of the individual. This approach 
would be from the ground up and not, as it currently stands, 
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from the top, down. Diagnostic labels are less useful than a 
description of a patient's symptoms for predicting treatment 
response (British Psychological Society, June 2011). 
Terminology used in the DSM System 
Definitions for ‘mental disorder’, ‘mental illness’ and 
‘mental health’ vary according to cultural norms, schools of 
thought, research criteria etc. (Gopalkrishnan, 2018). 
According to Kendell (2002), for example, the term ‘mental 
illness’ or ‘disorder’ are synonymous. Whereas behavioural 
theorists for example, object to any medical definition of 
mental illness based on their disagreement with the 
assumption that there is a physiological cause for 
psychological problems (Tilbury, 2002).  
In the DSM-IV, the challenges of defining these terms 
lessened by identifying biopsychosocial criteria for each 
mental disorder. 
Attempts to define ‘mental health’ often involve describing a 
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behavioural ‘baseline’ as ‘normal’. In this context, normality 
would then be the average or common behaviour within a 
community (Sands, 1991; Mayo Clinic, 2007). Societies 
define what is normal according to its religious, cultural, and 
behavioural characteristics (Gopalkrishnan, 2018). 
Key changes in the DSM-5 
The DSM-5 was published on May 18, 2013, overriding the 
DSM-IV-TR, which was published in 2000 (Wakefield, 
2013). The greatest difference when comparing the two 
manuals would be the removal of the DSM-IV multiaxial 
system of diagnosis and the Global Assessment of 
Functioning (GAF). The World Health Organisation's 
(WHO) Disability Assessment Schedule was added to the 
DSM-5 as a suggested method to assess functioning 




Additional changes in the DSM-5  
Neurodevelopmental disorders (A guide to DSM-5: 
Neurodevelopment; A guide to DSM-5: Neurodevelopment; 
A guide to DSM-5: Autism Spectrum; American Psychiatric 
Association, 2013). 
• Mental Retardation is now referred to as intellectual 
disability (intellectual developmental disorder). 
• Phonological disorder and stuttering are now 
collectively termed communication disorders, and 
include:  
• Language disorder 
• Speech sound disorder 
• Childhood-onset fluency disorder 
• Social (pragmatic) communication disorder. This 
disorder is new to the DSM classification system and 




• Autism spectrum disorder now incorporates: 
• Asperger disorder  
• Childhood disintegrative disorder 
• Pervasive developmental disorder not 
otherwise specified (PDD-NOS).  
• Motor disorders is a new sub-category, and includes:   
• Developmental coordination disorder  
• Stereotypic movement disorder 
• Tic disorders including Tourette syndrome  
Schizophrenia spectrum and other psychotic disorders 
(Highlights of Changes, 2015). 
• The DSM-5 no longer recognises schizophrenia 
subtypes (paranoid, disorganised, catatonic, 
undifferentiated, and residual).  
• For the diagnosis of schizoaffective disorder, a major 
mood episode is required. 
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• Catatonia is now diagnosed if three of 12 symptoms 
are present. Catatonia may be an indicator of 
depressive, bipolar, and psychotic disorders; part of 
another medical condition; or of another specified 
diagnosis. 
Depressive disorders (Guide to DSM-5: Disruptive Mood, 
2013; Highlights of Changes, 2015). 
• Disruptive mood dysregulation disorder (DMDD) is a 
new addition and is specified for children up to age 
18 years.  
• Premenstrual dysphoric disorder is a new addition.  





Anxiety disorders (Highlights of Changes, 2015). 
• For phobias and anxiety disorders, there is no longer 
the requirement that the patient need to acknowledge 
that their fear and anxiety is excessive or irrational. 
• Panic disorder and agoraphobia are now two distinct 
disorders.  
• Social phobia is now termed social anxiety disorder.  
• Separation anxiety disorder and selective mutism 
now fall under the umbrella term of anxiety 
disorders, where previously they were classified as 
disorders of early onset).  
Obsessive-compulsive and related disorders (Highlights of 
Changes, 2015). 
• Obsessive-compulsive and related disorders now 
include an additional four disorders, and they are: 
• Excoriation (skin-picking) disorder  
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• Hoarding disorder 
• Substance/medication-induced obsessive-
compulsive and related disorder. 
• Obsessive-compulsive and related disorder 
due to another medical condition.  
• Trichotillomania (hair-pulling disorder) is categorised 
as an obsessive-compulsive disorder, where it was 
classified as an impulse-control disorder in the DSM-
IV.  
• A new disorder, falling within the obsessive-
compulsive arena, is:  
• Body-focused repetitive behaviour disorder 
(such as nail biting, lip biting, and cheek 




Trauma and stressor-related disorders (Highlights of 
Changes, 2015). 
• Post-traumatic stress disorder (PTSD) is included in 
the new division: Trauma and Stressor-Related 
Disorders (Friedman, Resick, Bryant, Strain, 
Horowitz & Spiegel, 2011).  
• For the diagnosis of acute stress disorder and PTSD, 
specific emotional reactions were a requirement, but 
this has been eliminated (Friedman, Resick, Bryant & 
Brewin, 2011), so as not to exclude military, law 
enforcement and first responder staff, whose training 
prepared them to not react emotionally to traumatic 
events (Adler, Wright, Bliese, Eckford & Hoge, 
2008; Hathaway & Banks, 2010; Karam, Andrews, 
Bromet, Petukhova, Ruscio & Salamoun, 2010).  
• Two new trauma and stressor related disorders are: 
• Reactive attachment disorder  
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• Disinhibited social engagement disorder 
Somatic symptom and related disorders (Highlights of 
Changes, 2015; Diagnostic Ethics, 2015; DSM-5 Redefines 
Hypochondries, 2015; Pelletier, 2015). 
• Somatoform disorders are now termed somatic 
symptom and related disorders. 
• Patients that present with chronic pain can now be 
diagnosed with somatic symptom disorder (with 
predominant pain), or with an adjustment disorder. 
Feeding and eating disorders (A Guide to DSM-5: Binge 
Eating, 2013; Highlights of Changes, 2015). 
• Binge eating disorder is now a classified diagnosis. 
• Feeding disorder of infancy or early childhood is 




Sleep/wake disorders (Highlights of Changes, 2015). 
• Primary insomnia is now termed insomnia disorder, 
and narcolepsy is separate from other hyper-
somnolence.  
• Breathing-related sleep disorders include:  
• Obstructive sleep apnoea  
• Central sleep apnoea 
• Sleep-related hypoventilation  
• Circadian rhythm sleep–wake disorders are expanded 
to include: 
• Advanced sleep phase syndrome  
• Irregular sleep–wake type 
• Non-24-hour sleep–wake type  
• What was once ‘dyssomnia’ has been subdivided into 
two distinct disorders:  
• Rapid eye movement sleep behaviour disorder 
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• Restless legs syndrome  
Sexual dysfunctions (Highlights of Changes, 2015). 
• For females, sexual desire and arousal disorders are 
collectively termed female sexual interest/arousal 
disorder. 
• Genito-pelvic pain/penetration disorder is a new 
diagnosis.  
Gender Dysphoria (Gender Dysphoria in Adults, 2012; 
Highlights of Changes, 2015). 
• Gender identity disorder in DSM-IV is like, but not 
the same as, gender dysphoria in DSM-5, because 
separate criteria are now given for children, 
adolescents and adults. 
• Gender dysphoria is a stand-alone category and no 




Disruptive, impulse-control, and conduct disorders 
(Highlights of Changes, 2015). 
• Intermittent explosive disorder, pyromania, and 
kleptomania fall under the category of impulse-
control disorders.  
• Antisocial personality disorder is as a disruptive, 
impulse-control disorder.  
• Conduct disorder is listed as a personality disorder. 
• ADHD is listed as a neurodevelopmental disorder. 
Substance-related and addictive disorders (A Guide to 
DSM-5: Substance Use Disorder, 2013; Highlights of 
Changes: Psychological Subtype, 2013; Highlights of 
Changes, 2015). 
• Gambling disorder and tobacco use disorder are 
added to the disorders’ list.  
• Addictions and related disorders is a new category.  
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• Substance abuse and substance dependence are 
combined into specific substance use disorders. The 
Polysubstance dependence category is no longer 
accepted, and instead, the substance(s) must be 
specified. Substance dependencies include:  
o Alcohol dependence 
o Opioid dependence 
o Sedative, hypnotic, or anxiolytic dependence 
(including benzodiazepine dependence and 
barbiturate dependence) 
o Cocaine dependence 
o Cannabis dependence 
o Amphetamine dependence (or amphetamine-
like) 
o Hallucinogen dependence 
o Inhalant dependence 




o Other (or unknown) substance dependence 
o Nicotine dependence 
Neurocognitive disorders (A Guide to DSM-5: 
Neurocognitive Disorder, 2013; Highlights of Changes, 
2015). 
• Dementia and amnestic disorder are now termed 
major or mild neurocognitive disorder.  
Personality disorders (Personality Disorders, 2013; 
Highlights of Changes, 2015). 
• Personality disorder previously stood separate from 
the majority of disorders, but has been moved to a 
single axis, encompassing mental and other medical 
diagnoses.  
• Ten types of personality disorder are identified. Each 




• Cluster A (Odd, Bizarre, Eccentric): 
1. Paranoid personality disorder 
2. Schizoid personality disorder 
3. Schizotypal personality disorder 
• Cluster B (Dramatic, Erratic): 
1. Antisocial personality disorder 
2. Borderline personality disorder 
3. Histrionic personality disorder 
4. Narcissistic personality disorder 
• Cluster C (Anxious, fearful): 
1. Avoidant personality disorder 
2. Dependent personality disorder 
3. Obsessive-compulsive personality disorder 
Emerging diagnoses in the DSM-5 
The conditions listed below are not formally classified 
disorders, and are instead in the research phase, with the 
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potential for classification (American Psychiatric 
Association, 2013).  
• Attenuated psychosis syndrome 
• Depressive episodes with short-duration hypomania 
• Persistent complex bereavement disorder 
• Caffeine use disorder 
• Internet gaming disorder 
• Neurobehavioral disorder associated with prenatal 
alcohol exposure 
• Suicidal behaviour disorder 




An overview of mental health in South Africa 
Grobler1 classifies conditions with a biological basis, such as 
schizophrenia, as mental illness. A broader classification of 
mental disorders includes conditions that are not exclusively 
biological, such as alcohol and drug dependence. This 
classification is impactful when considering that from a 
mental health perspective, South Africa presents with high 
numbers of sufferers of mental disorders (when adopting the 
classification in the paragraph above) (Williams, Herman, 
Stein, Heeringa, Jackson & Moolmal, 2008).  
According to the Sunday Times (‘Sick State of Mental 
Health’ 06 July 2014), more than 17-million people in South 
Africa are sufferers of either depression, substance abuse, 
anxiety, bipolar mood disorder or schizophrenia, accounting 
for approximately one-third of South Africa’s 51.8-million 
population. 
 




The South African Stress and Health (SASH) Study of 2009 
(Herman, Stein, Seedat, Heeringa, Moomal & Williams, 
2009; Stein, Williams & Kessler, 2009) presents an overview 
of mental disorders in South Africa using a large 
representative sample size of 4 351 adults across the country. 
Conclusions show that the lifetime prevalence for any 
disorder was 30.3%. The most predominant twelve-month 
and lifetime disorders were anxiety-based disorders, with the 
highest rates occurring in the Western Cape. Furthermore, it 
was found that the most common disorder was alcohol abuse, 
at 11.4%. During the twelve months of the study period, a 
staggering one in six adults (16.5%) suffered from common 
mental disorders. A quarter of these cases were classified as 
serious, which translates to four out of every hundred South 
Africans. In addition, it was exposed that maternal mental 
disorders are significantly high in low socio-economic 
groups, with the pervasiveness of maternal depression 
ranging from an overwhelming 18% to 47% for antenatal 
depression (Manikkam & Burns, 2012; Rochat, Bland, 
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Tomlinson & Stein, 2013; Tsai, Tomlinson, Dewing, Le 
Roux, Harwood & Chopra, 2014;Brittain, Myer, Koen, 
Koopowitz, Donald & Barnett, 2015) and from 32% to 35% 
for postnatal depression (Cooper, Tomlinson, Swartz, 
Landman & Molteno, 2009). 
In South Africa, it is estimated that 4.5 to 5 million people, 
suffer from a mental disorder (Ngui, Khasakhala, Ndetei & 
Roberts, 2010). If alcohol and drug abuse are included, the 
number of sufferers’ spikes to a devastating 15 million 
people, ranking mental disorders as third in their contribution 
to the burden of disease, after HIV and AIDS and other 
infectious diseases (Bertozzi, Padian & Wegbreit, 2006).  
According to Dr David Bayever of South Africa’s Central 
Drug Authority (CDA), South Africa ranks among the top 
ten drug and alcohol abusers in the world. This shocking 
statistic is double that of the global average. According to 
him, at least 15% of South Africans have a drug problem and 
this number is expected to rise (Health24, 2017).  
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Bronwyn Meyers, chief specialist scientist in the alcohol and 
drug abuse unit of the South African Medical Research 
Council (MRC), states that 11% (5.7 million people) of the 
South African population have an addiction disorder 
(Health24, 2013). 
Furthermore, studies show extraordinarily high rates of 
traumatisation and post-traumatic stress disorder among the 
youth (Herman et al, 2009; Peltzer, Louw, Mchunu, Naidoo, 
Matseke & Tutshana, 2012). An estimated 20% of children 
suffer from a mental disorder because of exposure to levels 
of violence and domestic trauma, and approximately 10 000 
people commit suicide in South Africa per year, with most of 
these instances being young individuals (Stansfeld, Rothon, 
Das-Munshi, Mathews, Adams, Clark & Lund, 2017).  
Comparing South African suicide numbers against a global 
background, the 2015 WHO Global Health Estimates, 
calculated that 788 000 people died because of suicide (and 
many more than this number attempted suicide). Suicide 
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accounted for close to 1.5% of deaths worldwide, bringing it 
into the top 20 leading causes of death in 2015. Tragically, it 
was found that globally, suicide was the second leading 
cause of death among 15-29-year-olds in 2015, with 78% of 
global suicides occurred in low and middle-income countries 
(Brådvik, 2018). 
Millions of South Africans have a mental disorder diagnosis 
and yet, tragically, this area is grossly underfunded with only 
four percent of the National Budget apportioned towards 
mental healthcare. According to Williams, Herman, Stein, 
Heeringa, Jackson & Moolmal (2008), mental health 
concerns should be calculated at six-fold the cost of their 
relative treatments. The increase in budget allocations to 
public psychiatric hospitals is only 3.8% per annum, while to 
general hospitals is 10.2% per annum (Burns, 2010). It is 
deeply concerning that 75% of people who live with a mental 
disorder in South Africa do not receive adequate treatment 
(Lund, Breen, Flisher, Kakuma, Corrigall & Joska, 2010). Of 
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greater concern, is that since it is estimated that only 10 to 
15% of the global population with mental disorders seek 
help, the estimated number of South African mental illness 
sufferers must be even higher (Allen, Balfour, Bell & 
Marmot, 2014). 
The social and economic environment of a country shapes 
population mental health (Allen et al., 2014). and with over 
one fifth of the South African population living below the 
food poverty line, a Gini co-efficient of 0.65, South Africa 
has one of the highest rates of inequality globally (Statistics 
SA, 2014). This paints a very bleak mental health profile. 
The Mental Health and Poverty Project (MHaPP, 2019), 
found a strong correlation in South Africa, between poverty 
and mental disorders, because of factors such as elevated 
stress levels, inadequate housing, food insecurity and 
exposure to violence (Patel, 2001; Lund, et al., 2010). At the 
same time, people with mental disorders are vulnerable to 
sliding into poverty because of exclusion from social and 
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economic opportunities (Patel, 2001), the high cost and 
difficulty of accessing treatment, or the loss of employment 
because of diminished productivity (Saraceno, Levav & 
Kohn, 2005).  
In South Africa, mental disorders often co-occur with 
infectious diseases such as HIV and TB and non-
communicable diseases such as cardiovascular disease and 
diabetes (Boutayeb, 2006; Mayosi, Flisher, Lalloo, Sitas, 
Tollman & Bradshaw, 2009). Research reveals a high 
prevalence of mental disorders among people diagnosed with 
HIV and TB (Freeman, et al, 2008; Kagee & Martin, 2010; 
Peltzer et al, 2012). This is of relevance in South Africa, 
considering the pervasiveness of both TB and HIV (Karim, 
Churchyard, Karim & Lawn, 2009). 
The South African Mental Health Care Act (Government of 
South Africa, Mental Health Care Act, 2002) addresses 
mental health as a major public health issue, which must be 
consistent with international human rights standards. The Act 
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advocates the protection of the human rights of people with 
mental illness. The reality is that none of what is outlined in 
the Act has been actualised. To highlight this point, 53% of 
government hospitals are listed to provide 72-hour 
assessments of psychiatric emergencies (Lampros & Talias, 
2020). However, according to reports from the South African 
Depression and Anxiety Group (SADAG), these hospitals 
frequently do not have the capacity to provide the treatment 
required, with patients being admitted to general wards and 
even suicidal patients turned away because of space 
constraints.  
Allers (2012) cited an appallingly low figure of 320 
practising psychiatrists in South Africa, which translates to a 
ratio of 150 000 patients per psychiatrist. But, because a 
mere 15% of the population (Council for Medical Schemes, 
March 2019) belong to a medical aid scheme and with 200 of 
the 320 psychiatrists working in the private sector, this ratio 
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translates to 33 000 patients per private psychiatrist and 440 
000 patients per state psychiatrist. 
On the Essential Drug List for State medicines supply to 
state hospitals, low priority is given to psychiatric 
medication (Kar, Pradhan & Mohanta, 2010). This means 
that if medication for the treatment of psychiatric disorders is 
severely limited, the recovery of many patients becomes less 
likely. 
There is a significant inequality in mental health resources 
between provinces. Focusing on State hospitals, there is a 
single psychiatrist per 5 000 000 patients in the North West, 
compared to a single psychiatrist per 110 000 in the Western 
Cape. The number of beds in community residential 
facilities, range from zero in the North West and Northern 
Cape to 6.5 beds per 100 000 patients in Gauteng, showing 
the degree of under-sourcing. For many rural areas, in South 
Africa, there are no psychiatrists, even though, for example 
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1.5% of the rural population was treated for a mental illness 
in 2005 (De Kock & Pillay, 2017). 
There are 23 provincial mental hospitals, providing 18 beds 
per 100 000 patients. Of this, one percent are reserved for 
children and adolescents. Medical staff resources, dedicated 
to treatment in these mental hospitals are an untenable 0.28 
psychiatrists, 0.45 other medical doctors, 10.08 nurses, 0.32 
psychologists, 0.4 social workers, and 0.13 occupational 
therapists per 100 000 patients. There are 41 psychiatric 
inpatient units in general hospitals in South Africa with 2.8 
beds per 100 000 patients, with only 3.8% of these beds held 
in reserve for children and adolescents (Lund & Flisher, 
2002).  
It is important to provide this overview of the state of mental 
health services in South Africa, to highlight the severity of 
the lack of available resources for the overwhelming number 
of people desperately in need of adequate care and treatment.  
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Understanding that approximately 15% of the South African 
population belong to a Medical Aid Scheme (Council for 
Medical Schemes, March 2019), it is possible to: 
1. Extrapolate the findings within this database to 
establish a clearer picture of the South African 
mental illness landscape. Or 
2. Alternatively, using current mental illness 
statistics for South Africa, we can compare the 
mental health statistics in this dissertation (that 
represent private health care figures), against the 
general population and even global statistics.  
The cost of mental illness 
Mental disorders lead to considerable deterioration in health 
and functioning (National Collaborating Centre for Mental 
Health (UK), 2011). This deterioration can be extrapolated to 
the population level by multiplying the rate of occurrence of 
disorders by the average level of disability associated with 
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them. This calculation provides an estimate of Years Lived 
with Disability (YLD). YLD’s are added to Years of Life 
Lost (YLL) to calculate Disability-Adjusted Life Years 
(DALY’s). DALY’s are the measurement used to gauge the 
Global Burden of Disease (GBD) (Lopez, Mathers & Ezzati, 
2006; Disability Adjusted Life Years (DALYs), 2008; Vos, 
2010; Larson, 2013).  
In 2015, depressive disorders comprised a global total of 
over a confounding 50 million Years Lived with Disability 
(YLD) (Reddy, 2010). More than 80% of this non-fatal 
disease burden stemmed from in low and middle-income 
countries. Globally, depressive disorders rank as the single 
largest contributor to non-fatal health loss (7.5% of all Years 
Lived with Disability) (Lopez, Mathers & Ezzati, 2006; 
Reddy, 2010; Global Burden of Disease Study, 2013; Global 
Burden of Disease Collaborative Network (GBD), 2017).  
In 2015, anxiety disorders totalled a global figure of 24.6 
million YLD (Bandelow & Michaelis, 2015). Estimates are 
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lower for anxiety disorders compared to depression because 
these disorders are associated with a lower average level of 
disability (Bandelow & Michaelis, 2015). Anxiety disorders 
rank as the sixth largest contributor to non-fatal health loss 
globally and appear in the top 10 causes of YLD in all 
classified World Health Organisation regions (Whiteford, 
Ferrari, Degenhardt, Feigin & Vos, 2015; Rehm & Shield, 
2019). 
Mental disorders create a cascade of effects in terms of 
suffering, disability and mortality and are a major contributor 
to health and social care costs. Mental disorders result in a 
decline in economic productivity because of the inability to 
work, absenteeism or poor performance at work (Rajgopal, 
2010). Premature death from suicide or physical illness 
further contributes to a loss in productivity (Jenkins, 
Baingana, Ahmad, McDaid & Atun, 2011). For a dependent 
family, the loss of income from a breadwinner, diagnosed 
with a debilitating mental disorder, may (and easily) result in 
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a spiral into poverty (Knapp, Funk & Curran, 2006; Jenkins 
et al., 2011). 
A Kenyan based study (Kirigia & Sambo, 2003) estimated 
that the cost per patient hospitalised with mental disorders in 
1999 was US $2351. This value included the cost to family 
members at US $51 and productivity losses of US dollars. 
What is important is to look at these findings against the 
average income per head in Kenya. This gives a sense of the 
economic impact of mental illness. At the time of the study, 
the average income per head was a mere US $580 per 
annum, with more than 50% of the population surviving on 
less than US $1 per day (McDaid, Knapp & Raja, 2008).  
In a comparative study, in India (2005), the cost for an 
outpatient with schizophrenia was US $274. This amount 
included the cost of a loss of job opportunities for the patient. 
The cost also included the value of loans taken out to meet 
the cost of treatment (Grover, Avasthi & Chakrabarti, 2005).  
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A study in rural Ethiopia of 300 family caregivers concluded 
that these caregivers experienced financial difficulties, 
reduced work opportunities, tense family, and social 
relationships (Shibre, Kebede & Alem, 2003). A similar 
study in Zimbabwe of 66 caregivers reported that two-thirds 
experienced financial difficulties (Nyati & Sebit, 2002).  
The inadequate treatment of mental disorders results in 
intergenerational liability. Untreated disorders of childhood 
have the knock-on effect of affecting education, leading to 
unemployment and exacerbated illness in adulthood. The 
cycle then continues, with untreated adults negatively 
affecting the intellectual, physical and emotional 
development of their children creating an intergenerational 
cycle of disadvantage (Rutter & Quinton, 1984; Nyati & 
Sebit, 2002; Grover et al., 2005; McDaid et al., 2008).  
Child health intricately links to the health and wellbeing of 
the primary care giver. It has been found that if the child’s 
primary caregiver has a mental disorder, routine clinic visits 
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for immunisation will be missed, and the child’s health and 
nutritional needs will be negatively impacted (Rutter & 
Quinton, 1984). Depression among mothers significantly 
increases the risk for malnutrition in children (Patel, Rahman 
& Jacob, 2004). 
Many mental health disorders are chronic, and unless 
successfully treated, come with increased risk of physical co-
morbidities (Daré, Bruand & Gérard, 2019). There is scant 
data available in low and middle-income countries on the 
cost implications of physical co-morbidities, but Chisholm, 
Diehr & Knapp (2003), concluded that healthcare costs were 
between 17% and 46% higher for individuals who had co-
morbid depression and physical health problems.  
People diagnosed with mental illness, especially women, are 
more vulnerable to sexual abuse, putting them at higher risk 
for contracting and spreading HIV (Ciesla & Roberts, 2001; 
Des Jarlais, 2007; Altice, Kamarulzaman & Soriano, 2010). 
There is a correlation between the increased risk of co-
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morbid mental disorder and tuberculosis (Janmeja, Das & 
Bhargava, 2005; Prince, Patel & Saxena, 2007). It is 
therefore critical to initiate the early recognition and 
adequate treatment of mental disorders because this will 
improve the overall treatment outcome for HIV and 
tuberculosis (Ciesla & Roberts 2001; Janmeja et al., 2005; 
Prince et al., 2007).  
Another devastating correlation shows a high level of mental 
illness and learning disability in children affected by malaria, 
especially in Sub-Saharan African countries, where malaria 
is rife (Weiss, 1985; Amexo, Tolhurst & Barnish, 2004; 




Health Insurance and Medical Aid: Similarities and 
differences 
Health Insurance 
• The Long-Term Insurance Act regulates health 
insurance plans in South Africa. 
• Health insurance is aimed at providing for health 
costs (as is a medical aid scheme) but is also in place 
to protect the policyholder’s financial assets. 
• Health insurance covers various disabilities and 
accidental injuries. 
• Health insurance can be used to cover shortfalls in 
coverage of a regular medical aid scheme. 
• In the case of accidental injury or disability, health 
insurance can cover the salary of an individual, 
deemed unable to work. 
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• It is possible to consolidate a health insurance plan 
with a life insurance policy or funeral cover. 
• Health insurance pays the stated amount (benefits) 
directly to the policyholder (Institute of Medicine, 
2002; Kim, Lee, Yoo & Park, 2015). 
Medical Aid 
• The Council for Medical Schemes governs medical 
aid. 
• Medical aid pays out to the beneficiary (hospital or 
doctor), and not the policyholder. 
• Medical aid does not include accident, disability or 
cover for the loss of limbs. 
• Medical aid pays out according to the National 
Recommended Price List. 
• A medical aid scheme is not authorised to include 
death or funeral cover. 
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• A medical aid scheme is legally bound to the 
coverage of Prescribed Minimum Benefits (PMB) 
(Institute of Medicine, 2002; Kim et al., 2015).  
Medical aid schemes and support for mental illness 
Medical aid and health insurance schemes have affected the 
mental health arena considerably, to the point where Rappo 
(2002) views the current state as the management of health 
cost rather than health care.  
The current reality is that medical aid and health insurance 
providers determine access to and the delivery of health care 
services, as well as the regulation of reimbursement. The 
health insurance market in South Africa began developing in 
the mid-1980’s, and by 1989 there were approximately 50 
000 policies on offer, growing exponentially in the early 





Health insurance developed in response to spiralling health 
care costs and was modelled around consumers, medical and 
mental health professionals, hospitals, nursing homes and 
mental health organisations. The health insurance model 
centred on the feedback loop relationship between payers, 
providers and consumers so that services and their 
consequences are influenced and monitored (Cuffel, 
Snowden, Masland & Piccagli, 1996). 
Approximately 9 million people (one in six South Africans) 
are members of medical aid schemes (Gray & Vawda, 2018). 
The Medical Schemes Act of 1998 (Regulation 8) mandated 
Medical aid schemes to pay in full for the diagnosis and 
treatment of certain diseases. Regardless of the benefit 
option, any member has a guaranteed right to a minimum 
level of care, called prescribed minimum benefits (PMB’s). 
PMB’s were introduced to ensure that members of medical 
aid schemes would not run out of benefits for certain 
conditions and be forced to go to state hospitals for 
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treatment. In this way, PMB’s ensure continuous healthcare 
(Fish, Ramjee, Richards, Hongoro, Hoffman, & McLeod, 
2006). 
Prescribed minimum benefits cover 270 conditions (such as 
HIV, diabetes, epilepsy, various cancers, cardiac treatment 
and medical emergencies) and 27 chronic illnesses (such as 
schizophrenia, bipolar mood disorder and epilepsy).  
Medical aid schemes tag PMB’s as a major cost driver, and 
to this end, in September 2014, a case was submitted against 
the Minister of Health, arguing that he may determine the list 
of conditions that comprise the PMB’s, but he has no 
authority overregulating the scope of payment. Medical aid 
schemes argue that the open-ended costs for PMB conditions 
have forced them to increase their rates significantly because 
of the difficult managing expenditure on claims (Council for 
Medical Schemes, October 2019). 
If the court rules in favour of medical aid schemes, this 
means that schemes could lower the payment scope, 
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covering a much smaller proportion of the costs of PMB’s. 
This would leave patients under-covered and unable to afford 
to pay or co-pay for the treatment and medications required 
(McQuoid-Mason, 2011).  
Discovery Health Medical Aid Scheme is the largest medical 
aid scheme administrator in South Africa, with 2.8 million 
members. Discovery accounts for 56% of all beneficiaries in 
its sector and 31% of the overall market (Business Tech, 
2019). Discovery Health Medical Aid Scheme limits 
payment for 15 categories of health professionals, including 
psychologists. Psychologists fall under the ‘allied health 
benefits category’, a category that provides limited annual 
cover for art therapists, chiropractors, homeopaths, 
podiatrists, social workers and speech therapists (IFC, 2019). 
Because clinical psychology falls into the same category as 
art therapy (for example), the status of psychology is 
undermined. Bipolar mood disorder, for example, requires 
constant, long-term and intense management – management 
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that includes the expertise of a psychologist. That Discovery 
Medical Aid Scheme now limits payment to these medical 
professions translates to severely cutting access to mental-
health treatment. This is extremely serious, especially when 
viewed against the backdrop that The Medical Research 
Council estimates 15.8% of South Africans suffer from an 
anxiety disorder (Nel, Augustyn, Bartman, Koen, 
Liebenberg, Naudé & Joubert, 2018). 
There are opposing viewpoints around the value of managed 
health. Champions of managed health care see it as a realistic 
approach to cost control while sustaining quality health care 
(Cummings, Budman & Thomas, 1998). The main argument 
in support of managed healthcare is that cost containment 
drives lower insurance premiums (Johnsen, 1994). The 
reality though, is that as health care costs increase, so the 
number of constraints on reimbursement for mental health 
services increase (Austad, Hunter & Morgan, 1998; Bilynsky 
& Vernaglia, 1998; Cooper & Gottlieb, 2000). This amounts 
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to ever-diminishing access to services and where admission 
is granted, services are managed (Huff, 2000). 
A managed approach to mental health becomes particularly 
challenging when compensation is denied because of not 
honouring DSM codes (Kirk & Kutchins, 1988; Mead, 
Hohenshil, 1997; Glosoff, 1998; Murphy, DeBernardo & 
Shoemaker, 1998; Danzinger & Welfel, 2001). In some 
instances, when patients cannot afford to cover costs 
personally, therapists and patients may agree to submit an 
inaccurate mental disorder diagnosis that is reimbursable, so 
that patients can receive a measure of care. Wylie (1995) 
refers to this practice as “diagnosing for dollars.”  
Bipolar mood disorder, for instance, is eligible for PMB 
coverage, but other forms of depression are excluded. This 
means that some patients are falsely coded as having bipolar 
mood disorder to receive medical care. What this amounts to 
is discrimination against psychiatric patients, especially since 
depression is not listed as a prescribed minimum benefit 
 
72  
(Mbele, 2017).  
Certain DSM codes are denied medical aid reimbursement 
for various reasons. Two commonly used reasons are that 
medical necessity is regarded as not justifiable, or that 
benefits were exhausted. Medical aid schemes often deny 
benefits for adjustment disorders, for disorders requiring 
long-term counselling, and for diagnostic codes grouped 
exclusively to Axis II status (Glosoff, 1998).  
V-Codes assigned on Axis I are often denied when they are 
the primary focus of treatment. V-Codes are identified in the 
DSM-IV-TR (APA, 2000) under “Relational Problems” and 
“Other Conditions That May Be a Focus of Clinical 
Attention”. These include amongst others, problems related 
to physical and sexual abuse, bereavement and religious or 
spiritual problems (Murphy, DeBernardo & Shoemaker, 
1998). This is deeply concerning and short-sighted because 
the levels of distress associated with V-Code problems may 
be as severe as the distress experienced by Axis I disorders. 
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V-code problems can be more challenging than for example, 
generalised anxiety disorder (which is reimbursable) (Wylie, 
1995; Murphy et al., 1998).  
The majority of mental health counsellors admit that medical 
aid and health insurance requirements have a negative impact 
on their practices (Miller, 1996; Murphy et al., 1998; 
Danzinger & Welfel, 2001). Smith (1999) found that 6.6% of 
professional counsellors were very satisfied working within 
medical aid guidelines, 35.7% were somewhat satisfied and 
the majority (47%) were not satisfied.  
Managed health care has radically altered the counselling 
landscape (Stern, 1993; Cuffel, Snowden, Masland & 
Piccagli, 1996). Mental health benefits may be limited to 20 
sessions and brief therapy can be limited to as little as one to 
five sessions (Cuffel et al., 1996; Kiesler, 2000). This means 
that mental health workers battle to reconcile the demands of 
managed mental health care constraints and commitments to 
patients. This imbalance has created ethical and legal 
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dilemmas, a few of which are listed below (Acuff, Bennett, 
Bricklin, Canter, Knapp & Moldawsky, 1999; Glosoff, 
Garcia, Herlihy & Remley, 1999; Cooper & Gottlieb, 2000).  
1. Informed consent: Patients may not be aware of or be 
fully informed of their mental health benefits (Cooper 
& Gottlieb, 2000). 
2. Confidentiality: Before managed health care, patient-
doctor/counsellor confidentiality was sacrosanct 
(except in situations involving harm to self or to 
others, and in the event of court-mandated 
disclosure). Counsellors and doctors can no longer 
pledge non-disclosure because medical aid schemes 
can request patient information to determine 
treatment and reimbursement (Cooper & Gottlieb, 
2000; Danzinger & Welfel, 2001). 
3. Patient autonomy: Managed health care policies 
create limitations that reduce patient and counsellor 
autonomy in making decisions that are in the best 
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interest of the patient (Wineburgh, 1998; Meyers, 
1999; Danzinger & Welfel, 2001). 
4. Competence: Medical aid schemes advocate brief 
therapy models. Counsellors and psychologists may 
not be adequately trained in brief therapy techniques. 
This has the knock-on effect of not delivering 
treatments effectively (Cooper & Gottlieb, 2000). 
5. Treatment plans:  The first task of a managed care 
psychotherapist is to accommodate treatment to the 
parameters of the benefit package (Austad & Hoyt, as 
cited in Miller, 1996). Tragically, this translates to 
adhering to treatment plans that comply with medical 
aid payment policy, rather than patient need. 
6. Termination: Medical aid regulation dictates when 
counselling is to be terminated, where even requests 
for additional sessions are denied (Corcoran & 
Vandiver, as cited in Cooper & Gottlieb, 2000). Here 
again, is an example of the patient, not receiving the 
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care they require, because of the boundaries imposed 
by policy. The repercussions of this in the end are 
dire.  
Complying with medical aid policies present challenges for 
family counsellors who counsel from a family systems 
approach – an approach that focuses on managing strategies 
rather than pathology (Hawley, 2000). Family counsellors 
adopt the view that the family system is malfunctioning, and 
symptoms are manifestations of a dysfunctional whole and 
not just that of a single family member (Goldenberg & 
Goldenberg, 1996). This is why family counsellors can be 
ethically opposed to assigning an Axis I diagnosis other than 
V Codes because doing so inaccurately labels clients with 
the added stigma of mental illness (Brown & Bradley, 2002).  
The stigma attached to mental illness manifests in tangible 
ways, where, for example, certain mental illness diagnoses 
can result in denial, cancellation, or refusal to renew health, 
life, and/or vehicle insurance (Mental Health: A Report of 
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the Surgeon General—Executive Summary, 1999; Missouri 
Department of Labour and Industrial Relations, 2003; 
Barker, as cited in Strom, 1992). 
Inaccurate diagnoses create erroneous epidemiological trends 
over time. How reliable are mental health statistics when it is 
shown that counsellors, psychiatrists, social workers, 
therapists, and psychologists have intentionally 
misdiagnosed mental disorders? A case in point is the 
intentional misdiagnosis of depression or generalised anxiety 
disorder codes instead of a V-Code diagnosis (Davis, Sudlow 
& Hotopf, 2016). Intentional misdiagnosis creates data gaps 
around global mental health prevalence (Whiteford, Ferrari 
& Degenhardt, 2016; Davis et al., 2016; Ritchie & Roser, 
2019). 
The Code of Ethics of the American Mental Health 
Counsellors Association, Principle 1, Welfare of the 
Consumer, Item A.1 (AMHCA, 2000, p. 2), states, “the 
primary responsibility of counsellors is to respect the dignity 
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and to promote the welfare of clients.” Surely then 
counsellors/doctors/mental health workers violate this code 
when they intentionally misdiagnose a mental disorder for 
refund purposes? However, a counsellor will often 
intentionally misdiagnose to assist the patient because 
without a misdiagnosis that is refundable, the patient will not 
receive treatment or care (Pandit & Pandit, 2009). The 
question is then, are the counsellors or the medical aid 
schemes acting unethically? 
Mental health workers may interpret the rigidity of medical 
aid policy as a questioning of their professional authority by 
creating a polarisation between their professional 
commitment to their patients and their obligation to scheme 
policy (Grumet, 1989; Goold, Hofer, Zimmerman & 
Hayward, 1999). Manipulation of medical aid reimbursement 
policy falls under one of three strategies:  
1. Exaggerating the severity of conditions (Lo, 1995; 
Hilzenrath, 1998; Freeman, Rathore, Weinfurt, 
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Schulman & Sulmasy, 1999). 
2. Changing diagnoses (Matthew, Wynia, Cummins, 
Van Geest & Wilson, 2000) and/or  
3. Reporting signs or symptoms that did not present, to 
assist in securing coverage (Matthew et al., 2000). 
According to Matthew (JAMA, 2000), 39% of medical 
professionals admit to using these strategies, with 54% 
admitting to manipulation more often now, than 5 years ago. 
Manipulating managed health care is called ‘gaming the 
system’ for patients (Morreim, 1991), and can be interpreted 
as patient advocacy and even professional responsibility 
(Kalb, 1999; Nemes, 1993; Burda, 1993). 
The question at the root of this is whether health care be 
viewed as a market-based contractual model (Veatch, 1972), 
or a profession-based fiduciary model? A profession-based 
fiduciary model would see doctors striving to provide an 
equally high standard of care to all, regardless of what 
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patients can afford to pay (Eisenberg, 1986; Council on 
Ethical and Judicial affairs, JAMA, 1994; How Physician 
Organisations are responding to Managed Care, 1999).  
Prevalence rates of common mental disorders 
Valid and current estimates of the percentage of a general 
population affected by mental health disorders is critical for 
the:  
• Effective implementation of health policies.  
• Calculation of death and disability statistics.  
• Establishment of a clearer view of global occurrence.  
• Calculation of the distribution across low, middle to 
high-income countries. 
The most commonly occurring mental disorders are 
depression, anxiety, phobias and obsessive-compulsive 
disorders, psychosis (mainly schizophrenia and bipolar 
disorder), substance abuse (alcohol and drugs) and dementia 
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(mainly Alzheimer’s disease, vascular dementia and HIV-
related dementia) (National Collaborating Centre for Mental 
Health (UK), 2011). On a global scale, approximately 5 to 
15% of the population suffer from a common mental 
disorder and 0.5% from psychosis (Kessler & Ustun, 2001; 
WHO: World Mental Health Surveys, 2008). Learning 
difficulties are a common mental disorder, with incidences of 
severe mental retardation at approximately 3.5 per 1000 
people in prosperous countries and between 3 and 22 per 
1000 in disadvantaged countries (Institute of Medicine, 
2001). 
Certain common mental disorders are acute while others are 
chronic, with half lasting more than two years, unless 
effectively treated (Jenkins, Baingana, Ahmad, McDaid & 
Atun, 2011). Two-thirds of people with psychosis experience 
relapse or a deteriorating course of illness unless adequately 
treated (National Collaborating Centre for Mental Health 
(UK), 2011).  
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Neuropsychiatric disorders comprised 10.5% of the global 
burden of disease and extrapolated, this number could rise to 
15% by 2020 (World Bank, 1993). Currently, 
neuropsychiatric disorders make up 13% of the global 
burden of disease (WHO, 2015). It is predicted that 
neuropsychiatric disorders will be the leading cause of 
disability in high-income countries, second to HIV/AIDS in 
middle-income countries and third to HIV/AIDS and 
perinatal conditions in low-income countries (Mathers & 
Loncar, 2006). 
Progressive biological diseases of the brain (such as 
dementia) affect roughly 5% of people over 65, in several 
Asian and Latin American countries, while significantly 
lower rates of between 1 and 3% affect people in India and 
Sub-Saharan Africa (Kalaria, Maestre, Arizaga, Friedland, 
Galasko, Hall, Luchsinger, Ogunniyi, Perry, Potocnik, 
Prince, Stewart, Wimo, Zhang & Antuono, 2008). 
Worldwide, 47.5 million people have dementia, with the 
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illness becoming increasingly common in low and middle-
income countries because of the overall increase in life 
expectancy (Ferri, Prince & Brayne, 2005). In countries with 
high HIV-AIDS statistics, HIV-related dementia is a disease 
burden of concern. In high-income countries for example, 
HIV-related dementia affects up to 30% of people with late-
stage AIDS (Bell, 2004).  
Worldwide, in 2017, the number of people with depression 
exceeded 260 million, translating to an average of 4.4% of 
the global population (Ritchie & Roser, 2019) and ranging 
between 2 and 6% (Kleinman & Cohen, 1997). Overall, 
depression is more common among females (5.1%) than 
males (3.6%) (Albert, 2015). Depression is ranked by the 
World Health Organisation as the greatest global underwriter 
to disability (Malhi & Mann, 2018) and is the foremost 
contributor to suicide deaths, which are close to 800 000 per 
annum (Bachmann, 2018).  
The incidence of depression varies by region, from 2.6% 
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among males in the Western Pacific to 5.9% among females 
on the African continent (Kessler & Bromet, 2013). Sufferers 
of depression vary with age, with the highest incidence in 
later adulthood and although depression does occur in 
children, it is at a lower incidence (Fiske, Wetherell & Gatz, 
2009). 
The number of people diagnosed with depression increased 
by 18.4% between 2005 and 2015 (Lim, Tam, Lu, Ho, Zhang 
& Ho, 2018). According to Hidaka (2012), the increase in 
the global population over time, as well the accompanying 
increase in the age groups in which depression is more 
prevalent, could explain the escalation of depression 
numbers, but additional factors, such as the influence of 
pharmaceuticals and adverse environmental variables, should 
be considered. 
Anxiety disorders are a group of mental disorders 
characterised by feelings of anxiety and fear, including 
generalised anxiety disorder, panic disorder, phobias, social 
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anxiety disorder, obsessive-compulsive disorder and post-
traumatic stress disorder (Felman, 2018).  
The prevalence of anxiety disorders across the world varies 
from 2.5 to 7% (Remes, Brayne, Van der Linde & Lafortune, 
2016). Globally, in 2017, an estimated 284 million people 
experienced an anxiety disorder, making it the foremost 
mental disorder (Ritchie & Roser, 2019). 
Anxiety disorders are more common among females than 
males (4.6% compared to 2.6% respectively) (Jayashree, 
Mithra, Nair, Unnikrishnan & Pai, 2018), with the highest 
occurrence in the Americas (7.7% of the female and 3.6% of 





The global prognosis on treatment 
The prognosis for severe disorders such as psychosis follows 
three distinct trajectories where one-third of sufferers will 
experience a single psychotic episode and will recover fully, 
one-third will experience relapse if they do not continue 
preventative medication and in the final cohort, the illness 
deteriorates unless effective rehabilitation is received (Byrne, 
2007).  
From a global perspective, children with mental disorders 
(10% of the global population) can be effectively treated 
(Marquez & Saxena, 2016). Treatment for children is critical 
to allow sufferers the chance to attain education and to 
reduce the risk of progression into an adult disorder 
(Lieberman, Stroup & McEvoy, 2005; Bhattacharjee & El-
Sayeh, 2008; WHO: Integrating Mental Health into Primary 
Care, 2008; El-Sayeh & Morganti, 2009). The World Health 
Organisation (WHO) (2008) published best practice 
guidelines for integrating mental health into primary care, 
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which have been adapted in Kenya, Tanzania, Uganda and 
Malawi (Jenkins et al., 2010; Mbatia & Jenkins, 2010; 
Baingana, 2010).  
Cost-effective mental illness treatments for psychosis, 
depression and panic disorder are recognised worldwide, 
irrespective of how under resourced a country (Hyman, 
2006; Patel, 2007; Patel, Araya & Chatterjee, 2007). Up-to-
date antipsychotic medications and psychological 
interventions are not accessible in low-income countries 
(Saxena, Thornicroft & Knapp, 2007), however, in a 
resource-constrained country such as Nigeria, with 
schizophrenia, for example, the combination of older 
antipsychotic medicines and psychosocial treatment at 
community based level appears effective at a cost of $1,67 
per avoided DALY (Disability-Adjusted-Life-Year) 
(Chisholm, Gureje & Saldivia, 2008). Considering the 
constraints of developing countries, there is still much that 
can be done to instil effective mental health care at the 
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population level, at a cost of between $3 and $4 per capita 
per annum in Sub-Saharan Africa and Asia (Patel et al., 
2007).  
Access to medicines and treatments 
Depression can be treated effectively with psychological 
intervention, together with a range of medications, including 
low-cost older tricyclic antidepressants (InformedHealth, 
2017). The more modern medications that are available in 
developed countries and in private hospitals/clinics in 
developing countries are often easier to tolerate, but reviews 
do not show enhanced clinical outcomes (NICE, 2010; 
Mosadeghrad, 2014). Unfortunately, however, in developing 
countries, anxiety and depression are often treated with 
benzodiazepines and this is of great concern, because these 
are addictive and not beneficial in the treatment of the 
disorder (Bandelow, Michaelis & Wedekind, 2017).  
Antidepressants can be an effective form of treatment for 
moderate to severe depression but are not the first line of 
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treatment for cases of mild depression (Goldman, 2019), or 
for treating depression in children and adolescents (Driessen 
& Hollon, 2010). 
Mild and moderate depression and anxiety are treated 
effectively with behavioural therapies, but only with 
intensive management. Unfortunately, developing countries 
do not have enough trained specialists to provide this level of 
management against the number of sufferers (Gureje & 
Alem, 2000). On average a primary care centre of 10 000 
people will present with 100 patients with psychosis, 300 
with severe depression and 300 with epilepsy, of which at 
least half would require active rehabilitation (Jenkins et al., 
2011). 
Schizophrenia is a severe mental disorder, affecting about 21 
million people globally (McGrath, Saha, Chant & Welham, 
2008). Schizophrenia as a mental illness is particularly 
misunderstood and ignorance of the illness creates stigma 
and discrimination, resulting in a lack of access to health and 
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social services (Henderson, Evans-Lacko & Thornicroft, 
2013). Phenothiazine medication is given to treat acute 
episodes of psychosis, with these older medications proving 
to be highly cost-effective and widely available. Doctors and 
patients often prefer newer medications (with dissimilar drug 
profiles and side effects), but they are exponentially costlier 
(Patel et al., 2014). The newer medications do not show 
significantly improved outcomes (El-Sayeh & Morganti, 
2006; Bhattacharjee & El-Sayeh, 2008).  
Bipolar disorder affects about 60 million people worldwide 
(Charlson, Van Ommeren, Flaxman, Cornett, Whiteford & 
Saxena, 2019). The prevention of a relapse of bipolar 
disorder is managed with the use of lithium, but this requires 
the regular monitoring of drug levels in the blood and is 
therefore not available in primary care. What this translates 
to, is that rather than focusing on the provision of newer 
more costly medications, it would be of greater value in 
developing countries, to establish regular continuing 
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professional development (CPD) for primary and secondary 
care practitioners, to efficiently and effectively deliver 
existing medications and psychological therapies (Ranis, 
Stewart & Samman, 2005).  
Aims of Study 
The aim of this study is to show epidemiological trends in 
mental disorders against a background governed by health 
policy. It shows epidemiological trends in mental disorders 
of a private healthcare database compared against South 
African and global trends. This study examines possible 
contributing factors for the fluctuating nature of mental 
disorder frequencies. A factor underlying this study is the 
recognition that there are metamorphoses of mental disorders 
that may result in altered or overlapping symptoms. This 
overlapping/transformation of symptoms is the factor that 
inadvertently supports increasingly constrained medical aid 
policy. Altered, overlapping or even symptoms that may no 
longer present can be understood against a background 
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relating to the concept of a paradigm and the form it takes in 
psychology. 
Rationale 
Mental disorders can be difficult to diagnose (Wakefield, 
2007). The reason for this is that disorders often present with 
concurrent symptoms (Salloum & Thase, 2000). Medical 
practitioners diagnose symptoms as belonging to one or 
another psychopathology, but because of concurrency, 
misdiagnosis may be likely. The diagnoses of disorders are, 
in part, determined by social, economic and other 
circumstances rather than being exclusively clinical (Epstein 
& Ayanian, 2001). Highlighting these circumstances, 
together with trend analyses of mental disorders, can add 
value to the formulation of clinical policy guidelines in the 
private health care arena. It is of value to create a much-
needed awareness of the impact and prevalence of mental 












Chapter 2: Methodology 
Aims of the study revisited 
The aim of this study is to show epidemiological trends in 
mental disorders against a background governed by health 
policy. It shows epidemiological trends in mental disorders 
of a private healthcare database compared against South 
African and global trends. This study examines possible 
contributing factors for the fluctuating nature of mental 
disorder frequencies. A factor underlying this study is the 
recognition that there are metamorphoses of mental disorders 
that may result in altered or overlapping symptoms. This 
overlapping/transformation of symptoms is the factor that 
inadvertently supports increasingly constrained medical aid 
policy. Altered, overlapping or even symptoms that may no 
longer present can be understood against a background 






1. Are there changes in prevalence rates of mental 
disorders over time? 
2. If there are changes in prevalence rates of mental 
disorders over time, what are the values of these 
trends? 
3. Are there additional epidemiological trends 
apparent when examining mental disorders over 
time? 
4. Can these trends be attributed to an economic 
factor?  
5. Assuming the conclusion of an economic factor 
influencing mental health statistics, what is the 





Data source: Discovery Health Medical Aid Scheme 
Discovery Health Medical Aid Scheme has been in operation 
for almost three decades, with its inception in 1992 
(Discovery Integrated Annual Report, 2018). This degree of 
longevity allows for a reliable longitudinal analysis of 
diagnostic trends. Discovery Health Medical Aid Scheme 
covers 2.7 million beneficiaries as of the end of 2016 and is 
the largest open medical scheme in South Africa, with a 
market share of 56.6% of the open market (Discovery 
Integrated Annual Report, 2018). The Scheme is a non-profit 
entity governed by the Medical Schemes Act 131 of 1998 
and is regulated by the Council for Medical Schemes (CMS). 
Through consent of the Scheme, a database was provided, 
which lists mental disorder diagnoses over seven years from 
2008 to mid-way through 2015. Data from this data source 
was analysed, interpreted and graphically presented.  
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The data source will remain anonymous in any publications 
to follow from the dissertation. A contractual agreement to 
this end has been secured. 
Research design 
This study on the rise and fall of psychopathologies is an 
epidemiological study. Epidemiological research subscribes 
to several research designs, the choice of design is dependent 
on the nature of the data, its collection, and the hypothesis 
put forward. This section focuses on the research design, 
principles and reasons behind the design selection.  
John Last (1988) defined epidemiology as the study of the 
distribution and determinants of health-related states or 
events in specified populations, and the application of this 
study to the control of health problems. This study focuses 
on the distribution and possible determinants of mental 
health related states in a specified population. The population 
in this instance is the total population of a medical aid 
scheme database from 2008 and 2015. 
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This epidemiological study falls under the bracket of what 
London Health Observatory (2006) considers Public Health 
Intelligence. Public Health intelligence is the utilisation of 
population data which has been analysed, interpreted and 
presented in clear and accessible form, to inform proposed 
improvements to health services (London Health 
Observatory, 2006). This informative function aligns with 
the shift towards evidence-based practice in Public Health 
(Killoran & Kelly, 2009). Most of the variables in the study 
are nominal with binary categories like male or female, in-or 
outpatient, so ratios, rates, and proportions are applied 
because they best suit the analysis of dichotomous variables 
(Etikan, Abubakar & Alkassim, 2017). 
The role of a theoretical framework, whether overt or 
implied, shapes what we see, or do not see and what we 
consider relevant or irrelevant. While there are frameworks 
informing research in social epidemiology, literature 
articulating theoretical frameworks in descriptive 
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epidemiology are sparse. To this end, no formal framework 
was adopted, and the analysis of the data was approached 
without ambiguity. This was able to be done because of the 
binary nature of the data (Stallones, 1980; Krieger, 1994; 
Krieger & Zierler, 1995; Schwartz, Susser, & Susser, 1999). 
Primary principles of epidemiology 
The Centers for Disease Control (CDC, 2017) deconstruct 
Last’s (1988) definition of epidemiology to expose the 
primary principles of epidemiology. These are: 
1. Study: Assuming the scientific method of inquiry at 
its foundation, the epidemiological methods adopted 
for this study, include:  
a. Descriptive studies (investigating distribution) 
and,  
b. Analytical studies (investigating 
determinants) (WHO: Epidemiology, 2017). 
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2. Distribution: The principle of distribution is 
subdivided into the following concepts:  
a. Frequency: The number of health events in a 
population.  
b. Prevalence: For this study, prevalence 
measures the incidence of occurrence of a 
mental disorder in the database population 
over a period (including all data between two 
dates). Prevalence calculations are based on 
annual as well as monthly incidences of 
disorders.  
c. Incidence: The principle of incidence for this 
study reveals how patterns of disorders 
fluctuate over time and are then extrapolated 
to predict future patterns.  
i. Incidence is often confused with 
prevalence. Importantly, prevalence is 
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the proportion of cases in the overall 
population at a given time, whereas 
incidence is the pattern that forecasts 
the rate of occurrence of new cases. In 
summary then, incidence predicts the 
chance of suffering from a specific 
mental disorder, whereas prevalence 
shows how widespread the disorder is 
(Shields & Twycross, 2003). 
d. Determinants: The causes and other factors 
that influence the occurrence of a mental 
disorder. 
e. Specified population: Observations are often 
deduced from a study sample, which is 
selected from the target population (BMJ: 
Epidemiology, 2017). For this study, a study 
sample was not selected, but instead, the total 
target dataset was analysed.  
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Adopted research design 
In epidemiology, research designs range from solely 
quantitative to exclusively qualitative. Quantitative designs 
are either descriptive or analytic. The quantitative model 
adopted for this study embraces both descriptive and analytic 
techniques. The descriptive model concerns the ‘who, what, 
where and when’ of the occurrence of specified disorders 
and the analytical epidemiological model concerns the ‘who, 
what, where, when and why.’ Figure 1 below, summaries the 
quantitative model checklist (‘The five W’s’). The five W’s 
can be applied when considering any health condition in a 
population, where descriptive epidemiology highlights 
patterns of a disorder, followed by analytical epidemiology 
that is applied to propose the cause of that trend (Bhopal, 
2008). Figure 2 is a schema of the research design for this 
study and shows how the quantitative model utilised, is 
subdivided into two approaches:  
1. Descriptive epidemiology and  
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2. Analytical epidemiology.  
Each approach has its own techniques. Descriptive 
epidemiological techniques are applied to deduce patterns in 
the dataset, and from those patterns to infer a possible cause 
or possible causes (analytical epidemiological techniques). 
The sum of pattern and cause is what delivers the resultant 


























Patterns Cause  
Descriptive Techniques Analytical Techniques 
Results 
Analytical Epidemiology  
Figure 2: Schema of research design (Mesly, 2015). 
 
106  
Epidemiological study design within the quantitative model 
This study on fluctuation patterns of specified mental disorders, over a specified timeframe, 
is descriptive in approach. Since it is descriptive data, the selected approach for this study is 
described below: 
Quantitative data analysis  
Quantitative data analysis in epidemiology searches for illness patterns, organises, and 
analyses data to view variations in illness frequency over time (Ressing, Blettner & Klug, 
2010). This allows for the identification of illness trends, which enables concluding on 
possible explanations about the determinants of the viewed frequencies. In searching for 
patterns, pattern-indicators may be:  
a) Differences: If the frequency of a disorder differs across time.  
b) Similarities: If a high or low frequency of a disorder is found across time. 
c) Correlations: If the frequency of a disorder varies in relation to another disorder. 
Quantitative data analysis means transforming raw numbers into meaningful data through the 
application of rational and critical thinking, secondary data integrated in a logical and 
unbiased manner (Saunders, Lewis & Thornhill, 2012). Quantitative data analysis, for this 
study, includes the calculation of frequencies of variables and differences between variables. 
The aim of the quantitative approach is to find evidence that support or rejects the research 
questions of this study.  
The level of measurement associated with this dataset is nominal data. Nominal data is basic 
classification data and there is no order associated with fields in the dataset. For example, 
male patient numbers and female patient numbers are not placed in any order. 
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Quantitative methods emphasise objective measurements and the statistical and numerical 
analysis of data, with the aim of explaining a phenomenon, validating a hypothesis or 
answering a question. To validate, explain or answer effectively, the evidence obtained needs 
to be logically and unambiguously addressed (Robson, 2011). For this study, to uncover the 
narrative of the data, frequency distributions have been the primary approach.  
Secondary data 
A common source of secondary data used for quantitative research is administrative data. 
This study makes use of administrative data from the Discovery Health Medical Aid Scheme. 
This secondary data allows for investigation of the frequencies of mental disorders within the 
entire population of medical aid members. It is also considered secondary data because 
Discovery Health Medical Aid Scheme collected the data for purposes other than this study.  
Presenting epidemiological outputs 
The descriptive epidemiological outputs are presented graphically. Disorder charts, that 
reflect trends over time, is the technique used to illustrate changes of frequencies of 
diagnoses over time. This technique is also optimum for highlighting inequalities according 
to gender. Polynomial curves plot new the potential frequencies of specific disorders over 
time.  
After completion of the descriptive component of the quantitative approach, the analytical 
epidemiological facet, considers possible factors causing the frequency patterns for the 
various disorders (Bonita, Beaglehole & Kjellström, 2006). This means, investigating which 
factors can contribute to an increase or decrease in the volume of diagnoses. It is important to 
establish whether a factor is simply associated with the disorder pattern or whether it is 
causing it.  
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This study applied descriptive statistics in the interpretation of the dataset. Compared with the 
logic of inferential statistics, most descriptive statistics are intuitive compared to the more 
intricate rationale for statistical inference (probability theory, sampling theory, etc.) (Brown, 
2012). Descriptive statistical methods are fundamental since inferential methods are 
conceptually dependent on them (Ott & Longnecker, 2001). 
The use of graphics is an optimum tool for descriptive statistics. Descriptive data becomes 
significantly more informative through an aptly presented graphic. The work of Tufte (2001) 
is renowned for examples of best practices in the visual display of quantitative information.  
Graphical displays, such as bar charts (in this study) are a critical tool in the exploratory 
phase of data analysis. Interestingly, evidence has shown that the use of graphs in research in 
psychology and across other disciplines correlates highly with the ‘hardness’ of those 
scientific fields. An inverse relationship is found between hardness of certain sub-disciplines 
of psychology and the use of inferential statistics, indicating inferential methods are perhaps 
used in an attempt to deal with inadequate data (Smith, Best, Stubbs, Archibald & Roberson-
Nay, 2002). 
For this study, bar charts represent the frequency distribution of each disorder within the 
dataset. Classes (time/disorder/gender) are displayed on the horizontal axis and the 
frequencies/relative frequencies of the class on the vertical axis. Frequency is defined as the 
number of patients that fall in a specified class. The height of a bar indicates how common a 
particular value is in the distribution (the bar height is equal to the number of patients 
occurring within a defined class in the dataset). Relative frequency is measured in this study 
and is the ratio of the frequency of a class to the total population size/relative to another class 
and is the proportion or percentage of patients that fall into a class. 
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Linear regression analysis 
In Section I: Longitudinal Data, the disorder charts show a summary of the total number of 
patients diagnosed with each diagnosis per year (2008 – 2015). The diagnosis trend for each 
of these charts shows the overall frequency pattern of the disorder over time, with the forecast 
extension showing a prediction of frequency going forward. 
A linear approach to modelling the trend line is adopted. Linear regression is a well-suited 
approach, especially when prediction is the aim of the analysis. Despite the term ‘linear 
model,’ curvature can be modelled using a polynomial (Shields & Rangarajan, 2013). 
The line of best fit selected for the trend line charts in Section I is the polynomial trend line. 
This quadratic curved line is best suited to data that fluctuates (curves) and is more typical in 
real-world data (representative of the study database). The linear model with the quadratic 
approach, delivers solid predictions (Shields & Rangarajan, 2013; Kumar & Shanker, 2017). 
The bar charts are reflective of a continuous dependent variable, making linear regression the 
ideal approach. The continuous variable (y-axis) is the number of patients in a specific year, 
diagnosed with a specific disorder. The variable is dependent because the value is dependent 
on the data bound by a specific year. The variable is continuous because it can theoretically 
take on any value between its minimum value (no medical aid patients) and its maximum 
value (total number of medical aid patients in a given year). 
Although the continuous variable is subdivided into patient numbers per year for the disorder 
charts, it can be viewed as a single continuous variable since it is really the sampling of a 
specific disorder in various years. Therefore, it is most suited to test for linearity when using 
a single variable. 
Linear regression calculates an equation that minimises the distance between the fitted 
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(curved) line and the data points. A good fit is if the differences between the data values and 
the linear model's predicted values are small. R-squared (coefficient of determination) is the 
statistical measure of how close the data are to the fitted regression line (Lewis-Beck, 
Bryman & Futing Liao, 2004; Schneider, Hommel, & Blettner, 2010). R-squared is always 
between 0 and 100% with 0% indicating no commonality between actual values and fitted 
values, and 100% indicating perfect mirroring of actual and fitted values (Lewis-Beck et al., 
2004; Schneider et al., 2010). Therefore, the higher the R-squared, the better the model fits 
the data. Refer, below, to Table 1: R-squared values, showing goodness of fit for disorder 
trend charts. From the table, the R2 values for each disorder trend chart approach 1, giving 
confidence in the forecast for the disorder going forward, since the fit between actual and 
fitted values is very closely aligned (Lewis-Beck et al., 2004; Schneider et al., 2010; Shields 
& Rangarajan, 2013; Kumar & Shanker, 2017). 
Correlation 
Tables A5 and A6 (tables showing degrees of correlation between mental disorders), display 
the degree of strength (correlation) between disorders. A correlation coefficient measuring 
the strength of relationships between the mental disorders investigated in this study was 
calculated. Applying correlation to this study was suitable, knowing that correlation is suited 
to quantifiable data (Cheung & Chan, 2004). The quantity in this case being the number of 
patients diagnosed with specific mental disorders. 
From tables A5 and A6, in terms of the strength of relationships, the values of the correlation 
coefficients vary between 1 and 0. The value of 1 indicates a perfect degree of association, 
and so that is seen next to the disorder itself, since a disorder can only have a perfect 
correlation with itself. Thereafter, the closer the value is to 1, the greater any two disorders 
are associated, and as the correlation coefficient value goes towards 0, the relationship 
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between disorders will be weaker. The correlation coefficient results are all positive values, 
indicating positive relationships between disorders (Munshi, 2012). This and the nature of the 
relationships is discussed in Chapter 4: Discussion. 
For this study, Spearman’s correlation coefficient is selected over Pearson Correlation 
Coefficient, because unlike Pearson’s correlation, there is no requirement of normality, since 
Spearman’s correlation coefficient does not carry any assumptions about the distribution of 
the data (Coffman, Maydeu-Olivares & Arnau, 2008). 
For this study, the free and open-source software R was employed for the statistical analysis. 
R was selected because it is designed specifically for statistical computing and graphics. R 
provides an adaptable analysis toolkit housing all standard statistical techniques (R Core 





R-squared values, showing goodness of fit for disorder trend charts  
Mental Disorder R2 Value 
Abuse, dependence/overdose of opioid 0.8599 
Alcoholism 0.9602 
Anxiety disorder 0.9800 
Attention deficit and hyperactivity disorder 0.9997 
Behavioural disorder 0.9866 
Bipolar mood disorder 0.9999 
Delusional disorder 0.6489 
Depression 0.9999 
Developmental and learning disorder 0.9742 
Dissociative disorder 0.8966 
Eating disorder 0.9379 
Impulse control disorder 0.8915 
Mental retardation 0.9407 
Non-specific neuroses 0.9198 
Non-specific psychosis 0.9790 
Obsessive compulsive disorder 0.9454 
Parasomnia or sleep disorder 0.9998 
Personality disorder 0.8532 
Psychosis due to a general medical disorder 0.9748 
Psycho-social disorder of childhood 0.7297 
Schizophrenia 0.9344 
Sexual and gender identity disorder 0.9985 
Somatoform disorder 0.9171 
Substance abuse or dependence behaviour 0.9522 
Tic disorder 0.8531 
Unconfirmed psychology disorder 0.9830 




Quantitative research approach for this study 
Data fields made use of in this study, from the raw medical scheme database are: 
1. Date of admission (Year, Month) 
2. Patient gender 
3. Database population size per year 
4. Patient diagnosis (DEG Description)  
5. Sample total per DEG Description 
Data fields not used (not provided in raw data) in the data analysis of this study include: 
1. Patient details 
2. Patient age 
3. Contact details  
4. Personal notes  
5. Race 
What is key, from an analytics perspective, is the mental illness diagnosis recorded per 
patient admission.  
Each diagnosis (mental disorder) is presented in the following ways: 
9. Bar charts showing the volume of specific mental illnesses in a given year. The x-
axis listing mental disorders and the y-axis indicating the volume (number of 
patients diagnosed) within each disorder.  
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10. Bar charts showing fluctuations of occurrence of a specific mental illness over 
time. (Graph per mental disorder). For each, the x-axis indicates time in years and 
the y-axis indicates the volume (number of patients) in any given year.  
11. Frequency of specific mental illnesses over time, relative to the entire database 
population. (Graph per mental illness). The x-axis indicating the year (2008 – 
2015) and the y-axis showing the total volume database. 
12. Male:Female ratio per mental disorder. This is represented as pie charts per mental 
illness, as a sum of male and female numbers from 2008 – 2015. 
13. Female Outpatient vs. Inpatient volumes across each mental disorder and across 
all years (2008 – 2015).  
14. Male Outpatient vs. Inpatient volumes across each mental disorder and across all 
years (2008 – 2015). 
15. Total number of patients per mental disorder across time (2008 – 2015). 
16. Summary trends:  
a. Frequency polygons showing the fluctuation of a selected mental disorder 
over time as compared to other selected mental disorders. The x-axis 
indicates time in years and the y-axis indicates numbers of patients. The 
graph legend shows which mental disorders are represented.  
b. Emergent epidemiological trends require investigation. Is, for example, a 
‘spike’ in the volume of admissions of a specific mental disorder relative 
to other mental disorders indicative of an economic factor?
 
115  
List of mental disorders analysed for 
this study: 
1. Abuse, dependence, overdose of opioid 
2. Alcoholism 
3. Anxiety disorder 
4. Attention deficit and hyperactivity 
disorder 
5. Behavioural disorder 
6. Bipolar mood disorder 
7. Delusional disorder 
8. Depression 
9. Developmental and learning disorder 
10. Dissociative disorder 
11. Eating disorder 
12. Impulse control disorder 
13. Mental retardation 
14. Non-specific neuroses 
15. Non-specific psychoses 
16. Obsessive compulsive disorder 
17. Parasomnia or sleep disorder 
18. Personality disorder 
19. Psychosis due to a general medical 
disorder 
20. Psycho-social disorder of childhood 
21. Schizophrenia 
22. Sexual and gender identity disorder 
23. Somatoform disorder 
24. Substance abuse or dependence behaviour 
25. Tic disorder 
26. Unconfirmed psychology disorder 




Hallmarks of quantitative research 





Precision refers to a lack of random variation in a study's estimates (Rothman & Greenland, 
1998). Random variation arises from the subjects in the study, the way in which subjects are 
sampled, and the way in which variables are measured (Rothman & Greenland, 1998). In this 
study, the way in which the data are captured, is reliant on the diagnoses of the attending 
doctors. The research questions put forward in this study raise this point: to what degree are the 
mental disorder frequencies observed in the original data, the result of random variation? What 
is meant by this question is to what extent are the characteristics that define specific illnesses, 
different from the variables that are used in the medical scheme policy? Should they not be 
similar, then, the raw data from the medical aid scheme lacks precision, when viewed against 
the defining characteristics of specific illnesses. 
To evaluate the level of precision, the sample size needs to be considered, since according to 
Rothman & Greenland (1998), a larger study will produce estimates that are more precise. For 
this study, the sample size is the population size, since the entire database from 2008 – 2015 




global trends, the random variation is not due to the small sample size, but rather to the way in 
which subjects are sampled, and the way in which variables are measured. 
Random error is the result of fluctuations around a true value and is just that: random. Random 
error can take place during data collection or analysis for example. In this study, random error 
would be a typographical error during data capture on the original sheet. It is impossible to 
correct for random error, but to reduce it, is to increase the sample size of the study. Making use 
of the entire medical scheme population during 2008 – 2015, and filtering for mental disorder 
totals, means sample sizes are at their maximum.  
Validity 
Descriptive research is gauged in terms of both its internal and external validity. Internal 
validity refers to the strength of the inferences from the study and external validity is the ability 
to generalise study results to a global population (Mickenautsch, 2010; Rothman & Greenland, 
1998). Internal validity is, therefore, a precondition for external validity.  
An indication that a study lacks external validity is if the internal inferences are not 
representative of external findings. When applying the definitions of internal and external 
validity to this study, it is imperative that the inferences drawn from the raw data is strongly 
validated. By this, the numerical assessment of patient numbers for disorders across time and 
within the context of the entire medical scheme population must be aligned to the evidence. A 
test for this would be a perfect repetition of the numerical analysis by another researcher. This 




Based on the definitions of external and internal validity above, it is concluded, that if the 
internal analysis is validated, then the results should align to external trends (external 
validation). The aim of this study is to ensure internal validation, and then to compare the 
results to external disorder trends. If the internal results do not align to the external disorder 
trends, explanations for this are presented. For this study, there is the underlying question that 
the internal and external findings do not correlate. 
Confirmability 
Lincoln and Guba (1985) and Attride-Stirling (2001) suggest that a researcher leave a trail of 
work done that can be traced back to source. This means that analysis performed on raw data 
can be replicated, and in replication, credibility is added to the conclusion. The audit trail is 
then the raw data (Discovery Health Medical Aid Scheme data [available on request]), the 
products (charts and tables) of the data analysis, data forecasts and interpretations. 
Ethical Consideration 
Standard of Privacy and Confidentiality 
1. The scope of requested records is restricted to that which is consistent with the 
purposes of the study. This means no personally identifying data of patients was 
obtained. Identifying data includes patient name, contact information or any 
additional data fields that may lead to the identification of that patient. The scope of 
the data requested is limited to patient gender, admission date, in-or-out patient and 




2. The nature of this study precludes obtaining patient details and therefore by default, 
informed consent from patients was not required.  
3. Specific approval for the release of requested data was obtained from the Health 
Medical Scheme authorities concerned. 
4.  The data source will remain anonymous in any publications to follow from the 
dissertation.  
5.  A contractual agreement to this end (Point 4 above) was signed before proceeding 
with the study.  
Ethical principle of Research Integrity 
1. The researcher pledges honesty and accuracy in conveying research conclusions, 
discussion and research findings, and in acknowledging the potential limitations of 
the study.  
2. The researcher pledges to claim only appropriate ownership or credit for her 
research, published writings, or other scientific contributions. 
3.  The researcher explicitly states that the research study was approved by the 
















Chapter 3: Results 
Section I: Longitudinal Database: 2008 – 2015 
 
Abuse, Dependence, Overdose of Opioids 
Table LD1 and Chart LD1, summarise the total number of patients diagnosed with abuse, 
dependence and/or overdose of opioid per year (from 2008 – 2015). The total number of 
diagnoses per year are shown against the total database population per year.  
Chart LD21: Longitudinal Data (2008 – 2015): Abuse/Dependence, Overdose of Opioids 
 
 




Table LD1  
Longitudinal Data (2008 – 2015): Abuse/Dependence, Overdose of Opioids 
Diagnosis Year Total Patients Total DP 
Abuse, dependence, overdose of 
opioids 
2008 253 2092183 
Abuse, dependence, overdose of 
opioids 
2009 234 2192129 
Abuse, dependence, overdose of 
opioids 
2010 328 2434220 
Abuse, dependence, overdose of 
opioids 
2011 342 2581043 
Abuse, dependence, overdose of 
opioids 
2012 388 2711594 
Abuse, dependence, overdose of 
opioids 
2013 407 2822416 
Abuse, dependence, overdose of 
opioids 
2014 375 2923433 
Abuse, dependence, overdose of 
opioids 
2015 239 2984103 
The results are as follows: 
a. 2008 
In 2008, 253 patients were diagnosed as suffering from abuse, dependence and or an overdose 
of opioids. This is the total number of diagnoses, includes both male and female patients. The 
ratio of male to female patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Abuse/dependence/overdose of opioids as a diagnosis is one 
of 27 mental illness disorders, as classified for this specific database. Refer to Table X for a 
summary of disorders specified in this dataset.  




translates to 0.012% of the total claimant population for 2008.  
b. 2009  
In 2009, 234 patients were diagnosed as suffering from abuse, dependence and or an overdose 
of opioids. This value is 19 less patients than in 2008 and translates to a 7.5% decrease in 
diagnosis of abuse/dependency and or overdose of opioids, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year.  
234 out of 2 192 129 patients diagnosed with abuse, dependence and or overdose of opioids, 
translates to 0.011% of the total claimant population.  
c. 2010 
In 2010, 328 patients were diagnosed as suffering from abuse, dependence and or an overdose 
of opioids. This value is 94 more patients than in 2009 and translates to a 28.7% increase in 
diagnosis of abuse/dependency and or overdose of opioids, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
328 out of 2 434 220 patients diagnosed with abuse, dependence and or overdose of opioids, 
translates to 0.013% of the total claimant population.  
d. 2011 




of opioids. This value is 14 more patients than in 2010 and translates to a 4.1% increase in 
diagnosis of abuse/dependency and or overdose of opioids, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
342 out of 2 581 043 patients diagnosed with abuse, dependence and or overdose of opioids, 
translates to 0.013% of the total claimant population.  
e. 2012 
In 2012, 388 patients were diagnosed as suffering from abuse, dependence and or an overdose 
of opioids. This value is 46 more patients than in 2011 and translates to an 11.9% increase in 
diagnosis of abuse/dependency and or overdose of opioids, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
388 out of 2 711 594 patients diagnosed with abuse, dependence and or overdose of opioids, 
translates to 0.014% of the total claimant population.  
f. 2013 
In 2013, 407 patients were diagnosed as suffering from abuse, dependence and or an overdose 
of opioids. This value is 19 more patients than in 2012 and translates to a 4.7% increase in 
diagnosis of abuse/dependency and or overdose of opioids, when compared to 2012.  




in 2012 and translates to a 3.9% growth in claimant population in one year. 
407 out of 2 822 416 patients diagnosed with abuse, dependence and or overdose of opioids, 
translates to 0.014% of the total claimant population.  
g. 2014 
In 2014, 375 patients were diagnosed as suffering from abuse, dependence and or an overdose 
of opioids. This value is 32 less patients than in 2013 and translates to a 7.9% decrease in 
diagnosis of abuse/dependency and or overdose of opioids, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
375 out of 2 923 433 patients diagnosed with abuse, dependence and or overdose of opioids, 
translates to 0.013% of the total claimant population.  
h. 2015 
From January to June of 2015, 239 patients were diagnosed as suffering from abuse, 
dependence and or an overdose of opioids. By mid-year 2014, the number of patients is 214 
(according to Table: Database_2008_2015_Abuse Dependence). By June 2015, 25 more 
patients are recorded when compared to the half-year sum for 2014. This translates to a 10.5% 
increase in patient diagnosis. Therefore the 10.5% increase is extrapolated for the remaining 
(unrecorded) subsequent 6 months, to give an estimated patient number of 414 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 




population of 3 031 600. This is 108 167 more claimants than in 2014. 
414 out of 3 031 600 patients diagnosed with abuse, dependence and or overdose of opioids, 
translates to 0.014% of the total claimant population.  
Table LD2 
Results summary: Abuse, Dependence, Overdose of Opioids 
Year Diagnosis % Increase/Decrease % Diagnosis across Population 
2008 N/A 0.012% 
2009 7.5% decrease 0.011% 
2010 28.7% increase 0.013% 
2011 4.1% increase 0.013% 
2012 11.9% increase 0.014% 
2013 4.7% increase 0.014% 
2014 7.9% decrease 0.013% 
2015 10.5% increase 0.014% 
Chart LD2: Disorder Trend: Abuse/Dependence, Overdose of Opioids 
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Summary of Table LD2 and Chart LD2. This summary table shows a year-on-year increase or 
decrease (when compared to the previous year), in the percentage of patients diagnosed with the 
disorder, with the adjacent column displaying the overall percentage frequency, year on year, 
within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with abuse/dependence, and/or overdose of opioids is 0.013%, within the 
entire database. The lowest frequency of abuse/dependence, and/or overdose of opioids is in 
2009, with a percentage of 0.011% occurrence within the entire population and the highest 
frequency is in 2015, with 0.014% of the total database population.  
The diagnosis trend shows an initial increase in patient numbers from 2008 - 2010, followed by 
a gradual increase. The forecast predicts a levelling out of the frequency of patient numbers for 







Table LD3 and Chart LD3, summarise the total number of patients diagnosed with alcoholism 
per year (from 2008 – 2015). The total number of diagnoses per year are shown against the total 
database population per year.  
Chart LD3: Longitudinal Data (2008 – 2015): Alcoholism 
 





Table LD3  
Longitudinal Data (2008 – 2015): Alcoholism 
Diagnosis Year Total Patients Total DP 
Alcoholism 2008 1,798 2,092,183  
Alcoholism 2009 2,394 2,192,129  
Alcoholism 2010 2,350 2,434,220  
Alcoholism 2011 2,817 2,581,043  
Alcoholism 2012 2,958 2,711,594  
Alcoholism 2013 3,057 2,822,416  
Alcoholism 2014 3,362 2,923,433  
Alcoholism 2015 1,848 2,984,103  
The results are as follows: 
a. 2008 
In 2008, 1798 patients were diagnosed as suffering from alcoholism. This is the total number of 
diagnoses, includes both male and female patients. The ratio of male to female patients will be 
discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Alcoholism as a diagnosis is one of 27 mental illness 
disorders, as classified for this specific database. Refer to Table X for a summary of disorders 
specified in this dataset. 
1798 out of 2 092 183 patients diagnosed with alcoholism, translates to 0.086% of the total 




b. 2009  
In 2009, 2394 patients were diagnosed as suffering from alcoholism. This value is 596 more 
patients than in 2008 and translates to a 24.9% increase in diagnosis of alcoholism, when 
compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
2394 out of 2 192 129 patients diagnosed with alcoholism, translates to 0.109% of the total 
claimant population.  
c. 2010 
In 2010, 2350 patients were diagnosed as suffering from alcoholism. This value is 44 less 
patients than in 2009 and translates to a 1.84% decrease in diagnosis of alcoholism, when 
compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
2350 out of 2 434 220 patients diagnosed with alcoholism, translates to 0.097% of the total 
claimant population.  
d. 2011 
In 2011, 2817 patients were diagnosed as suffering from alcoholism. This value is 467 more 




compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
2817 out of 2 581 043 patients diagnosed with alcoholism, translates to 0.109% of the total 
claimant population.  
e. 2012 
In 2012, 2958 patients were diagnosed as suffering from alcoholism. This value is 141 more 
patients than in 2011 and translates to a 4.8% increase in diagnosis of alcoholism, when 
compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
2958 out of 2 711 594 patients diagnosed with alcoholism, translates to 0.109% of the total 
claimant population.  
f. 2013 
In 2013, 3057 patients were diagnosed as suffering from alcoholism. This value is 99 more 
patients than in 2012 and translates to a 3.2% increase in diagnosis of alcoholism, when 
compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




3057 out of 2 822 416 patients diagnosed with alcoholism, translates to 0.108% of the total 
claimant population.  
g. 2014 
In 2014, 3362 patients were diagnosed as suffering from alcoholism. This value is 305 more 
patients than in 2013 and translates to a 9.1% increase in diagnosis alcoholism, when compared 
to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
3362 out of 2 923 433 patients diagnosed with alcoholism, translates to 0.115% of the total 
claimant population.  
h. 2015 
From January to June of 2015, 1848 patients were diagnosed as suffering alcoholism. By mid-
year 2014, the number of patients is 1661 (according to Table: 
Database_2008_2015_Alcoholism). By June 2015, 187 more patients are recorded when 
compared to the half-year sum for 2014. This translates to a 10.12% increase in patient 
diagnosis. Therefore the 10.5% increase is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 3702 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




3702 out of 3 031 600 patients diagnosed with alcoholism, translates to 0.122% of the total 
claimant population.  
Table LD4  
Results summary: Alcoholism 
Year Diagnosis % Increase/Decrease % Diagnosis across Population 
2008 N/A 0.086% 
2009 24.90% increase 0.109% 
2010 1.84% decrease 0.097% 
2011 16.58% increase 0.109% 
2012 4.80% increase 0.109% 
2013 3.20% increase 0.108% 
2014 9.10% increase 0.115% 
2015 10.12% increase 0.122% 
Chart LD4: Disorder Trend: Alcoholism 
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Summary of Table LD4 and Chart LD4. This summary table shows a year-on-year increase or 
decrease (when compared to the previous year), in the percentage of patients diagnosed with the 
disorder, with the adjacent column displaying the overall percentage frequency, year on year, 
within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with alcoholism is 0.107%, within the entire database. The lowest frequency 
of alcoholism is in 2008, with a percentage of 0.086% occurrence within the entire population 
and the highest frequency is in 2015, with a percentage of 0.122% of the total database 
population.  
The diagnosis trend shows a steady increase in patient numbers across time. The forecast 







Table LD5 and Chart LD5, summarise the total number of patients diagnosed with anxiety 
disorder per year (from 2008 – 2015). The total number of diagnoses per year are shown against 
the total database population per year.  
Chart LD5: Longitudinal Data (2008 – 2015): Anxiety Disorder 
 





Table LD5  
Longitudinal Data (2008 – 2015): Anxiety Disorder 
Diagnosis Year Total Patients Total DP 
Anxiety disorder 2008 51 401 2,092,183 
Anxiety disorder 2009 50 023 2,192,129 
Anxiety disorder 2010 52 140 2,434,220 
Anxiety disorder 2011 54 181 2,581,043 
Anxiety disorder 2012 57 401 2,711,594 
Anxiety disorder 2013 59 364 2,822,416 
Anxiety disorder 2014 63 135 2,923,433 
Anxiety disorder 2015 36 420 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 51 401 patients were diagnosed as suffering from anxiety disorder. This is the total 
number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Anxiety disorder as a diagnosis is one of 27 mental illness 
disorders, as classified for this specific database. Refer to Table X for a summary of disorders 
specified in this dataset. 
51 401 out of 2 092 183 patients diagnosed with anxiety disorder, translates to 2.46% of the 




b. 2009  
In 2009, 50 023 patients were diagnosed as suffering from anxiety disorder. This value is 1378 
less patients than in 2008 and translates to a 2.68% decrease in diagnosis of anxiety disorder, 
when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
50 023 out of 2 192 129 patients diagnosed with anxiety disorder, translates to 2.28% of the 
total claimant population.  
c. 2010 
In 2010, 52 140 patients were diagnosed as suffering from anxiety disorder. This value is 2117 
more patients than in 2009 and translates to a 4.06% increase in diagnosis of anxiety disorder, 
when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
52 149 out of 2 434 220 patients diagnosed with anxiety disorder, translates to 2.14% of the 
total claimant population.  
d. 2011 
In 2011, 54 181 patients were diagnosed as suffering from anxiety disorder. This value is 2041 




when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
54 181 out of 2 581 043 patients diagnosed with anxiety disorder, translates to 2.01% of the 
total claimant population.  
e. 2012 
In 2012, 57 401 patients were diagnosed as suffering from anxiety disorder. This value is 3220 
more patients than in 2011 and translates to a 5.6% increase in diagnosis of anxiety disorder, 
when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
57 401 out of 2 711 594 patients diagnosed with anxiety disorder, translates to 2.12% of the 
total claimant population.  
f. 2013 
In 2013, 59 364 patients were diagnosed as suffering from anxiety disorder. This value is 1963 
more patients than in 2012 and translates to a 3.3% increase in diagnosis of anxiety disorder, 
when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




59 364 out of 2 822 416 patients diagnosed with anxiety disorder, translates to 2.1% of the total 
claimant population.  
g. 2014 
In 2014, 63 135 patients were diagnosed as suffering from anxiety disorder. This value is 3771 
more patients than in 2013 and translates to a 6.0% increase in diagnosis anxiety disorder, when 
compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
63 135 out of 2 923 433 patients diagnosed with anxiety disorder, translates to 2.14% of the 
total claimant population.  
h. 2015 
From January to June of 2015, 36 420 patients were diagnosed as suffering anxiety disorder. By 
mid-year 2014, the number of patients is 32 509 (according to Table: Database_2008_2015_ 
Anxiety Disorder). By June 2015, 3911 more patients are recorded when compared to the half-
year sum for 2014. This translates to a 10.74% increase in patient diagnosis. Therefore the 
10.74% increase is extrapolated for the remaining (unrecorded) subsequent 6 months, to give an 
estimated patient number of 69 916 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




69 916 out of 3 031 600 patients diagnosed with anxiety disorder, translates to 2.31% of the 
total claimant population.  
Table LD6  
Results summary: Anxiety Disorder 
Year Diagnosis % Increase/Decrease % Diagnosis across Population 
2008 N/A 2.46% 
2009 2.68% decrease 2.28% 
2010 4.06% increase 2.14% 
2011 3.77% increase 2.01% 
2012 5.60% increase 2.12% 
2013 3.30% increase 2.10% 
2014 6.00% increase 2.14% 
2015 10.74% increase 2.31% 
Chart LD6: Disorder Trend: Anxiety Disorder 
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Summary of Table LD6 and Chart LD6. This summary table shows a year-on-year increase or 
decrease (when compared to the previous year), in the percentage of patients diagnosed with the 
disorder, with the adjacent column displaying the overall percentage frequency, year on year, 
within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with anxiety disorder is 2.2%, within the entire database. The lowest 
frequency of anxiety disorder is in 2011, with a percentage of 2.01% occurrence within the 
entire population and the highest frequency is in 2015, with a percentage of 2.46% of the total 
database population.  
The diagnosis trend shows a steady increase in patient numbers across time. The forecast 






Attention Deficit Hyperactivity Disorder 
Table LD7 and Chart LD7, summarise the total number of patients diagnosed with attention 
deficit hyperactivity disorder per year (from 2008 – 2015). The total number of diagnoses per 
year are shown against the total database population per year.  
Chart LD7: Longitudinal Data (2008 – 2015): Attention Deficit Hyperactivity Disorder 
 





Table LD7  
Longitudinal Data (2008 – 2015): Attention Deficit Hyperactivity Disorder 
Diagnosis Year Total Patients Total DP 
Attention deficit and hyperactivity disorder 2008 70 243 2,092,183 
Attention deficit and hyperactivity disorder 2009 93 549 2,192,129 
Attention deficit and hyperactivity disorder 2010 115 636 2,434,220 
Attention deficit and hyperactivity disorder 2011 137 235 2,581,043 
Attention deficit and hyperactivity disorder 2012 159 071 2,711,594 
Attention deficit and hyperactivity disorder 2013 180 795 2,822,416 
Attention deficit and hyperactivity disorder 2014 196 648 2,923,433 
Attention deficit and hyperactivity disorder 2015 108 067 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 70 243 patients were diagnosed as suffering from attention deficit hyperactivity 
disorder. This is the total number of diagnoses, includes both male and female patients. The 
ratio of male to female patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Attention deficit hyperactivity disorder as a diagnosis is one 
of 27 mental illness disorders, as classified for this specific database. Refer to Table X for a 
summary of disorders specified in this dataset. 
70 243 out of 2 092 183 patients diagnosed with attention deficit hyperactivity disorder, 




b. 2009  
In 2009, 93 549 patients were diagnosed as suffering from attention deficit hyperactivity 
disorder. This value is 23 306 more patients than in 2008 and translates to a 24.91% increase in 
diagnosis of attention deficit dyperactivity disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
93 549 out of 2 192 129 patients diagnosed with attention deficit hyperactivity disorder, 
translates to 4.27% of the total claimant population.  
c. 2010 
In 2010, 115 636 patients were diagnosed as suffering from attention deficit hyperactivity 
disorder. This value is 22 087 more patients than in 2009 and translates to a 19.1% increase in 
diagnosis of attention deficit hyperactivity disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
115 636 out of 2 434 220 patients diagnosed with attention deficit hyperactivity disorder, 
translates to 4.75% of the total claimant population.  
d. 2011 
In 2011, 137 235 patients were diagnosed as suffering from attention deficit hyperactivity 
disorder. This value is 21 599 more patients than in 2010 and translates to a 15.74% increase in 




The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
137 235 out of 2 581 043 patients diagnosed with attention deficit hyperactivity disorder, 
translates to 5.32% of the total claimant population.  
e. 2012 
In 2012, 159 071 patients were diagnosed as suffering from attention deficit hyperactivity 
disorder. This value is 21 836 more patients than in 2011 and translates to a 13.73% increase in 
diagnosis of attention deficit hyperactivity disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
159 071 out of 2 711 594 patients diagnosed with attention deficit hyperactivity disorder, 
translates to 5.87% of the total claimant population.  
f. 2013 
In 2013, 180 795 patients were diagnosed as suffering from attention deficit hyperactivity 
disorder. This value is 21 724 more patients than in 2012 and translates to a 12.02% increase in 
diagnosis of attention deficit hyperactivity disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 
in 2012 and translates to a 12.9% growth in claimant population in one year. 
180 795 out of 2 822 416 patients diagnosed with attention deficit hyperactivity disorder, 





In 2014, 196 648 patients were diagnosed as suffering from attention deficit hyperactivity 
disorder. This value is 15 853 more patients than in 2013 and translates to an 8.06% increase in 
diagnosis attention deficit hyperactivity disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
196 648 out of 2 923 433 patients diagnosed with attention deficit hyperactivity disorder, 
translates to 6.73% of the total claimant population.  
h. 2015 
From January to June of 2015, 108 067 patients were diagnosed as suffering attention deficit 
hyperactivity disorder. By mid-year 2014, the number of patients is 102 299 (according to 
Table: Database_2008_2015_ Attention Deficit Hyperactivity Disorder). By June 2015, 5768 
more patients are recorded when compared to the half-year sum for 2014. This translates to a 
5.34% increase in patient diagnosis. Therefore the 5.34% increase is extrapolated for the 
remaining (unrecorded) subsequent 6 months, to give an estimated patient number of 207 149 
for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 
population of 3 031 600. This is 108 167 more claimants than in 2014. 




translates to 6.83% of the total claimant population.  
Table LD8  
Results summary: Attention Deficit Hyperactivity Disorder 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 3.36% 
2009 24.91% increase 4.27% 
2010 19.10% increase 4.75% 
2011 15.74% increase 5.32% 
2012 13.73% increase 5.87% 
2013 12.02% increase 6.41% 
2014 8.06% increase 6.73% 
2015 5.34% increase 6.83% 
Chart LD8: Disorder Trend: Attention Deficit and Hyperactivity Disorder 
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Summary of Table LD8 and Chart LD8. This summary table shows a year-on-year increase or 
decrease (when compared to the previous year), in the percentage of patients diagnosed with the 
disorder, with the adjacent column displaying the overall percentage frequency, year on year, 
within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with attention deficit and hyperactivity disorder is 5.44%, within the entire 
database. The lowest frequency of attention deficit and hyperactivity disorder is in 2008, with a 
percentage of 3.36% occurrence within the entire population and the highest frequency is in 
2015, with a percentage of 6.83% of the total database population.  
The diagnosis trend shows a steady increase in patient numbers across time. The forecast 
predicts a consistent increase in patients diagnosed with attention deficit and hyperactivity 
disorder going forward. From 2008 to 2015, the number of patients diagnosed with attention 







Table LD9 and Chart LD9, summarise the total number of patients diagnosed with behavioural 
disorder per year (from 2008 – 2015). The total number of diagnoses per year are shown against 
the total database population per year.  
Chart LD9: Longitudinal Data (2008 – 2015): Behavioural Disorder 
 





Table LD9  
Longitudinal Data (2008 – 2015): Behavioural Disorder 
Diagnosis Year Total Patients Total DP 
Behavioural disorder 2008 1 343 2,092,183 
Behavioural disorder 2009 1 780 2,192,129 
Behavioural disorder 2010 1 948 2,434,220 
Behavioural disorder 2011 2 031 2,581,043 
Behavioural disorder 2012 2 372 2,711,594 
Behavioural disorder 2013 2 504 2,822,416 
Behavioural disorder 2014 2 826 2,923,433 
Behavioural disorder 2015 1 688 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 1343 patients were diagnosed as suffering from behavioural disorder. This is the total 
number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Behavioural disorder as a diagnosis is one of 27 mental illness 
disorders, as classified for this specific database. Refer to Table X for a summary of disorders 
specified in this dataset. 
1343 out of 2 092 183 patients diagnosed with behavioural disorder, translates to 0.064% of the 




b. 2009  
In 2009, 1780 patients were diagnosed as suffering from behavioural disorder. This value is 437 
more patients than in 2008 and translates to a 24.55% increase in diagnosis of behavioural 
disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
1780 out of 2 192 129 patients diagnosed with behavioural disorder, translates to 0.081% of the 
total claimant population.  
c. 2010 
In 2010, 1948 patients were diagnosed as suffering from behavioural disorder. This value is 168 
more patients than in 2009 and translates to an 8.64% increase in diagnosis of behavioural 
disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
1948 out of 2 434 220 patients diagnosed with behavioural disorder, translates to 0.080% of the 
total claimant population.  
d. 2011 
In 2011, 2031 patients were diagnosed as suffering from behavioural disorder. This value is 83 




disorder, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
2031 out of 2 581 043 patients diagnosed with behavioural disorder, translates to 0.079% of the 
total claimant population.  
e. 2012 
In 2012, 2372 patients were diagnosed as suffering from behavioural disorder. This value is 341 
more patients than in 2011 and translates to a 14.78% increase in diagnosis of behavioural 
disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
2372 out of 2 711 594 patients diagnosed with behavioural disorder, translates to 0.087% of the 
total claimant population.  
f. 2013 
In 2013, 2504 patients were diagnosed as suffering from behavioural disorder. This value is 132 
more patients than in 2012 and translates to a 5.27% increase in diagnosis of behavioural 
disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




2504 out of 2 822 416 patients diagnosed with behavioural disorder, translates to 0.089% of the 
total claimant population.  
g. 2014 
In 2014, 2826 patients were diagnosed as suffering from behavioural disorder. This value is 322 
more patients than in 2013 and translates to a 11.39% increase in diagnosis behavioural 
disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
2826 out of 2 923 433 patients diagnosed with behavioural disorder, translates to 0.097% of the 
total claimant population.  
h. 2015 
From January to June of 2015, 1688 patients were diagnosed as suffering from behavioural 
disorder. By mid-year 2014, the number of patients is 1445 (according to Table: 
Database_2008_2015_ Behavioural Disorder). By June 2015, 243 more patients are recorded 
when compared to the half-year sum for 2014. This translates to a 14.4% increase in patient 
diagnosis. Therefore the 14.4% increase is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 3232 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




3232 out of 3 031 600 patients diagnosed with behavioural disorder, translates to 0.107% of the 
total claimant population.  
Table LD10  
Results summary: Behavioural Disorder 
Year Diagnosis % Increase/Decrease % Diagnosis with Population 
2008 N/A 0.064% 
2009 24.55% increase 0.081% 
2010 8.64% increase 0.080% 
2011 4.03% increase 0.079% 
2012 14.78% increase 0.087% 
2013 5.27% increase 0.089% 
2014 11.39% increase 0.097% 
2015 14.40% increase 0.107% 
Chart LD10: Disorder Trend: Behavioural Disorder 
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Summary of Table LD10 and Chart LD10. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with behavioural disorder is 0.09%, within the entire database. The lowest 
frequency of behavioural disorder is in 2008, with a percentage of 0.064% occurrence within 
the entire population and the highest frequency is in 2015, with a percentage of 0.107% of the 
total database population.  
The diagnosis trend shows a steady increase in patient numbers across time. The forecast 






Bipolar Mood Disorder 
Table LD11 and Chart LD11, summarise the total number of patients diagnosed with bipolar 
mood disorder per year (from 2008 – 2015). The total number of diagnoses per year are shown 
against the total database population per year.  
Chart LD11: Longitudinal Data (2008 – 2015): Bipolar Mood Disorder 
 





Table LD11  
Longitudinal Data (2008 – 2015): Bipolar Mood Disorder 
Diagnosis Year Total Patients Total DP 
Bipolar mood disorder 2008 78 037 2,092,183 
Bipolar mood disorder 2009 101 863 2,192,129 
Bipolar mood disorder 2010 132 191 2,434,220 
Bipolar mood disorder 2011 164 882 2,581,043 
Bipolar mood disorder 2012 194 988 2,711,594 
Bipolar mood disorder 2013 220 587 2,822,416 
Bipolar mood disorder 2014 240 403 2,923,433 
Bipolar mood disorder 2015 127 832 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 78 037 patients were diagnosed as suffering from bipolar mood disorder. This is the 
total number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Bipolar mood disorder as a diagnosis is one of 27 mental 
illness disorders, as classified for this specific database. Refer to Table X for a summary of 
disorders specified in this dataset. 
78 037 out of 2 092 183 patients diagnosed with bipolar mood disorder, translates to 3.73% of 




b. 2009  
In 2009, 101 863 patients were diagnosed as suffering from bipolar mood disorder. This value 
is 23 826 more patients than in 2008 and translates to a 23.39% increase in diagnosis of bipolar 
mood disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
101 863 out of 2 192 129 patients diagnosed with bipolar mood disorder, translates to 4.65% of 
the total claimant population.  
c. 2010 
In 2010, 132 191 patients were diagnosed as suffering from bipolar mood disorder. This value 
is 30 328 more patients than in 2009 and translates to a 22.94% increase in diagnosis of bipolar 
mood disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
132 191 out of 2 434 220 patients diagnosed with bipolar mood disorder, translates to 5.43% of 
the total claimant population.  
d. 2011 
In 2011, 164 882 patients were diagnosed as suffering from bipolar mood disorder. This value 




mood disorder, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
164 882 out of 2 581 043 patients diagnosed with bipolar mood disorder, translates to 6.39% of 
the total claimant population.  
e. 2012 
In 2012, 194 988 patients were diagnosed as suffering from bipolar mood disorder. This value 
is 30 106 more patients than in 2011 and translates to a 15.44% increase in diagnosis of bipolar 
mood disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
194 988 out of 2 711 594 patients diagnosed with bipolar mood disorder, translates to 7.19% of 
the total claimant population.  
f. 2013 
In 2013, 220 587 patients were diagnosed as suffering from bipolar mood disorder. This value 
is 25 599 more patients than in 2012 and translates to a 11.6% increase in diagnosis of bipolar 
mood disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




220 587 out of 2 822 416 patients diagnosed with bipolar mood disorder, translates to 7.86% of 
the total claimant population.  
g. 2014 
In 2014, 240 403 patients were diagnosed as suffering from bipolar mood disorder. This value 
is 19 816 more patients than in 2013 and translates to an 8.24% increase in diagnosis bipolar 
mood disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
240 403 out of 2 923 433 patients diagnosed with bipolar mood disorder, translates to 8.22% of 
the total claimant population.  
h. 2015 
From January to June of 2015, 127 832 patients were diagnosed as suffering from bipolar mood 
disorder. By mid-year 2014, the number of patients is 119 034 (according to Table: 
Database_2008_2015_ Bipolar Mood Disorder). By June 2015, 8798 more patients are 
recorded when compared to the half-year sum for 2014. This translates to a 6.88% increase in 
patient diagnosis. Therefore the 6.88% increase is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 256 943 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




256 943 out of 3 031 600 patients diagnosed with bipolar mood disorder, translates to 8.48% of 
the total claimant population.  
Table LD12 
Results summary: Bipolar Mood Disorder 
Year Diagnosis % Increase/Decrease % Diagnosis with Population 
2008 N/A 3.73% 
2009 23.39% increase 4.65% 
2010 22.94% increase 5.43% 
2011 19.83% increase 6.39% 
2012 15.44% increase 7.19% 
2013 11.60% increase 7.86% 
2014   8.24% increase 8.22% 
2015   6.88% increase 8.48% 
Chart LD12: Disorder Trend: Bipolar Mood Disorder 
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Summary of Table LD12 and Chart LD12. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with bipolar mood disorder is 6.49%, within the entire database. The lowest 
frequency of bipolar mood disorder is in 2008, with a percentage of 3.73% occurrence within 
the entire population and the highest frequency is in 2015, with a percentage of 8.48% of the 
total database population.  
The diagnosis trend shows a steady increase in patient numbers across time. The forecast 
predicts a steep increase in patients diagnosed with bipolar mood disorder going forward. The 







Table LD13 and Chart LD13, summarise the total number of patients diagnosed with delusional 
disorder per year (from 2008 – 2015). The total number of diagnoses per year are shown against 
the total database population per year.  
Chart LD13: Longitudinal Data (2008 – 2015): Delusional Disorder 
 





Table LD13  
Longitudinal Data (2008 – 2015): Delusional Disorder 
Diagnosis Year Total Patients Total DP 
Delusional disorder 2008 323 2,092,183 
Delusional disorder 2009 322 2,192,129 
Delusional disorder 2010 292 2,434,220 
Delusional disorder 2011 315 2,581,043 
Delusional disorder 2012 264 2,711,594 
Delusional disorder 2013 359 2,822,416 
Delusional disorder 2014 367 2,923,433 
Delusional disorder 2015 183 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 323 patients were diagnosed as suffering from delusional disorder. This is the total 
number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Delusional disorder as a diagnosis is one of 27 mental illness 
disorders, as classified for this specific database. Refer to Table X for a summary of disorders 
specified in this dataset. 
323 out of 2 092 183 patients diagnosed with delusional disorder, translates to 0.015% of the 




b. 2009  
In 2009, 322 patients were diagnosed as suffering from delusional disorder. This value is 1 less 
patient than in 2008 and translates to a 0.31% decrease in diagnosis of delusional disorder, 
when compared to 2008. 
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
322 out of 2 192 129 patients diagnosed with delusional disorder, translates to 0.015% of the 
total claimant population.  
c. 2010 
In 2010, 292 patients were diagnosed as suffering from delusional disorder. This value is 30 
less patients than in 2009 and translates to a 9.32% decrease in diagnosis of delusional disorder, 
when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
292 out of 2 434 220 patients diagnosed with delusional disorder, translates to 0.012% of the 
total claimant population.  
d. 2011 
In 2011, 315 patients were diagnosed as suffering from delusional disorder. This value is 23 




when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
315 out of 2 581 043 patients diagnosed with delusional disorder, translates to 0.012% of the 
total claimant population.  
e. 2012 
In 2012, 264 patients were diagnosed as suffering from delusional disorder. This value is 51 
less patients than in 2011 and translates to a 16.2% decrease in diagnosis of delusional disorder, 
when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
264 out of 2 711 594 patients diagnosed with delusional disorder, translates to 0.010% of the 
total claimant population.  
f. 2013 
In 2013, 359 patients were diagnosed as suffering from delusional disorder. This value is 95 
more patients than in 2012 and translates to a 26.46% increase in diagnosis of delusional 
disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




359 out of 2 822 416 patients diagnosed with delusional disorder, translates to 0.013% of the 
total claimant population.  
g. 2014 
In 2014, 367 patients were diagnosed as suffering from delusional disorder. This value is 8 
more patients than in 2013 and translates to a 2.18% increase in diagnosis of delusional 
disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
367 out of 2 923 433 patients diagnosed with delusional disorder, translates to 0.013% of the 
total claimant population.  
h. 2015 
From January to June of 2015, 183 patients were diagnosed as suffering from delusional 
disorder. By mid-year 2014, the number of patients is 202 (according to Table: 
Database_2008_2015_ Delusional Disorder). By June 2015, 19 less patients are recorded when 
compared to the half-year sum for 2014. This translates to a 9.41% decrease in patient 
diagnosis. Therefore the 9.41% decrease is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 333 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




333 out of 3 031 600 patients diagnosed with delusional disorder, translates to 0.011% of the 
total claimant population.  
Table LD14  
Results summary: Delusional Disorder 
Year Diagnosis % 
Increase/Decrease 
% Diagnosis within Population 
2008 N/A 0.015% 
2009 0.31% decrease 0.015% 
2010 9.32% decrease 0.012% 
2011 7.30% increase 0.012% 
2012 16.20% decrease 0.010% 
2013 26.46% increase 0.013% 
2014 2.18% increase 0.013% 
2015 9.41% decrease 0.011% 
Chart LD14: Disorder Trend: Delusional Disorder 
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Summary of Table LD14 and Chart LD14. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with delusional disorder is 0.013%, within the entire database. The lowest 
frequency of delusional disorder is in 2012, with a percentage of 0.010% occurrence within the 
entire population and the highest frequencies are in 2008 and 2009, with a percentage of 
0.015% of the total database population.  
The diagnosis trend shows patient numbers are highly fluctuating across time. The order 4 
polynomial forecast predicts a downward frequency rate in patients diagnosed with delusional 







Table LD15 and Chart LD15, summarise the total number of patients diagnosed with 
depression per year (from 2008 – 2015). The total number of diagnoses per year are shown 
against the total database population per year.  
Chart LD15: Longitudinal Data (2008 – 2015): Depression 
 





Table LD15  
Longitudinal Data (2008 – 2015): Depression 
Diagnosis Year Total Patients Total DP 
Depression 2008 312 710 2,092,183 
Depression 2009 432 159 2,192,129 
Depression 2010 532 048 2,434,220 
Depression 2011 615 448 2,581,043 
Depression 2012 688 689 2,711,594 
Depression 2013 766 447 2,822,416 
Depression 2014 839 314 2,923,433 
Depression 2015 455 952 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 312 710 patients were diagnosed as suffering from depression. This is the total number 
of diagnoses, includes both male and female patients. The ratio of male to female patients will 
be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Depression as a diagnosis is one of 27 mental illness 
disorders, as classified for this specific database. Refer to Table X for a summary of disorders 
specified in this dataset. 
312 710 out of 2 092 183 patients diagnosed with depression, translates to 14.95% of the total 




b. 2009  
In 2009, 432 159 patients were diagnosed as suffering from depression. This value is 119 449 
more patients than in 2008 and translates to a 27.64% increase in diagnosis of depression, when 
compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
432 159 out of 2 192 129 patients diagnosed with depression, translates to 19.71% of the total 
claimant population.  
c. 2010 
In 2010, 532 048 patients were diagnosed as suffering from depression. This value is 99 889 
more patients than in 2009 and translates to an 18.77% increase in diagnosis of depression, 
when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
532 048 out of 2 434 220 patients diagnosed with depression, translates to 21.86% of the total 
claimant population.  
d. 2011 
In 2011, 615 448 patients were diagnosed as suffering from depression. This value is 83 400 




compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
615 448 out of 2 581 043 patients diagnosed with depression, translates to 23.84% of the total 
claimant population.  
e. 2012 
In 2012, 688 689 patients were diagnosed as suffering from depression. This value is 73 241 
more patients than in 2011 and translates to a 10.63% increase in diagnosis of depression, when 
compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
688 689 out of 2 711 594 patients diagnosed with depression, translates to 25.40% of the total 
claimant population.  
f. 2013 
In 2013, 766 447 patients were diagnosed as suffering from depression. This value is 77 758 
more patients than in 2012 and translates to a 10.14% increase in diagnosis of depression, when 
compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




766 447 out of 2 822 416 patients diagnosed with depression, translates to 27.16% of the total 
claimant population.  
g. 2014 
In 2014, 839 314 patients were diagnosed as suffering from depression. This value is 72 867 
more patients than in 2013 and translates to an 8.68% increase in diagnosis of depression, when 
compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
839 314 out of 2 923 433 patients diagnosed with depression, translates to 28.71% of the total 
claimant population.  
h. 2015 
From January to June of 2015, 455 952 patients were diagnosed as suffering from depression. 
By mid-year 2014, the number of patients is 432 864 (according to Table: 
Database_2008_2015_ Depression). By June 2015, 32 088 more patients are recorded when 
compared to the half-year sum for 2014. This translates to a 7.04% increase in patient 
diagnosis. Therefore the 7.04% increase is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 898 402 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




898 402 out of 3 031 600 patients diagnosed with depression, translates to 29.63% of the total 
claimant population.  
Table LD16  
Results summary: Depression 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 14.95% 
2009 27.64% increase 19.71% 
2010 18.77% increase 21.86% 
2011 13.55% increase 23.84% 
2012 10.63% increase 25.40% 
2013 10.14% increase 27.16% 
2014 8.68% increase 28.71% 
2015 7.04% increase 29.63% 
Chart LD16: Disorder Trend: Depression 
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Summary of Table LD16 and Chart LD16. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with depression is 23.91%, within the entire database. The lowest frequency 
of depression is in 2008, with a percentage of 14.95% occurrence within the entire population 
and the highest frequency is in 2015, with a percentage of 29.63% of the total database 
population.  
The diagnosis trend shows a steady increase in patient numbers across time. The forecast 
predicts a steep increase in patients diagnosed with depression going forward. The percentage 






Developmental and Learning Disorder 
Table LD17 and Chart LD17, summarise the total number of patients diagnosed with 
developmental and learning disorder per year (from 2008 – 2015). The total number of 
diagnoses per year are shown against the total database population per year.  
Chart LD17: Longitudinal Data (2008 – 2015): Developmental and Learning Disorder 
 





Table LD17  
Longitudinal Data (2008 – 2015): Developmental and Learning Disorder 
Diagnosis Year Total Patients Total DP 
Developmental and learning disorder 2008 50 354 2,092,183 
Developmental and learning disorder 2009 53 290 2,192,129 
Developmental and learning disorder 2010 58 194 2,434,220 
Developmental and learning disorder 2011 62 550 2,581,043 
Developmental and learning disorder 2012 63 244 2,711,594 
Developmental and learning disorder 2013 68 251 2,822,416 
Developmental and learning disorder 2014 76 268 2,923,433 
Developmental and learning disorder 2015 42 993 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 312 710 patients were diagnosed as suffering from developmental and learning 
disorder. This is the total number of diagnoses, includes both male and female patients. The 
ratio of male to female patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. developmental and learning disorder as a diagnosis is one of 
27 mental illness disorders, as classified for this specific database. Refer to Table X for a 
summary of disorders specified in this dataset. 
50 354 out of 2 092 183 patients diagnosed with developmental and learning disorder, translates 




b. 2009  
In 2009, 53 290 patients were diagnosed as suffering from developmental and learning disorder. 
This value is 2 936 more patients than in 2008 and translates to a 5.51% increase in diagnosis of 
developmental and learning disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
53 290 out of 2 192 129 patients diagnosed with developmental and learning disorder, translates 
to 2.43% of the total claimant population.  
c. 2010 
In 2010, 58 194 patients were diagnosed as suffering from developmental and learning disorder. 
This value is 4 904 more patients than in 2009 and translates to an 8.43% increase in diagnosis 
of developmental and learning disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
58 194 out of 2 434 220 patients diagnosed with developmental and learning disorder, translates 
to 2.39% of the total claimant population.  
d. 2011 
In 2011, 62 550 patients were diagnosed as suffering from developmental and learning disorder. 




developmental and learning disorder, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
62 550 out of 2 581 043 patients diagnosed with developmental and learning disorder, translates 
to 2.42% of the total claimant population.  
e. 2012 
In 2012, 63 244 patients were diagnosed as suffering from developmental and learning disorder. 
This value is 694 more patients than in 2011 and translates to a 1.1% increase in diagnosis of 
developmental and learning disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
63 244 out of 2 711 594 patients diagnosed with developmental and learning disorder, translates 
to 2.33% of the total claimant population.  
f. 2013 
In 2013, 68 251 patients were diagnosed as suffering from developmental and learning disorder. 
This value is 5 007 more patients than in 2012 and translates to a 7.34% increase in diagnosis of 
developmental and learning disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




68 251 out of 2 822 416 patients diagnosed with developmental and learning disorder, translates 
to 2.42% of the total claimant population.  
g. 2014 
In 2014, 76 268 patients were diagnosed as suffering from developmental and learning disorder. 
This value is 8 017 more patients than in 2013 and translates to a 10.51% increase in diagnosis 
of developmental and learning disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
76 268 out of 2 923 433 patients diagnosed with developmental and learning disorder, translates 
to 2.61% of the total claimant population.  
h. 2015 
From January to June of 2015, 42 993 patients were diagnosed as suffering from developmental 
and learning disorder. By mid-year 2014, the number of patients is 38 924 (according to Table: 
Database_2008_2015_Developmental and Learning Disorder). By June 2015, 4 069 more 
patients are recorded when compared to the half-year sum for 2014. This translates to a 9.46% 
increase in patient diagnosis. Therefore the 9.46% increase is extrapolated for the remaining 
(unrecorded) subsequent 6 months, to give an estimated patient number of 83 483 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




83 483 out of 3 031 600 patients diagnosed with developmental and learning disorder, translates 
to 2.75% of the total claimant population.  
Table LD18  
Results summary: Developmental and learning disorder 
Year Diagnosis % Increase/Decrease % Diagnosis with Population 
2008 N/A 2.41% 
2009 27.64% increase 2.43% 
2010 18.77% increase 2.39% 
2011 13.55% increase 2.42% 
2012 10.63% increase 2.33% 
2013 10.14% increase 2.42% 
2014 8.68% increase 2.61% 
2015 7.04% increase 2.75% 
Chart LD18: Disorder Trend: Development and Learning Disorder 
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Summary of Table LD18 and Chart LD18. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with development and learning disorder is 2.47%, within the entire database. 
The lowest frequency of development and learning disorder is in 2012, with a percentage of 
2.33% occurrence within the entire population and the highest frequency is in 2015, with a 
percentage of 2.75% of the total database population.  
The diagnosis trend shows an incremental increase in patient numbers across time. The forecast 









Table LD19 and Chart LD19, summarise the total number of patients diagnosed with 
dissociative disorder per year (from 2008 – 2015). The total number of diagnoses per year are 
shown against the total database population per year.  
Chart LD19: Longitudinal Data (2008 – 2015): Dissociative Disorder 
 






Longitudinal Data (2008 – 2015): Dissociative Disorder 
Diagnosis Year Total Patients Total DP 
Dissociative disorder 2008 360 2,092,183 
Dissociative disorder 2009 522 2,192,129 
Dissociative disorder 2010 477 2,434,220 
Dissociative disorder 2011 538 2,581,043 
Dissociative disorder 2012 596 2,711,594 
Dissociative disorder 2013 631 2,822,416 
Dissociative disorder 2014 652 2,923,433 
Dissociative disorder 2015 369 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 360 patients were diagnosed as suffering from dissociative disorder. This is the total 
number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Dissociative disorder as a diagnosis is one of 27 mental illness 
disorders, as classified for this specific database. Refer to Table X for a summary of disorders 
specified in this dataset. 
360 out of 2 092 183 patients diagnosed with dissociative disorder, translates to 0.017% of the 




b. 2009  
In 2009, 522 patients were diagnosed as suffering from dissociative disorder. This value is 162 
more patients than in 2008 and translates to a 31.03% increase in diagnosis of dissociative 
disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
522 out of 2 192 129 patients diagnosed with dissociative disorder, translates to 0.024% of the 
total claimant population.  
c. 2010 
In 2010, 477 patients were diagnosed as suffering from dissociative disorder. This value is 45 
less patients than in 2009 and translates to an 8.62% decrease in diagnosis of dissociative 
disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
477 out of 2 434 220 patients diagnosed with dissociative disorder, translates to 0.020% of the 
total claimant population. 
d. 2011 
In 2011, 538 patients were diagnosed as suffering from dissociative disorder. This value is 61 




disorder, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
538 out of 2 581 043 patients diagnosed with dissociative disorder, translates to 0.021% of the 
total claimant population.  
e. 2012 
In 2012, 596 patients were diagnosed as suffering from dissociative disorder. This value is 58 
more patients than in 2011 and translates to a 9.73% increase in diagnosis of dissociative 
disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
596 out of 2 711 594 patients diagnosed with dissociative disorder, translates to 0.022% of the 
total claimant population. 
f. 2013 
In 2013, 631 patients were diagnosed as suffering from dissociative disorder. This value is 35 
more patients than in 2012 and translates to a 5.55% increase in diagnosis of dissociative 
disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




631 out of 2 822 416 patients diagnosed with dissociative disorder, translates to 0.022% of the 
total claimant population.  
g. 2014 
In 2014, 652 patients were diagnosed as suffering from dissociative disorder. This value is 21 
more patients than in 2013 and translates to a 3.22% increase in diagnosis of dissociative 
disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
652 out of 2 923 433 patients diagnosed with dissociative disorder, translates to 0.022% of the 
total claimant population. 
h. 2015 
From January to June of 2015, 369 patients were diagnosed as suffering from dissociative 
disorder. By mid-year 2014, the number of patients is 324 (according to Table: 
Database_2008_2015_ Dissociative Disorder). By June 2015, 45 more patients are recorded 
when compared to the half-year sum for 2014. This translates to a 12.20% increase in patient 
diagnosis. Therefore the 12.20% increase is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 732 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




732 out of 3 031 600 patients diagnosed with dissociative disorder, translates to 0.024% of the 
total claimant population.  
Table LD20  
Results summary: Dissociative Disorder 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 0.017% 
2009 31.03% increase 0.024% 
2010 8.62% decrease 0.020% 
2011 11.34% increase 0.021% 
2012 9.73% increase 0.022% 
2013 5.55% increase 0.022% 
2014 3.22% increase 0.022% 
2015 12.20% increase 0.024% 
Chart LD20: Disorder Trend: Dissociative Disorder 
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Summary of Table LD20 and Chart LD20. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with dissociative disorder is 0.022%, within the entire database. The lowest 
frequency of dissociative disorder is in 2008, with a percentage of 0.017% occurrence within 
the entire population and the highest frequencies are in 2009 and 2015, with a percentage of 
0.024% of the total database population.  
The diagnosis trend shows a gentle fluctuation in patient numbers across time, followed by a 
steadily increasing frequency rate for this diagnosis. The forecast predicts a consistent increase 







Table LD21 and Chart LD21, summarise the total number of patients diagnosed with eating 
disorder per year (from 2008 – 2015). The total number of diagnoses per year are shown against 
the total database population per year.  
Chart LD21: Longitudinal Data (2008 – 2015): Eating Disorder 
 






Longitudinal Data (2008 – 2015): Eating Disorder 
Diagnosis Year Total Patients Total DP 
Eating disorder 2008 2 911 2,092,183 
Eating disorder 2009 3 110 2,192,129 
Eating disorder 2010 3 589 2,434,220 
Eating disorder 2011 4 098 2,581,043 
Eating disorder 2012 4 413 2,711,594 
Eating disorder 2013 4 410 2,822,416 
Eating disorder 2014 4 655 2,923,433 
Eating disorder 2015 2 585 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 2911 patients were diagnosed as suffering from eating disorder. This is the total 
number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Eating disorder as a diagnosis is one of 27 mental illness 
disorders, as classified for this specific database. Refer to Table X for a summary of disorders 
specified in this dataset. 
2199 out of 2 092 183 patients diagnosed with eating disorder, translates to 0.139% of the total 




b. 2009  
In 2009, 3110 patients were diagnosed as suffering from eating disorder. This value is 199 more 
patients than in 2008 and translates to a 6.40% increase in diagnosis of eating disorder, when 
compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
3110 out of 2 192 129 patients diagnosed with eating disorder, translates to 0.142% of the total 
claimant population.  
c. 2010 
In 2010, 3589 patients were diagnosed as suffering from eating disorder. This value is 479 more 
patients than in 2009 and translates to a 13.35% increase in diagnosis of eating disorder, when 
compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
3589 out of 2 434 220 patients diagnosed with eating disorder, translates to 0.147% of the total 
claimant population. 
d. 2011 
In 2011, 4098 patients were diagnosed as suffering from eating disorder. This value is 509 more 




compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
4098 out of 2 581 043 patients diagnosed with eating disorder, translates to 0.159% of the total 
claimant population.  
e. 2012 
In 2012, 4413 patients were diagnosed as suffering from eating disorder. This value is 315 more 
patients than in 2011 and translates to a 7.14% increase in diagnosis of eating disorder, when 
compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
4413 out of 2 711 594 patients diagnosed with eating disorder, translates to 0.163% of the total 
claimant population.  
f. 2013 
In 2013, 4410 patients were diagnosed as suffering from eating disorder. This value is 3 less 
patients than in 2012 and translates to a 0.07% decrease in diagnosis of eating disorder, when 
compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




4410 out of 2 822 416 patients diagnosed with eating disorder, translates to 0.156% of the total 
claimant population.  
g. 2014 
In 2014, 4655 patients were diagnosed as suffering from eating disorder. This value is 245 more 
patients than in 2013 and translates to a 5.26% increase in diagnosis of eating disorder, when 
compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
4655 out of 2 923 433 patients diagnosed with eating disorder, translates to 0.159% of the total 
claimant population.  
h. 2015 
From January to June of 2015, 2585 patients were diagnosed as suffering from eating disorder. 
By mid-year 2014, the number of patients is 2389 (according to Table: Database_2008_2015_ 
Eating Disorder). By June 2015, 196 more patients are recorded when compared to the half-
year sum for 2014. This translates to a 7.58% increase in patient diagnosis. Therefore the 7.58% 
increase is extrapolated for the remaining (unrecorded) subsequent 6 months, to give an 
estimated patient number of 5008 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




5008 out of 3 031 600 patients diagnosed with eating disorder, translates to 0.165% of the total 
claimant population.  
Table LD22  
Results summary: Eating Disorder 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 0.139% 
2009 6.40% increase 0.142% 
2010 13.35% increase 0.147% 
2011 12.42% increase 0.159% 
2012 7.14% increase 0.163% 
2013 0.07% decrease 0.156% 
2014 5.26% increase 0.159% 
2015 7.58% increase 0.165% 
Chart LD22: Disorder Trend: Eating Disorder 
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Summary of Table LD22 and Chart LD22. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with eating disorder is 0.154%, within the entire database. The lowest 
frequency of eating disorder is in 2008, with a percentage of 0.139% occurrence within the 
entire population and the highest frequency is in 2015, with a percentage of 0.165% of the total 
database population.  
The diagnosis trend shows an initial increase in patient numbers across time, followed by an 
incremental increase in diagnosis numbers, which approach a constant frequency rate for this 
diagnosis. The forecast predicts a small increase in frequency rate of patients diagnosed with 





Impulse Control Disorder 
Table LD23 and Chart LD23, summarise the total number of patients diagnosed with impulse 
control disorder per year (from 2008 – 2015). The total number of diagnoses per year are shown 
against the total database population per year.  
Chart LD23: Longitudinal Data (2008 – 2015): Impulse Control Disorder 
 





Table LD23  
Longitudinal Data (2008 – 2015): Impulse Control Disorder 
Diagnosis Year Total Patients Total DP 
Impulse control disorder 2008 2 918 2,092,183 
Impulse control disorder 2009 3 098 2,192,129 
Impulse control disorder 2010 3 111 2,434,220 
Impulse control disorder 2011 3 008 2,581,043 
Impulse control disorder 2012 3 333 2,711,594 
Impulse control disorder 2013 3 720 2,822,416 
Impulse control disorder 2014 3 761 2,923,433 
Impulse control disorder 2015 2 387 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 2918 patients were diagnosed as suffering from impulse control disorder. This is the 
total number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. impulse control disorder as a diagnosis is one of 27 mental 
illness disorders, as classified for this specific database. Refer to Table X for a summary of 
disorders specified in this dataset. 
2918 out of 2 092 183 patients diagnosed with impulse control disorder, translates to 0.139% of 




b. 2009  
In 2009, 3098 patients were diagnosed as suffering from impulse control disorder. This value is 
180 more patients than in 2008 and translates to a 5.81% increase in diagnosis of impulse 
control disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
3098 out of 2 192 129 patients diagnosed with impulse control disorder, translates to 0.141% of 
the total claimant population.  
c. 2010 
In 2010, 3111 patients were diagnosed as suffering from impulse control disorder. This value is 
13 more patients than in 2009 and translates to a 0.42% increase in diagnosis of impulse control 
disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
3111 out of 2 434 220 patients diagnosed with impulse control disorder, translates to 0.128% of 
the total claimant population.  
d. 2011 
In 2011, 3008 patients were diagnosed as suffering from impulse control disorder. This value is 




disorder, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
3008 out of 2 581 043 patients diagnosed with impulse control disorder, translates to 0.117% of 
the total claimant population.  
e. 2012 
In 2012, 3333 patients were diagnosed as suffering from impulse control disorder. This value is 
325 more patients than in 2011 and translates to a 9.75% increase in diagnosis of impulse 
control disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
3333 out of 2 711 594 patients diagnosed with impulse control disorder, translates to 0.123% of 
the total claimant population.  
f. 2013 
In 2013, 3720 patients were diagnosed as suffering from impulse control disorder. This value is 
387 more patients than in 2012 and translates to a 10.40% increase in diagnosis of impulse 
control disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




3720 out of 2 822 416 patients diagnosed with impulse control disorder, translates to 0.132% of 
the total claimant population.  
g. 2014 
In 2014, 3761 patients were diagnosed as suffering from impulse control disorder. This value is 
41 more patients than in 2013 and translates to a 1.09% increase in diagnosis of impulse control 
disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
3761 out of 2 923 433 patients diagnosed with impulse control disorder, translates to 0.129% of 
the total claimant population.  
h. 2015 
From January to June of 2015, 2387 patients were diagnosed as suffering from impulse control 
disorder. By mid-year 2014, the number of patients is 2085 (according to Table: 
Database_2008_2015_ Impulse Control Disorder). By June 2015, 302 more patients are 
recorded when compared to the half-year sum for 2014. This translates to a 12.65% increase in 
patient diagnosis. Therefore the 12.65% increase is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 4237 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




4237 out of 3 031 600 patients diagnosed with impulse control disorder, translates to 0.140% of 
the total claimant population.  
Table LD24  
Results summary: Impulse Control Disorder 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 0.139% 
2009 5.81% increase 0.141% 
2010 0.42% increase 0.128% 
2011 2.31% decrease 0.117% 
2012 9.75% increase 0.123% 
2013 10.40% increase 0.132% 
2014 1.09% increase 0.129% 
2015 12.65% increase 0.140% 
Chart LD24: Disorder Trend: Impulse Control Disorder 
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Summary of Table LD24 and Chart LD24. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with impulse control disorder is 0.131%, within the entire database. The 
lowest frequency of impulse control disorder is in 2011, with a percentage of 0.117% 
occurrence within the entire population and the highest frequency is in 2009, with a percentage 
of 0.141% of the total database population.  
The diagnosis trend shows a steady increase in patient numbers across time. The forecast 
predicts a constant increase in frequency rate of patients diagnosed with impulse control 







Table LD25 and Chart LD25, summarise the total number of patients diagnosed with mental 
retardation per year (from 2008 – 2015). The total number of diagnoses per year are shown 
against the total database population per year. 
Chart LD25: Longitudinal Data (2008 – 2015): Mental Retardation  
 





Table LD25  
Longitudinal Data (2008 – 2015): Mental Retardation 
Diagnosis Year Total Patients Total DP 
Mental retardation 2008 391 2,092,183 
Mental retardation 2009 500 2,192,129 
Mental retardation 2010 535 2,434,220 
Mental retardation 2011 626 2,581,043 
Mental retardation 2012 601 2,711,594 
Mental retardation 2013 657 2,822,416 
Mental retardation 2014 633 2,923,433 
Mental retardation 2015 421 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 391 patients were diagnosed as suffering from mental retardation. This is the total 
number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Mental retardation as a diagnosis is one of 27 mental illness 
disorders, as classified for this specific database. Refer to Table X for a summary of disorders 
specified in this dataset. 
391 out of 2 092 183 patients diagnosed with mental retardation, translates to 0.019% of the 




b. 2009  
In 2009, 500 patients were diagnosed as suffering from mental retardation. This value is 109 
more patients than in 2008 and translates to a 21.8% increase in diagnosis of mental retardation, 
when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
500 out of 2 192 129 patients diagnosed with mental retardation, translates to 0.023% of the 
total claimant population.  
c. 2010 
In 2010, 535 patients were diagnosed as suffering from mental retardation. This value is 35 
more patients than in 2009 and translates to a 6.54% increase in diagnosis of mental retardation, 
when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
535 out of 2 434 220 patients diagnosed with mental retardation, translates to 0.022% of the 
total claimant population.  
d. 2011 
In 2011, 626 patients were diagnosed as suffering from mental retardation. This value is 91 




retardation, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
626 out of 2 581 043 patients diagnosed with mental retardation, translates to 0.024% of the 
total claimant population.  
e. 2012 
In 2012, 601 patients were diagnosed as suffering from mental retardation. This value is 25 less 
patients than in 2011 and translates to a 3.99% decrease in diagnosis of mental retardation, 
when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
601 out of 2 711 594 patients diagnosed with mental retardation, translates to 0.022% of the 
total claimant population.  
f. 2013 
In 2013, 657 patients were diagnosed as suffering from mental retardation. This value is 56 
more patients than in 2012 and translates to an 8.52% increase in diagnosis of mental 
retardation, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




657 out of 2 822 416 patients diagnosed with mental retardation, translates to 0.023% of the 
total claimant population.  
g. 2014 
In 2014, 633 patients were diagnosed as suffering from mental retardation. This value is 24 less 
patients than in 2013 and translates to a 3.65% decrease in diagnosis of mental retardation, 
when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
633 out of 2 923 433 patients diagnosed with mental retardation, translates to 0.022% of the 
total claimant population.  
h. 2015 
From January to June of 2015, 421 patients were diagnosed as suffering from mental 
retardation. By mid-year 2014, the number of patients is 273 (according to Table: 
Database_2008_2015_ Mental Retardation). By June 2015, 148 more patients are recorded 
when compared to the half-year sum for 2014. This translates to a 35.15% increase in patient 
diagnosis. Therefore the 35.15% increase is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 855 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




855 out of 3 031 600 patients diagnosed with mental retardation, translates to 0.028% of the 
total claimant population.  
Table LD26 
Results summary: Mental Retardation 
Year Diagnosis % Increase/Decrease % Diagnosis with Population 
2008 N/A 0.019% 
2009 21.80% increase 0.023% 
2010 6.54% increase 0.022% 
2011 14.54% increase 0.024% 
2012 3.99% decrease 0.022% 
2013 8.52% increase 0.023% 
2014 3.65% decrease 0.022% 
2015 35.15% increase 0.028% 
Chart LD26: Disorder Trend: Mental Retardation 
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Summary of Table LD26 and Chart LD26. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with mental retardation is 0.023%, within the entire database. The lowest 
frequency of mental retardation is in 2008, with a percentage of 0.019% occurrence within the 
entire population and the highest frequency is in 2015, with a percentage of 0.028% of the total 
database population.  
The diagnosis trend shows an initial increase in patient numbers across time, followed by an 
incremental increase in diagnosis numbers, which approach a constant frequency rate for this 
diagnosis. The forecast predicts a constant frequency rate of patients diagnosed with mental 







Table LD27 and Chart LD27, summarise the total number of patients diagnosed with non-
specific neuroses per year (from 2008 – 2015). The total number of diagnoses per year are 
shown against the total database population per year.  
Chart LD27: Longitudinal Data (2008 – 2015): Non-Specific Neuroses 
 





Table LD27  
Longitudinal Data (2008 – 2015): Non-Specific Neuroses 
Diagnosis Year Total Patients Total DP 
Non-specific neuroses 2008 60 033 2,092,183 
Non-specific neuroses 2009 56 811 2,192,129 
Non-specific neuroses 2010 59 611 2,434,220 
Non-specific neuroses 2011 61 981 2,581,043 
Non-specific neuroses 2012 63 631 2,711,594 
Non-specific neuroses 2013 64 061 2,822,416 
Non-specific neuroses 2014 65 193 2,923,433 
Non-specific neuroses 2015 34 870 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 60 033 patients were diagnosed as suffering from non-specific neuroses. This is the 
total number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. non-specific neuroses as a diagnosis is one of 27 mental 
illness disorders, as classified for this specific database. Refer to Table X for a summary of 
disorders specified in this dataset. 
60 033 out of 2 092 183 patients diagnosed with non-specific neuroses, translates to 2.870% of 




b. 2009  
In 2009, 56 811 patients were diagnosed as suffering from non-specific neuroses. This value is 
3222 less patients than in 2008 and translates to a 5.37% decrease in diagnosis of non-specific 
neuroses, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
56 811 out of 2 192 129 patients diagnosed with non-specific neuroses, translates to 2.592% of 
the total claimant population.  
c. 2010 
In 2010, 59 611 patients were diagnosed as suffering from non-specific neuroses. This value is 
2800 more patients than in 2009 and translates to a 4.7% increase in diagnosis of non-specific 
neuroses, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
59 611 out of 2 434 220 patients diagnosed with non-specific neuroses, translates to 2.449% of 
the total claimant population.  
d. 2011 
In 2011, 61 981 patients were diagnosed as suffering from non-specific neuroses. This value is 




neuroses, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
61 981 out of 2 581 043 patients diagnosed with non-specific neuroses, translates to 2.401% of 
the total claimant population.  
e. 2012 
In 2012, 63 631 patients were diagnosed as suffering from non-specific neuroses. This value is 
1650 more patients than in 2011 and translates to a 2.59% increase in diagnosis of non-specific 
neuroses, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
63 631 out of 2 711 594 patients diagnosed with non-specific neuroses, translates to 2.347% of 
the total claimant population.  
f. 2013 
In 2013, 64 061 patients were diagnosed as suffering from non-specific neuroses. This value is 
430 more patients than in 2012 and translates to a 0.67% increase in diagnosis of non-specific 
neuroses, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




64 061 out of 2 822 416 patients diagnosed with non-specific neuroses, translates to 2.270% of 
the total claimant population.  
g. 2014 
In 2014, 65 193 patients were diagnosed as suffering from non-specific neuroses. This value is 
1132 more patients than in 2013 and translates to a 1.74% increase in diagnosis of non-specific 
neuroses, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
65 193 out of 2 923 433 patients diagnosed with non-specific neuroses, translates to 2.23% of 
the total claimant population.  
h. 2015 
From January to June of 2015, 34 870 patients were diagnosed as suffering from non-specific 
neuroses. By mid-year 2014, the number of patients is 34 984 (according to Table: 
Database_2008_2015_ Non-Specific Neuroses). By June 2015, 114 less patients are recorded 
when compared to the half-year sum for 2014. This translates to a 0.33% decrease in patient 
diagnosis. Therefore the 35.15% decrease is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 64 978 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




64 978 out of 3 031 600 patients diagnosed with non-specific neuroses, translates to 2.143% of 
the total claimant population.  
Table LD28  
Results summary: Non-Specific Neuroses 
Year Diagnosis % 
Increase/Decrease 
% Diagnosis within Population 
2008 N/A 2.870% 
2009 5.37% decrease 2.592% 
2010 4.70% increase 2.449% 
2011 3.82% increase 2.401% 
2012 2.59% decrease 2.347% 
2013 0.67% increase 2.270% 
2014 1.74% increase 2.230% 
2015 0.33% decrease 2.143% 
Chart LD28: Disorder Trend: Non-Specific Neuroses 
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Summary of Table LD28 and Chart LD28. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with non-specific neuroses is 2.413%, within the entire database. The lowest 
frequency of non-specific neuroses is in 2015, with a percentage of 2.143% occurrence within 
the entire population and the highest frequency is in 2008, with a percentage of 2.87% of the 
total database population.  
The diagnosis trend shows an initial decrease in patient numbers across time, followed by a 
steep increase in diagnosis number from 2010 - 2013, but which thereafter approach a constant 
frequency rate for this diagnosis. The forecast predicts a decline in frequency rate of patients 







Table LD29 and Chart LD29, summarise the total number of patients diagnosed with non-
specific psychoses per year (from 2008 – 2015). The total number of diagnoses per year are 
shown against the total database population per year.  
Chart LD29: Longitudinal Data (2008 – 2015): Non-Specific Psychoses 
 





Table LD29  
Longitudinal Data (2008 – 2015): Non-Specific Psychoses 
Diagnosis Year Total Patients Total DP 
Non-specific psychoses 2008 432 2,092,183 
Non-specific psychoses 2009 454 2,192,129 
Non-specific psychoses 2010 402 2,434,220 
Non-specific psychoses 2011 380 2,581,043 
Non-specific psychoses 2012 408 2,711,594 
Non-specific psychoses 2013 509 2,822,416 
Non-specific psychoses 2014 494 2,923,433 
Non-specific psychoses 2015 280 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 432 patients were diagnosed as suffering from non-specific psychoses. This is the total 
number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Non-specific psychoses as a diagnosis is one of 27 mental 
illness disorders, as classified for this specific database. Refer to Table X for a summary of 
disorders specified in this dataset. 
432 out of 2 092 183 patients diagnosed with non-specific psychoses, translates to 0.021% of 




b. 2009  
In 2009, 454 patients were diagnosed as suffering from non-specific psychoses. This value is 22 
more patients than in 2008 and translates to a 4.85% increase in diagnosis of non-specific 
psychoses, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
454 out of 2 192 129 patients diagnosed with non-specific psychoses, translates to 0.021% of 
the total claimant population.  
c. 2010 
In 2010, 402 patients were diagnosed as suffering from non-specific psychoses. This value is 
2800 less patients than in 2009 and translates to an 11.45% decrease in diagnosis of non-
specific psychoses, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
402 out of 2 434 220 patients diagnosed with non-specific psychoses, translates to 0.017% of 
the total claimant population.  
d. 2011 
In 2011, 380 patients were diagnosed as suffering from non-specific psychoses. This value is 22 




psychoses, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
380 out of 2 581 043 patients diagnosed with non-specific psychoses, translates to 0.015% of 
the total claimant population.  
e. 2012 
In 2012, 408 patients were diagnosed as suffering from non-specific psychoses. This value is 28 
more patients than in 2011 and translates to a 6.86% increase in diagnosis of non-specific 
psychoses, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
408 out of 2 711 594 patients diagnosed with non-specific psychoses translates to 0.015% of the 
total claimant population.  
f. 2013 
In 2013, 509 patients were diagnosed as suffering from non-specific psychoses. This value is 
430 more patients than in 2012 and translates to a 19.84% increase in diagnosis of non-specific 
psychoses, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




509 out of 2 822 416 patients diagnosed with non-specific psychoses, translates to 0.018% of 
the total claimant population.  
g. 2014 
In 2014, 494 patients were diagnosed as suffering from non-specific psychoses. This value is 15 
less patients than in 2013 and translates to a 2.95% decrease in diagnosis of non-specific 
psychoses, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
494 out of 2 923 433 patients diagnosed with non-specific psychoses, translates to 0.017% of 
the total claimant population.  
h. 2015 
From January to June of 2015, 280 patients were diagnosed as suffering from non-specific 
psychoses. By mid-year 2014, the number of patients is 254 (according to Table: 
Database_2008_2015_ Non-Specific Psychoses). By June 2015, 114 more patients are recorded 
when compared to the half-year sum for 2014. This translates to a 9.29% increase in patient 
diagnosis. Therefore the 9.29% increase is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 540 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




540 out of 3 031 600 patients diagnosed with non-specific psychoses, translates to 0.018% of 
the total claimant population.  
Table LD30  
Results summary: Non-Specific Psychoses 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 0.021% 
2009 4.85% increase 0.021% 
2010 11.45% decrease 0.017% 
2011 5.47% decrease 0.015% 
2012 6.86% increase 0.015% 
2013 19.84% increase 0.018% 
2014 2.95% decrease 0.017% 
2015 9.29% increase 0.018% 
Chart LD30: Disorder Trend: Non-Specific Psychoses 
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Summary of Table LD30 and Chart LD30. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with non-specific psychoses is 0.018%, within the entire database. The 
lowest frequencies of non-specific psychoses are in 2011 and 2012, with a percentage of 
0.015% occurrence within the entire population and the highest frequencies are in 2008 and 
2009, with a percentage of 0.021% of the total database population.  
The diagnosis trend shows a significant fluctuating in patient numbers until 2013, but thereafter 
the trend shows a decline in frequency rate for this diagnosis. The forecast predicts a steep 






Obsessive Compulsive Disorder 
Table LD31 and Chart LD31, summarise the total number of patients diagnosed with obsessive 
compulsive disorder per year (from 2008 – 2015). The total number of diagnoses per year are 
shown against the total database population per year.  
Chart LD31: Longitudinal Data (2008 – 2015): Obsessive Compulsive Disorder 
 





Table LD31  
Longitudinal Data (2008 – 2015): Obsessive Compulsive Disorder 
Diagnosis Year Total Patients Total DP 
Obsessive compulsive disorder 2008 4 530 2,092,183 
Obsessive compulsive disorder 2009 5 281 2,192,129 
Obsessive compulsive disorder 2010 5 753 2,434,220 
Obsessive compulsive disorder 2011 6 802 2,581,043 
Obsessive compulsive disorder 2012 7 227 2,711,594 
Obsessive compulsive disorder 2013 7 976 2,822,416 
Obsessive compulsive disorder 2014 8 003 2,923,433 
Obsessive compulsive disorder 2015 3 991 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 4530 patients were diagnosed as suffering from obsessive compulsive disorder. This is 
the total number of diagnoses, includes both male and female patients. The ratio of male to 
female patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Obsessive compulsive disorder as a diagnosis is one of 27 
mental illness disorders, as classified for this specific database. Refer to Table X for a summary 
of disorders specified in this dataset. 
4530 out of 2 092 183 patients diagnosed with obsessive compulsive disorder, translates to 




b. 2009  
In 2009, 5281 patients were diagnosed as suffering from obsessive compulsive disorder. This 
value is 751 more patients than in 2008 and translates to a 14.22% increase in diagnosis of 
obsessive compulsive disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
5281 out of 2 192 129 patients diagnosed with obsessive compulsive disorder, translates to 
0.241% of the total claimant population.  
c. 2010 
In 2010, 5753 patients were diagnosed as suffering from obsessive compulsive disorder. This 
value is 472 more patients than in 2009 and translates to an 8.20% increase in diagnosis of 
obsessive compulsive disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
5753 out of 2 434 220 patients diagnosed with obsessive compulsive disorder, translates to 
0.236% of the total claimant population.  
d. 2011 
In 2011, 6802 patients were diagnosed as suffering from obsessive compulsive disorder. This 




obsessive compulsive disorder, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
6802 out of 2 581 043 patients diagnosed with obsessive compulsive disorder, translates to 
0.264% of the total claimant population.  
e. 2012 
In 2012, 7227 patients were diagnosed as suffering from obsessive compulsive disorder. This 
value is 425 more patients than in 2011 and translates to a 5.88% increase in diagnosis of 
obsessive compulsive disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
7227 out of 2 711 594 patients diagnosed with obsessive compulsive disorder translates to 
0.267% of the total claimant population.  
f. 2013 
In 2013, 7976 patients were diagnosed as suffering from obsessive compulsive disorder. This 
value is 749 more patients than in 2012 and translates to a 9.39% increase in diagnosis of 
obsessive compulsive disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




7976 out of 2 822 416 patients diagnosed with obsessive compulsive disorder, translates to 
0.283% of the total claimant population.  
g. 2014 
In 2014, 8003 patients were diagnosed as suffering from obsessive compulsive disorder. This 
value is 27 more patients than in 2013 and translates to a 0.34% increase in diagnosis of 
obsessive compulsive disorder, when compared to 2013 
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
8003 out of 2 923 433 patients diagnosed with obsessive compulsive disorder, translates to 
0.274% of the total claimant population.  
h. 2015 
From January to June of 2015, 3991 patients were diagnosed as suffering from obsessive 
compulsive disorder. By mid-year 2014, the number of patients is 4148 (according to Table: 
Database_2008_2015_Obsessive Compulsive Disorder). By June 2015, 157 less patients are 
recorded when compared to the half-year sum for 2014. This translates to a 3.78% decrease in 
patient diagnosis. Therefore the 3.78% decrease is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 7700 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




7700 out of 3 031 600 patients diagnosed with obsessive compulsive disorder, translates to 
0.254% of the total claimant population.  
Table LD32  
Results summary: Obsessive Compulsive Disorder 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 0.021% 
2009 4.85% increase 0.021% 
2010 11.45% decrease 0.017% 
2011 5.47% decrease 0.015% 
2012 6.86% increase 0.015% 
2013 19.84% increase 0.018% 
2014 2.95% decrease 0.017% 
2015 9.29% increase 0.018% 
Chart LD32: Disorder Trend: Obsessive Compulsive Disorder 
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Summary of Table LD32 and Chart LD32. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with obsessive compulsive disorder is 0.018%, within the entire database. 
The lowest frequencies of obsessive compulsive disorder are in 2011 and 2012, with a 
percentage of 0.015% occurrence within the entire population and the highest frequencies are in 
2008 and 2009, with a percentage of 0.021% of the total database population.  
The diagnosis trend shows an increase in patient numbers from 2008 to 2011, but the trend 
approaches a constant frequency rate for this diagnosis. The forecast predicts a constant 






Parasomnia or Sleep Disorder 
Table LD33 and Chart LD33, summarise the total number of patients diagnosed with 
parasomnia or sleep disorder per year (from 2008 – 2015). The total number of diagnoses per 
year are shown against the total database population per year.  
Chart LD33: Longitudinal Data (2008 – 2015): Parasomnia or Sleep Disorder 
 





Table LD33  
Longitudinal Data (2008 – 2015): Parasomnia or Sleep Disorder 
Diagnosis Year Total Patients Total DP 
Parasomnia or sleep disorder 2008 66 776 2,092,183 
Parasomnia or sleep disorder 2009 95 149 2,192,129 
Parasomnia or sleep disorder 2010 116 527 2,434,220 
Parasomnia or sleep disorder 2011 133 122 2,581,043 
Parasomnia or sleep disorder 2012 144 336 2,711,594 
Parasomnia or sleep disorder 2013 158 248 2,822,416 
Parasomnia or sleep disorder 2014 171 598 2,923,433 
Parasomnia or sleep disorder 2015 93 776 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 66 776 patients were diagnosed as suffering from parasomnia or sleep disorder. This is 
the total number of diagnoses, includes both male and female patients. The ratio of male to 
female patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Parasomnia or sleep disorder as a diagnosis is one of 27 
mental illness disorders, as classified for this specific database. Refer to Table X for a summary 
of disorders specified in this dataset. 
66 776 out of 2 092 183 patients diagnosed with parasomnia or sleep disorder, translates to 




b. 2009  
In 2009, 95 149 patients were diagnosed as suffering from parasomnia or sleep disorder. This 
value is 28 373 more patients than in 2008 and translates to a 29.82% increase in diagnosis of 
parasomnia or sleep disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
95 149 out of 2 192 129 patients diagnosed with parasomnia or sleep disorder, translates to 
4.34% of the total claimant population.  
c. 2010 
In 2010, 116 527 patients were diagnosed as suffering from parasomnia or sleep disorder. This 
value is 21 378 more patients than in 2009 and translates to an 18.36% increase in diagnosis of 
parasomnia or sleep disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
116 527 out of 2 434 220 patients diagnosed with parasomnia or sleep disorder, translates to 
4.796% of the total claimant population.  
d. 2011 
In 2011, 133 122 patients were diagnosed as suffering from parasomnia or sleep disorder. This 




parasomnia or sleep disorder, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 5.7% growth in claimant population in one year. 
133 122 out of 2 581 043 patients diagnosed with parasomnia or sleep disorder, translates to 
5.16% of the total claimant population.  
e. 2012 
In 2012, 144 336 patients were diagnosed as suffering from parasomnia or sleep disorder. This 
value is 11 214 more patients than in 2011 and translates to a 5.88% increase in diagnosis of 
parasomnia or sleep disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
144 336 out of 2 711 594 patients diagnosed with parasomnia or sleep disorder translates to 
5.33% of the total claimant population.  
f. 2013 
In 2013, 158 248 patients were diagnosed as suffering from parasomnia or sleep disorder. This 
value is 13 912 more patients than in 2012 and translates to an 8.79% increase in diagnosis of 
parasomnia or sleep disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




158 248 out of 2 822 416 patients diagnosed with parasomnia or sleep disorder, translates to 
5.61% of the total claimant population.  
g. 2014 
In 2014, 171 598 patients were diagnosed as suffering from parasomnia or sleep disorder. This 
value is 13 350 more patients than in 2013 and translates to a 7.78% increase in diagnosis of 
parasomnia or sleep disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
171 598 out of 2 923 433 patients diagnosed with parasomnia or sleep disorder, translates to 
5.87% of the total claimant population.  
h. 2015 
From January to June of 2015, 93 776 patients were diagnosed as suffering from parasomnia or 
sleep disorder. By mid-year 2014, the number of patients is 98 550 (according to Table: 
Database_2008_2015_Parasomnia or Sleep Disorder). By June 2015, 4 774 less patients are 
recorded when compared to the half-year sum for 2014. This translates to a 4.84% decrease in 
patient diagnosis. Therefore the 4.84% decrease is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 163 910 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




163 910 out of 3 031 600 patients diagnosed with parasomnia or sleep disorder, translates to 
5.41% of the total claimant population.  
Table LD34  
Results summary: Parasomnia or Sleep Disorder 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 3.19% 
2009 29.82% increase 4.34% 
2010 18.63% increase 4.80% 
2011 12.47% increase 5.16% 
2012 5.88% increase 5.33% 
2013 8.79% increase 5.61% 
2014 7.78% increase 5.87% 
2015 4.84% decrease 5.14% 
Chart LD34: Disorder Trend: Parasomnia or Sleep Disorder 
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Summary of Table LD34 and Chart LD34. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with parasomnia or sleep disorder is 4.93%, within the entire database. The 
lowest frequency of parasomnia or sleep disorder is in 2008, with a percentage of 3.19% 
occurrence within the entire population and the highest frequency is in 2014, with a percentage 
of 5.87% of the total database population.  
The diagnosis trend shows a steep increase in patient numbers across time. The forecast 







Table LD35 and Chart LD35, summarise the total number of patients diagnosed with 
personality disorder per year (from 2008 – 2015). The total number of diagnoses per year are 
shown against the total database population per year.  
Chart LD35: Longitudinal Data (2008 – 2015): Personality Disorder 
 





Table LD35  
Longitudinal Data (2008 – 2015): Personality Disorder 
Diagnosis Year Total Patients Total DP 
Personality disorder 2008 553 2,092,183 
Personality disorder 2009 607 2,192,129 
Personality disorder 2010 701 2,434,220 
Personality disorder 2011 760 2,581,043 
Personality disorder 2012 712 2,711,594 
Personality disorder 2013 686 2,822,416 
Personality disorder 2014 784 2,923,433 
Personality disorder 2015 484 2,984,103 
The results are as follows: 
a) 2008 
In 2008, 553 patients were diagnosed as suffering from personality disorder. This is the total 
number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. personality disorder as a diagnosis is one of 27 mental illness 
disorders, as classified for this specific database. Refer to Table X for a summary of disorders 
specified in this dataset. 
553 out of 2 092 183 patients diagnosed with personality disorder, translates to 0.03% of the 




b. 2009  
In 2009, 607 patients were diagnosed as suffering from personality disorder. This value is 54 
more patients than in 2008 and translates to an 8.9% increase in diagnosis of personality 
disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
607 out of 2 192 129 patients diagnosed with personality disorder, translates to 0.03% of the 
total claimant population.  
c. 2010 
In 2010, 701 patients were diagnosed as suffering from personality disorder. This value is 94 
more patients than in 2009 and translates to a 13.41% increase in diagnosis of personality 
disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
701 out of 2 434 220 patients diagnosed with personality disorder, translates to 0.03% of the 
total claimant population.  
d. 2011 
In 2011, 760 patients were diagnosed as suffering from personality disorder. This value is 59 




disorder, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 7.76% growth in claimant population in one year. 
760 out of 2 581 043 patients diagnosed with personality disorder, translates to 0.03% of the 
total claimant population.  
e. 2012 
In 2012, 712 patients were diagnosed as suffering from personality disorder. This value is 48 
less patients than in 2011 and translates to a 6.32% decrease in diagnosis of personality 
disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
712 out of 2 711 594 patients diagnosed with personality disorder translates to 0.03% of the 
total claimant population.  
f. 2013 
In 2013, 686 patients were diagnosed as suffering from personality disorder. This value is 26 
less patients than in 2012 and translates to a 3.65% decrease in diagnosis of personality 
disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




686 out of 2 822 416 patients diagnosed with personality disorder, translates to 0.02% of the 
total claimant population.  
g. 2014 
In 2014, 784 patients were diagnosed as suffering from personality disorder. This value is 98 
more patients than in 2013 and translates to a 12.5% increase in diagnosis of Personality 
Disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 3.5% growth in claimant population in one year. 
784 out of 2 923 433 patients diagnosed with personality disorder, translates to 0.03% of the 
total claimant population.  
h. 2015 
From January to June of 2015, 484 patients were diagnosed as suffering from personality 
disorder. By mid-year 2014, the number of patients is 408 (according to Table: 
Database_2008_2015_Personality Disorder). By June 2015, 76 more patients are recorded 
when compared to the half-year sum for 2014. This translates to a 15.7% increase in patient 
diagnosis. Therefore the 15.7% increase is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 907 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




907 out of 3 031 600 patients diagnosed with personality disorder, translates to 0.03% of the 
total claimant population.  
Table LD36  
Results summary: Personality Disorder 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 0.03% 
2009 8.9% increase 0.03% 
2010 13.41% increase 0.03% 
2011 7.76% increase 0.03% 
2012 6.32% decrease 0.03% 
2013 3.65% decrease 0.02% 
2014 12.50% increase 0.03% 
2015 15.70% increase 0.03% 
Chart LD36: Disorder Trend: Personality Disorder 
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Summary of Table LD36 and Chart LD36. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with personality disorder is 0.03%, within the entire database. The lowest 
frequency of personality disorder is in 2013, with a percentage of 0.03% occurrence within the 
entire population and the remaining years have a frequency rate of 0.03% of the total database 
population.  
The diagnosis trend shows patient numbers fluctuate gently across time. The forecast predicts a 
significant increase in frequency rate in patients diagnosed with personality disorder going 






Psychosis due to General Medical Disorder 
Table LD37 and Chart LD37, summarise the total number of patients diagnosed with psychosis 
due to general medical disorder per year (from 2008 – 2015). The total number of diagnoses per 
year are shown against the total database population per year.  
Chart LD37: Longitudinal Data (2008 – 2015): Psychosis due to General Medical Disorder 
 






Longitudinal Data (2008 – 2015): Psychosis due to General Medical Disorder 
Diagnosis Year Total Patients Total DP 
Psychosis due to a general medical disorder 2008 627 2,092,183 
Psychosis due to a general medical disorder 2009 666 2,192,129 
Psychosis due to a general medical disorder 2010 651 2,434,220 
Psychosis due to a general medical disorder 2011 698 2,581,043 
Psychosis due to a general medical disorder 2012 734 2,711,594 
Psychosis due to a general medical disorder 2013 854 2,822,416 
Psychosis due to a general medical disorder 2014 1 015 2,923,433 
Psychosis due to a general medical disorder 2015 563 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 627 patients were diagnosed as suffering from psychosis due to general medical 
disorder. This is the total number of diagnoses, includes both male and female patients. The 
ratio of male to female patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Psychosis due to general medical disorder as a diagnosis is 
one of 27 mental illness disorders, as classified for this specific database. Refer to Table X for a 
summary of disorders specified in this dataset. 
627 out of 2 092 183 patients diagnosed with psychosis due to general medical disorder, 





b. 2009  
In 2009, 666 patients were diagnosed as suffering from psychosis due to general medical 
disorder. This value is 39 more patients than in 2008 and translates to an 5.86% increase in 
diagnosis of psychosis due to general medical disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
666 out of 2 192 129 patients diagnosed with psychosis due to general medical disorder, 
translates to 0.03% of the total claimant population.  
c. 2010 
In 2010, 651 patients were diagnosed as suffering from psychosis due to general medical 
disorder. This value is 15 less patients than in 2009 and translates to a 2.25% decrease in 
diagnosis of psychosis due to general medical disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
651 out of 2 434 220 patients diagnosed with psychosis due to general medical disorder, 
translates to 0.03% of the total claimant population.  
d. 2011 
In 2011, 698 patients were diagnosed as suffering from psychosis due to general medical 




diagnosis of psychosis due to general medical disorder, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 7.76% growth in claimant population in one year. 
698 out of 2 581 043 patients diagnosed with psychosis due to general medical disorder, 
translates to 0.03% of the total claimant population.  
e. 2012 
In 2012, 734 patients were diagnosed as suffering from psychosis due to general medical 
disorder. This value is 36 more patients than in 2011 and translates to a 4.9% increase in 
diagnosis of psychosis due to general medical disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
734 out of 2 711 594 patients diagnosed with psychosis due to general medical disorder 
translates to 0.03% of the total claimant population.  
f. 2013 
In 2013, 854 patients were diagnosed as suffering from psychosis due to general medical 
disorder. This value is 120 more patients than in 2012 and translates to a 14.05% increase in 
diagnosis of psychosis due to general medical disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




854 out of 2 822 416 patients diagnosed with psychosis due to general medical disorder, 
translates to 0.03% of the total claimant population.  
g. 2014 
In 2014, 1 015 patients were diagnosed as suffering from psychosis due to general medical 
disorder. This value is 161 more patients than in 2013 and translates to a 12.5% increase in 
diagnosis of psychosis due to general medical disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 15.86% growth in claimant population in one year. 
1 015 out of 2 923 433 patients diagnosed with psychosis due to general medical disorder, 
translates to 0.03% of the total claimant population.  
h. 2015 
From January to June of 2015, 563 patients were diagnosed as suffering from psychosis due to 
general medical disorder. By mid-year 2014, the number of patients is 528 (according to Table: 
Database_2008_2015_Obsessive Compulsive Disorder). By June 2015, 35 more patients are 
recorded when compared to the half-year sum for 2014. This translates to a 6.22% increase in 
patient diagnosis. Therefore the 6.22% increase is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 1 078 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




1 078 out of 3 031 600 patients diagnosed with psychosis due to general medical disorder, 
translates to 0.04% of the total claimant population.  
Table LD38  
Results summary: Psychosis due to General Medical Disorder 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 0.03% 
2009 5.86% increase 0.03% 
2010 2.25% decrease 0.03% 
2011 6.73% increase 0.03% 
2012 4.90% increase 0.03% 
2013 14.05% increase 0.03% 
2014 15.86% increase 0.03% 
2015 6.22% increase 0.04% 
Chart LD38: Disorder Trend: Psychosis due to General Medical Disorder 
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Summary of Table LD38 and Chart LD38. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with psychosis due to general medical disorder is 0.03%, within the entire 
database. The highest frequency of psychosis due to general medical disorder is in 2015, with a 
percentage of 0.04% occurrence within the entire population and the remaining years have a 
frequency rate of 0.03% of the total database population.  
The diagnosis trend shows patient numbers reveal a constant increase across time. The forecast 
predicts a significant increase in frequency rate in patients diagnosed with psychosis due to 






Psycho-Social Disorder of Childhood 
Table LD39 and Chart LD39, summarise the total number of patients diagnosed with psycho-
social disorder of childhood per year (from 2008 – 2015). The total number of diagnoses per 
year are shown against the total database population per year.  
Chart LD39: Longitudinal Data (2008 – 2015): Psycho-Social Disorder of Childhood 
 





Table LD39  
Longitudinal Data (2008 – 2015): Psycho-Social Disorder of Childhood 
Diagnosis Year Total Patients Total DP 
Psycho-social disorder of childhood 2008 8 051 2,092,183 
Psycho-social disorder of childhood 2009 8 393 2,192,129 
Psycho-social disorder of childhood 2010 8 302 2,434,220 
Psycho-social disorder of childhood 2011 8 739 2,581,043 
Psycho-social disorder of childhood 2012 8 482 2,711,594 
Psycho-social disorder of childhood 2013 8 466 2,822,416 
Psycho-social disorder of childhood 2014 8 246 2,923,433 
Psycho-social disorder of childhood 2015 5 106 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 8 051 patients were diagnosed as suffering from psycho-social disorder of childhood. 
This is the total number of diagnoses, includes both male and female patients. The ratio of male 
to female patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Psycho-social disorder of childhood as a diagnosis is one of 
27 mental illness disorders, as classified for this specific database. Refer to Table X for a 
summary of disorders specified in this dataset. 
8 051 out of 2 092 183 patients diagnosed with psycho-social disorder of childhood, translates 





b. 2009  
In 2009, 8 393 patients were diagnosed as suffering from psycho-social disorder of childhood. 
This value is 342 more patients than in 2008 and translates to a 4.07% increase in diagnosis of 
psycho-social disorder of childhood, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
8 393 out of 2 192 129 patients diagnosed with psycho-social disorder of childhood, translates 
to 0.38% of the total claimant population.  
c. 2010 
In 2010, 8 302 patients were diagnosed as suffering from psycho-social disorder of childhood. 
This value is 91 less patients than in 2009 and translates to a 1.08% decrease in diagnosis of 
psycho-social disorder of childhood, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
8 302 out of 2 434 220 patients diagnosed with psycho-social disorder of childhood, translates 
to 0.34% of the total claimant population.  
d. 2011 
In 2011, 8 739 patients were diagnosed as suffering from psycho-social disorder of childhood. 




psycho-social disorder of childhood, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 7.76% growth in claimant population in one year. 
8 739 out of 2 581 043 patients diagnosed with psycho-social disorder of childhood, translates 
to 0.34% of the total claimant population.  
e. 2012 
In 2012, 8 482 patients were diagnosed as suffering from psycho-social disorder of childhood. 
This value is 257 less patients than in 2011 and translates to a 2.94% decrease in diagnosis of 
psycho-social disorder of childhood, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
8 482 out of 2 711 594 patients diagnosed with psycho-social disorder of childhood translates to 
0.31% of the total claimant population.  
f. 2013 
In 2013, 8 466 patients were diagnosed as suffering from psycho-social disorder of childhood. 
This value is 16 less patients than in 2012 and translates to a 0.19% decrease in diagnosis of 
psycho-social disorder of childhood, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




8 466 out of 2 822 416 patients diagnosed with psycho-social disorder of childhood, translates 
to 0.3% of the total claimant population.  
g. 2014 
In 2014, 8 246 patients were diagnosed as suffering from psycho-social disorder of childhood. 
This value is 220 less patients than in 2013 and translates to a 2.6% decrease in diagnosis of 
psycho-social disorder of childhood, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 15.86% growth in claimant population in one year. 
8 246 out of 2 923 433 patients diagnosed with psycho-social disorder of childhood, translates 
to 0.28% of the total claimant population.  
h. 2015 
From January to June of 2015, 5 106 patients were diagnosed as suffering from psycho-social 
disorder of childhood. By mid-year 2014, the number of patients is 4 400 (according to Table: 
Database_2008_2015_Psycho-Social Disorder of Childhood). By June 2015, 706 more patients 
are recorded when compared to the half-year sum for 2014. This translates to a 13.83% increase 
in patient diagnosis. Therefore the 13.83% increase is extrapolated for the remaining 
(unrecorded) subsequent 6 months, to give an estimated patient number of 9 386 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




9 386 out of 3 031 600 patients diagnosed with psycho-social disorder of childhood, translates 
to 0.31% of the total claimant population.  
Table LD40 
Results summary: Psycho-Social Disorder of Childhood 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 0.38% 
2009 4.07% increase 0.38% 
2010 1.08% decrease 0.34% 
2011 5.00% increase 0.34% 
2012 2.94% decrease 0.31% 
2013 0.19% decrease 0.30% 
2014 2.60% decrease 0.28% 
2015 13.86% increase 0.31% 
Chart LD40: Disorder Trend: Psycho-Social Disorder of Childhood 
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Summary of Table LD40 and Chart LD40. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with psycho-social disorder of childhood is 0.33%, within the entire 
database. The lowest frequency of psycho-social disorder of childhood is in 2014, with a 
percentage of 0.28% occurrence within the entire population and the highest frequencies are in 
2008 and 2009, with a percentage of 0.38% of the total database population.   
The diagnosis trend shows a clear polynomial trend, with an initial increase in patient numbers, 
peaking in 2011. Thereafter, from 2011 onwards, there is a mirrored equivalent decline in 







Table LD41 and Chart LD41, summarise the total number of patients diagnosed with 
schizophrenia per year (from 2008 – 2015). The total number of diagnoses per year are shown 
against the total database population per year.  
Chart LD41: Longitudinal Data (2008 – 2015): Schizophrenia 
 





Table LD41  
Longitudinal Data (2008 – 2015): Schizophrenia 
Diagnosis Year Total Patients Total DP 
Schizophrenia 2008 11 930 2,092,183 
Schizophrenia 2009 12 702 2,192,129 
Schizophrenia 2010 13 608 2,434,220 
Schizophrenia 2011 15 173 2,581,043 
Schizophrenia 2012 16 027 2,711,594 
Schizophrenia 2013 16 545 2,822,416 
Schizophrenia 2014 17 280 2,923,433 
Schizophrenia 2015 9 014 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 11 930 patients were diagnosed as suffering from schizophrenia. This is the total 
number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Schizophrenia as a diagnosis is one of 27 mental illness 
disorders, as classified for this specific database. Refer to Table X for a summary of disorders 
specified in this dataset. 
11 930 out of 2 092 183 patients diagnosed with schizophrenia, translates to 0.57% of the total 




b. 2009  
In 2009, 12 702 patients were diagnosed as suffering from schizophrenia. This value is 772 
more patients than in 2008 and translates to a 6.08% increase in diagnosis of schizophrenia, 
when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
12 702 out of 2 192 129 patients diagnosed with schizophrenia, translates to 0.58% of the total 
claimant population.  
c. 2010 
In 2010, 13 608 patients were diagnosed as suffering from schizophrenia. This value is 906 
more patients than in 2009 and translates to a 6.68% increase in diagnosis of schizophrenia, 
when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
13 608 out of 2 434 220 patients diagnosed with schizophrenia, translates to 0.56% of the total 
claimant population.  
d. 2011 
In 2011, 15 173 patients were diagnosed as suffering from schizophrenia. This value is 1 565 




when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 7.76% growth in claimant population in one year. 
15 173 out of 2 581 043 patients diagnosed with schizophrenia, translates to 0.59% of the total 
claimant population.  
e. 2012 
In 2012, 16 027 patients were diagnosed as suffering from schizophrenia. This value is 257 
more patients than in 2011 and translates to a 5.33% increase in diagnosis of schizophrenia, 
when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
16 027 out of 2 711 594 patients diagnosed with schizophrenia translates to 0.59% of the total 
claimant population.  
f. 2013 
In 2013, 16 545 patients were diagnosed as suffering from schizophrenia. This value is 518 
more patients than in 2012 and translates to a 3.1% increase in diagnosis of schizophrenia, 
when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




16 545 out of 2 822 416 patients diagnosed with schizophrenia, translates to 0.59% of the total 
claimant population.  
g. 2014 
In 2014, 17 280 patients were diagnosed as suffering from schizophrenia. This value is 735 
more patients than in 2013 and translates to a 4.25% increase in diagnosis of schizophrenia, 
when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 15.86% growth in claimant population in one year. 
17 280 out of 2 923 433 patients diagnosed with schizophrenia, translates to 0.59% of the total 
claimant population.  
h. 2015 
From January to June of 2015, 9 014 patients were diagnosed as suffering from schizophrenia. 
By mid-year 2014, the number of patients is 8 608 (according to Table: 
Database_2008_2015_Schizoprenia). By June 2015, 406 more patients are recorded when 
compared to the half-year sum for 2014. This translates to a 4.5% increase in patient diagnosis. 
Therefore the 4.5% increase is extrapolated for the remaining (unrecorded) subsequent 6 
months, to give an estimated patient number of 18 057 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




18 057 out of 3 031 600 patients diagnosed with schizophrenia, translates to 0.6% of the total 
claimant population.  
Table LD42  
Results summary: Schizophrenia 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 0.57% 
2009 6.08% increase 0.58% 
2010 6.68% increase 0.56% 
2011 10.30% increase 0.59% 
2012 5.33% increase 0.59% 
2013 3.10% increase 0.59% 
2014 4.25% increase 0.59% 
2015 4.50% increase 0.60% 
Chart LD42: Disorder Trend: Schizophrenia 
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Summary of Table LD42 and Chart LD42. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with schizophrenia is 0.58%, within the entire database. The lowest 
frequency of schizophrenia is in 2008, with a percentage of 0.57% occurrence within the entire 
population and the highest frequency is in 2015, with a percentage of 0.6% of the total database 
population.   
The diagnosis trend shows an incremental increase in patient numbers across time, with the 
trend line approaching a plateau, signally a constant frequency rate for this diagnosis. The 







Sexual and Gender Identity Disorder 
Table LD43 and Chart LD43, summarise the total number of patients diagnosed with sexual 
and gender identity disorder per year (from 2008 – 2015). The total number of diagnoses per 
year are shown against the total database population per year.  
Chart LD43: Longitudinal Data (2008 – 2015): Sexual and Gender Identity Disorder 
 





Table LD43  
Longitudinal Data (2008 – 2015): Sexual and Gender Identity Disorder 
Diagnosis Year Total Patients Total DP 
Sexual and gender identity disorder 2008 2 306 2,092,183 
Sexual and gender identity disorder 2009 3 531 2,192,129 
Sexual and gender identity disorder 2010 4 316 2,434,220 
Sexual and gender identity disorder 2011 5 153 2,581,043 
Sexual and gender identity disorder 2012 5 504 2,711,594 
Sexual and gender identity disorder 2013 5 882 2,822,416 
Sexual and gender identity disorder 2014 6 203 2,923,433 
Sexual and gender identity disorder 2015 3 372 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 2 306 patients were diagnosed as suffering from sexual and gender identity disorder. 
This is the total number of diagnoses, includes both male and female patients. The ratio of male 
to female patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. sexual and gender identity disorder as a diagnosis is one of 27 
mental illness disorders, as classified for this specific database. Refer to Table X for a summary 
of disorders specified in this dataset. 
2 306 out of 2 092 183 patients diagnosed with sexual and gender identity disorder, translates to 




b. 2009  
In 2009, 3 531 patients were diagnosed as suffering from sexual and gender identity disorder. 
This value is 1 225 more patients than in 2008 and translates to a 34.69% increase in diagnosis 
of sexual and gender identity disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
3 531 out of 2 192 129 patients diagnosed with sexual and gender identity disorder, translates to 
0.16% of the total claimant population.  
c. 2010 
In 2010, 4 316 patients were diagnosed as suffering from sexual and gender identity disorder. 
This value is 785 more patients than in 2009 and translates to a 18.19% increase in diagnosis of 
sexual and gender identity disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
4 316 out of 2 434 220 patients diagnosed with sexual and gender identity disorder, translates to 
0.18% of the total claimant population.  
d. 2011 
In 2011, 5 153 patients were diagnosed as suffering from sexual and gender identity disorder. 




sexual and gender identity disorder, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 7.76% growth in claimant population in one year. 
5 153 out of 2 581 043 patients diagnosed with sexual and gender identity disorder, translates to 
0.2% of the total claimant population.  
e. 2012 
In 2012, 5 504 patients were diagnosed as suffering from sexual and gender identity disorder. 
This value is 351 more patients than in 2011 and translates to a 6.4% increase in diagnosis of 
sexual and gender identity disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
5 504 out of 2 711 594 patients diagnosed with sexual and gender identity disorder translates to 
0.2% of the total claimant population.  
f. 2013 
In 2013, 5 882 patients were diagnosed as suffering from sexual and gender identity disorder. 
This value is 378 more patients than in 2012 and translates to a 6.43% increase in diagnosis of 
sexual and gender identity disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




5 882 out of 2 822 416 patients diagnosed with sexual and gender identity disorder, translates to 
0.21% of the total claimant population.  
g. 2014 
In 2014, 6 203 patients were diagnosed as suffering from sexual and gender identity disorder. 
This value is 321 more patients than in 2013 and translates to a 5.17% increase in diagnosis of 
sexual and gender identity disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 15.86% growth in claimant population in one year. 
6 203 out of 2 923 433 patients diagnosed with sexual and gender identity disorder, translates to 
0.21% of the total claimant population.  
h. 2015 
From January to June of 2015, 3 372 patients were diagnosed as suffering from sexual and 
gender identity disorder. By mid-year 2014, the number of patients is 3 160 (according to 
Table: Database_2008_2015_Sexual and Gender Identity Disorder). By June 2015, 212 more 
patients are recorded when compared to the half-year sum for 2014. This translates to a 6.29% 
increase in patient diagnosis. Therefore the 6.29% increase is extrapolated for the remaining 
(unrecorded) subsequent 6 months, to give an estimated patient number of 6 593 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




6 593 out of 3 031 600 patients diagnosed with sexual and gender identity disorder, translates to 
0.22% of the total claimant population.  
Table LD44  
Results summary: Sexual and Gender Identity Disorder 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 0.11% 
2009 34.69% increase 0.16% 
2010 18.19% increase 0.18% 
2011 16.24% increase 0.2% 
2012 6.40% increase 0.2% 
2013 6.43% increase 0.21% 
2014 5.17% increase 0.21% 
2015 6.29% increase 0.22% 
Chart LD44: Disorder Trend: Sexual and Gender Identity Disorder 
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Summary of Table LD44 and Chart LD44. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with sexual and gender identity disorder is 0.19%, within the entire database. 
The lowest frequency of sexual and gender identity disorder is in 2008, with a percentage of 
0.11% occurrence within the entire population and the highest frequency is in 2015, with a 
percentage of 0.22% of the total database population.   
The diagnosis trend shows a steady increase in patient numbers across time. The forecast 








Table LD45 and Chart LD45, summarise the total number of patients diagnosed with 
somatoform disorder per year (from 2008 – 2015). The total number of diagnoses per year are 
shown against the total database population per year.  
Chart LD45: Longitudinal Data (2008 – 2015): Somatoform Disorder 
 






Longitudinal Data (2008 – 2015): Somatoform Disorder 
Diagnosis Year Total Patients Total DP 
Somatoform disorder 2008 3 832 2,092,183 
Somatoform disorder 2009 3 512 2,192,129 
Somatoform disorder 2010 3 845 2,434,220 
Somatoform disorder 2011 4 153 2,581,043 
Somatoform disorder 2012 4 252 2,711,594 
Somatoform disorder 2013 4 609 2,822,416 
Somatoform disorder 2014 4 793 2,923,433 
Somatoform disorder 2015 2 524 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 3 832 patients were diagnosed as suffering from somatoform disorder. This is the total 
number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Somatoform disorder as a diagnosis is one of 27 mental 
illness disorders, as classified for this specific database. Refer to Table X for a summary of 
disorders specified in this dataset. 
3 832 out of 2 092 183 patients diagnosed with somatoform disorder, translates to 0.18% of the 




b. 2009  
In 2009, 3 512 patients were diagnosed as suffering from somatoform disorder. This value is 
320 less patients than in 2008 and translates to an 8.35% decrease in diagnosis of somatoform 
disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
3 512 out of 2 192 129 patients diagnosed with somatoform disorder, translates to 0.16% of the 
total claimant population.  
c. 2010 
In 2010, 3 845 patients were diagnosed as suffering from somatoform disorder. This value is 
333 more patients than in 2009 and translates to an 8.66% increase in diagnosis of somatoform 
disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
3 845 out of 2 434 220 patients diagnosed with somatoform disorder, translates to 0.16% of the 
total claimant population.  
d. 2011 
In 2011, 4 153 patients were diagnosed as suffering from somatoform disorder. This value is 




disorder, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 7.76% growth in claimant population in one year. 
4 153 out of 2 581 043 patients diagnosed with somatoform disorder, translates to 0.16% of the 
total claimant population.  
e. 2012 
In 2012, 4 252 patients were diagnosed as suffering from somatoform disorder. This value is 99 
more patients than in 2011 and translates to a 2.3% increase in diagnosis of somatoform 
disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
4 252 out of 2 711 594 patients diagnosed with somatoform disorder translates to 0.16% of the 
total claimant population.  
f. 2013 
In 2013, 4 609 patients were diagnosed as suffering from somatoform disorder. This value is 
357 more patients than in 2012 and translates to a 7.75% increase in diagnosis of somatoform 
disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




4 609 out of 2 822 416 patients diagnosed with somatoform disorder, translates to 0.16% of the 
total claimant population.  
g. 2014 
In 2014, 4 793 patients were diagnosed as suffering from somatoform disorder. This value is 
184 more patients than in 2013 and translates to a 3.84% increase in diagnosis of somatoform 
disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 15.86% growth in claimant population in one year. 
4 793 out of 2 923 433 patients diagnosed with somatoform disorder, translates to 0.16% of the 
total claimant population.  
h. 2015 
From January to June of 2015, 2 524 patients were diagnosed as suffering from somatoform 
disorder. By mid-year 2014, the number of patients is 2 461 (according to Table: 
Database_2008_2015_Somatoform Disorder). By June 2015, 63 more patients are recorded 
when compared to the half-year sum for 2014. This translates to a 2.5% increase in patient 
diagnosis. Therefore the 2.5% increase is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 4 912 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




4 912 out of 3 031 600 patients diagnosed with somatoform disorder, translates to 0.16% of the 
total claimant population.  
Table LD46  
Results summary: Somatoform Disorder 
Year Diagnosis % 
Increase/Decrease 
% Diagnosis within Population 
2008 N/A 0.18% 
2009 8.35% decrease 0.16% 
2010 8.66% increase 0.16% 
2011 7.42% increase 0.16% 
2012 2.30% increase 0.16% 
2013 7.75% increase 0.16% 
2014 3.84% Increase 0.16% 
2015 2.50% increase 0.16% 
Chart LD46: Disorder Trend: Somatoform Disorder 
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Summary of Table LD46 and Chart LD46. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with somatoform disorder is 0.16%, within the entire database. The highest 
frequency of somatoform disorder is in 2008, with a percentage of 0.18% occurrence within the 
entire population and the remaining years have a frequency rate of 0.16% of the total database 
population.  
The diagnosis trend shows patient numbers are constantly increasing across time. The forecast 







Substance Abuse or Dependence Behaviour 
Table LD47 and Chart LD47, summarise the total number of patients diagnosed with substance 
abuse or dependence behaviour per year (from 2008 – 2015). The total number of diagnoses per 
year are shown against the total database population per year.  
Chart LD47: Longitudinal Data (2008 – 2015): Substance Abuse or Dependence Behaviour 
 





Table LD47  
Longitudinal Data (2008 – 2015): Substance Abuse or Dependence Behaviour 
Diagnosis Year Total Patients Total DP 
Substance abuse or dependence behaviour 2008 2 285 2,092,183 
Substance abuse or dependence behaviour 2009 2 483 2,192,129 
Substance abuse or dependence behaviour 2010 2 578 2,434,220 
Substance abuse or dependence behaviour 2011 3 588 2,581,043 
Substance abuse or dependence behaviour 2012 4 806 2,711,594 
Substance abuse or dependence behaviour 2013 4 530 2,822,416 
Substance abuse or dependence behaviour 2014 4 647 2,923,433 
Substance abuse or dependence behaviour 2015 2 234 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 2 285 patients were diagnosed as suffering from substance abuse or dependence 
behaviour. This is the total number of diagnoses, includes both male and female patients. The 
ratio of male to female patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Substance abuse or dependence behaviour as a diagnosis is 
one of 27 mental illness disorders, as classified for this specific database. Refer to Table X for a 
summary of disorders specified in this dataset. 
2 285 out of 2 092 183 patients diagnosed with substance abuse or dependence behaviour, 





b. 2009  
In 2009, 2 483 patients were diagnosed as suffering from substance abuse or dependence 
behaviour. This value is 198 more patients than in 2008 and translates to a 7.97% increase in 
diagnosis of substance abuse or dependence behaviour, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
2 483 out of 2 192 129 patients diagnosed with substance abuse or dependence behaviour, 
translates to 0.11% of the total claimant population.  
c. 2010 
In 2010, 2 578 patients were diagnosed as suffering from substance abuse or dependence 
behaviour. This value is 95 more patients than in 2009 and translates to a 3.69% increase in 
diagnosis of substance abuse or dependence behaviour, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
2 578 out of 2 434 220 patients diagnosed with substance abuse or dependence behaviour, 
translates to 0.11% of the total claimant population.  
d. 2011 
In 2011, 3 588 patients were diagnosed as suffering from substance abuse or dependence 




diagnosis of substance abuse or dependence behaviour, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 7.76% growth in claimant population in one year. 
3 588 out of 2 581 043 patients diagnosed with substance abuse or dependence behaviour, 
translates to 0.14% of the total claimant population.  
e. 2012 
In 2012, 4 806 patients were diagnosed as suffering from substance abuse or dependence 
behaviour. This value is 1 218 more patients than in 2011 and translates to a 25.34% increase in 
diagnosis of substance abuse or dependence behaviour, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
4 806 out of 2 711 594 patients diagnosed with substance abuse or dependence behaviour 
translates to 0.18% of the total claimant population.  
f. 2013 
In 2013, 4 530 patients were diagnosed as suffering from substance abuse or dependence 
behaviour. This value is 276 less patients than in 2012 and translates to a 5.74% decrease in 
diagnosis of substance abuse or dependence behaviour, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




4 530 out of 2 822 416 patients diagnosed with substance abuse or dependence behaviour, 
translates to 0.16% of the total claimant population.  
g. 2014 
In 2014, 4 647 patients were diagnosed as suffering from substance abuse or dependence 
behaviour. This value is 117 more patients than in 2013 and translates to a 2.52% increase in 
diagnosis of substance abuse or dependence behaviour, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 15.86% growth in claimant population in one year. 
4 647 out of 2 923 433 patients diagnosed with substance abuse or dependence behaviour, 
translates to 0.16% of the total claimant population.  
h. 2015 
From January to June of 2015, 2 234 patients were diagnosed as suffering from substance abuse 
or dependence behaviour. By mid-year 2014, the number of patients is 2 553 (according to 
Table: Database_2008_2015_ Substance Abuse or Dependence Behaviour). By June 2015, 319 
less patients are recorded when compared to the half-year sum for 2014. This translates to a 
12.5% decrease in patient diagnosis. Therefore the 12.5% decrease is extrapolated for the 
remaining (unrecorded) subsequent 6 months, to give an estimated patient number of 4 066 for 
2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 




population of 3 031 600. This is 108 167 more claimants than in 2014. 
4 066 out of 3 031 600 patients diagnosed with substance abuse or dependence behaviour, 
translates to 0.13% of the total claimant population.  
Table LD48  
Results summary: Substance Abuse or Dependence Behaviour 
Year Diagnosis % Increase/Decrease % Diagnosis within Population 
2008 N/A 0.11% 
2009 7.97% increase 0.11% 
2010 3.69% increase 0.11% 
2011 28.12% increase 0.14% 
2012 25.34% increase 0.18% 
2013 5.74% decrease 0.16% 
2014 2.52% increase 0.16% 
2015 12.50% decrease 0.13% 
Chart LD48: Disorder Trend: Substance Abuse or Dependence Behaviour
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Summary of Table LD48 and Chart LD48. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with substance abuse or dependence behaviour is 0.14%, within the entire 
database. The lowest frequencies of substance abuse or dependence behaviour are in 2008, 
2009 and 2010, with a percentage of 0.11% occurrence within the entire population and the 
highest frequency is in 2012, with a percentage of 0.18% of the total database population.   
The diagnosis trend shows a steep increase in patient numbers from 2008 to 2011, with the 
frequency rate peaking in 2012. Thereafter, there is a steady decline in frequency rate. The 
forecast predicts a steady decrease in patients diagnosed with substance abuse or dependence 







Table LD49 and Chart LD49, summarise the total number of patients diagnosed with tic 
disorder per year (from 2008 – 2015). The total number of diagnoses per year are shown against 
the total database population per year.  
Chart LD49: Longitudinal Data (2008 – 2015): Tic Disorder 
 






Longitudinal Data (2008 – 2015): Tic Disorder 
Diagnosis Year Total Patients Total DP 
Tic disorder 2008 285 2,092,183 
Tic disorder 2009 384 2,192,129 
Tic disorder 2010 379 2,434,220 
Tic disorder 2011 492 2,581,043 
Tic disorder 2012 565 2,711,594 
Tic disorder 2013 518 2,822,416 
Tic disorder 2014 510 2,923,433 
Tic disorder 2015 259 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 285 patients were diagnosed as suffering from tic disorder. This is the total number of 
diagnoses, includes both male and female patients. The ratio of male to female patients will be 
discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Tic disorder as a diagnosis is one of 27 mental illness 
disorders, as classified for this specific database. Refer to Table X for a summary of disorders 
specified in this dataset. 
285 out of 2 092 183 patients diagnosed with tic disorder, translates to 0.01% of the total 




b. 2009  
In 2009, 384 patients were diagnosed as suffering from tic disorder. This value is 99 more 
patients than in 2008 and translates to a 25.78% increase in diagnosis of tic disorder, when 
compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
384 out of 2 192 129 patients diagnosed with tic disorder, translates to 0.02% of the total 
claimant population.  
c. 2010 
In 2010, 379 patients were diagnosed as suffering from tic disorder. This value is 5 less patients 
than in 2009 and translates to a 1.3% decrease in diagnosis of tic disorder, when compared to 
2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
379 out of 2 434 220 patients diagnosed with tic disorder, translates to 0.02% of the total 
claimant population.  
d. 2011 
In 2011, 492 patients were diagnosed as suffering from tic disorder. This value is 113 more 




compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 7.76% growth in claimant population in one year. 
492 out of 2 581 043 patients diagnosed with tic disorder, translates to 0.02% of the total 
claimant population.  
e. 2012 
In 2012, 565 patients were diagnosed as suffering from tic disorder. This value is 73 more 
patients than in 2011 and translates to a 12.92% increase in diagnosis of tic disorder, when 
compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
565 out of 2 711 594 patients diagnosed with tic disorder translates to 0.02% of the total 
claimant population.  
f. 2013 
In 2013, 518 patients were diagnosed as suffering from tic disorder. This value is 47 less 
patients than in 2012 and translates to an 8.3% decrease in diagnosis of tic disorder, when 
compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




518 out of 2 822 416 patients diagnosed with tic disorder, translates to 0.02% of the total 
claimant population.  
g. 2014 
In 2014, 510 patients were diagnosed as suffering from tic disorder. This value is 8 less patients 
than in 2013 and translates to a 1.5% decrease in diagnosis of tic disorder, when compared to 
2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 15.86% growth in claimant population in one year. 
510 out of 2 923 433 patients diagnosed with tic disorder, translates to 0.02% of the total 
claimant population.  
h. 2015 
From January to June of 2015, 259 patients were diagnosed as suffering from tic disorder. By 
mid-year 2014, the number of patients is 268 (according to Table: Database_2008_2015_ Tic 
Disorder). By June 2015, 9 less patients are recorded when compared to the half-year sum for 
2014. This translates to a 3.4% decrease in patient diagnosis. Therefore the 3.4% decrease is 
extrapolated for the remaining (unrecorded) subsequent 6 months, to give an estimated patient 
number of 492 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




492 out of 3 031 600 patients diagnosed with tic disorder, translates to 0.02% of the total 
claimant population.  
Table LD50 
Results summary: Tic Disorder 
Year Diagnosis % 
Increase/Decrease 
% Diagnosis within Population 
2008 N/A 0.01% 
2009 25.78% increase 0.02% 
2010 1.30% decrease 0.02% 
2011 22.98% increase 0.02% 
2012 12.92% increase 0.02% 
2013 8.30% decrease 0.02% 
2014 1.50% decrease 0.02% 
2015 3.40% decrease 0.02% 
Chart LD50: Disorder Trend: Tic Disorder 
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Summary of Table LD50 and Chart LD50. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with tic disorder is 0.02%, within the entire database. The lowest frequency 
of tic disorder is in 2008, with a percentage of 0.01% occurrence within the entire population 
and the remaining years have a frequency rate of 0.02% of the total database population.  
The diagnosis trend shows patient numbers steadily increasing, with the polynomial forecast 







Unconfirmed Psychology Disorder 
Table LD51 and Chart LD51, summarise the total number of patients diagnosed with 
unconfirmed psychology disorder per year (from 2008 – 2015). The total number of diagnoses 
per year are shown against the total database population per year.  
Chart LD51: Longitudinal Data (2008 – 2015): Unconfirmed Psychology Disorder 
 





Table LD51  
Longitudinal Data (2008 – 2015): Unconfirmed Psychology Disorder 
Diagnosis Year Total 
Patients 
Total DP 
Unconfirmed psychology disorder 2008 41 396 2,092,183 
Unconfirmed psychology disorder 2009 38 307 2,192,129 
Unconfirmed psychology disorder 2010 41 237 2,434,220 
Unconfirmed psychology disorder 2011 42 217 2,581,043 
Unconfirmed psychology disorder 2012 45 589 2,711,594 
Unconfirmed psychology disorder 2013 49 330 2,822,416 
Unconfirmed psychology disorder 2014 54 085 2,923,433 
Unconfirmed psychology disorder 2015 37 151 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 41 396 patients were diagnosed as suffering from unconfirmed psychology disorder. 
This is the total number of diagnoses, includes both male and female patients. The ratio of male 
to female patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Unconfirmed psychology disorder as a diagnosis is one of 27 
mental illness disorders, as classified for this specific database. Refer to Table X for a summary 
of disorders specified in this dataset. 
41 396 out of 2 092 183 patients diagnosed with unconfirmed psychology disorder, translates to 




b. 2009  
In 2009, 38 307 patients were diagnosed as suffering from unconfirmed psychology disorder. 
This value is 3 089 less patients than in 2008 and translates to a 7.46% decrease in diagnosis of 
unconfirmed psychology disorder, when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
38 307 out of 2 192 129 patients diagnosed with unconfirmed psychology disorder, translates to 
1.75% of the total claimant population.  
c. 2010 
In 2010, 41 237 patients were diagnosed as suffering from unconfirmed psychology disorder. 
This value is 2 930 more patients than in 2009 and translates to a 7.11% increase in diagnosis of 
unconfirmed psychology disorder, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009, and translates to a 9.9% growth in claimant population in one year. 
41 237 out of 2 434 220 patients diagnosed with unconfirmed psychology disorder, translates to 
1.69% of the total claimant population.  
d. 2011 
In 2011, 42 217 patients were diagnosed as suffering from unconfirmed psychology disorder. 




unconfirmed psychology disorder, when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 7.76% growth in claimant population in one year. 
42 217 out of 2 581 043 patients diagnosed with unconfirmed psychology disorder, translates to 
1.64% of the total claimant population.  
e. 2012 
In 2012, 45 589 patients were diagnosed as suffering from unconfirmed psychology disorder. 
This value is 3 372 more patients than in 2011 and translates to a 7.4% increase in diagnosis of 
unconfirmed psychology disorder, when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
45 589 out of 2 711 594 patients diagnosed with unconfirmed psychology disorder translates to 
1.68% of the total claimant population.  
f. 2013 
In 2013, 49 330 patients were diagnosed as suffering from unconfirmed psychology disorder. 
This value is 3 741 more patients than in 2012 and translates to a 7.58% increase in diagnosis of 
unconfirmed psychology disorder, when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




49 330 out of 2 822 416 patients diagnosed with unconfirmed psychology disorder, translates to 
1.75% of the total claimant population.  
g. 2014 
In 2014, 54 085 patients were diagnosed as suffering from unconfirmed psychology disorder. 
This value is 4 755 more patients than in 2013 and translates to an 8.79% increase in diagnosis 
of unconfirmed psychology disorder, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 15.86% growth in claimant population in one year. 
54 085 out of 2 923 433 patients diagnosed with unconfirmed psychology disorder, translates to 
1.85% of the total claimant population.  
h. 2015 
From January to June of 2015, 37 151 patients were diagnosed as suffering from unconfirmed 
psychology disorder. By mid-year 2014, the number of patients is 27 163 (according to Table: 
Database_2008_2015_ Unconfirmed Psychology Disorder). By June 2015, 9 988 more patients 
are recorded when compared to the half-year sum for 2014. This translates to a 26.88% increase 
in patient diagnosis. Therefore the 26.88% increase is extrapolated for the remaining 
(unrecorded) subsequent 6 months, to give an estimated patient number of 68 623 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




68 623 out of 3 031 600 patients diagnosed with unconfirmed psychology disorder, translates to 
2.26% of the total claimant population.  
Table LD52  
Results summary: Unconfirmed Psychology Disorder 
Year Diagnosis % 
Increase/Decrease 
% Diagnosis within Population 
2008 N/A 1.98% 
2009 7.47% decrease 1.75% 
2010 7.11% increase 1.69% 
2011 2.32% increase 1.64% 
2012 7.40% increase 1.68% 
2013 7.58% increase 1.75% 
2014 8.79% increase 1.85% 
2015 26.88% increase 2.26% 
Chart LD52: Disorder Trend: Unconfirmed Psychology Disorder 
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Summary of Table LD52 and Chart LD52. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with unconfirmed psychology disorder is 1.83%, within the entire database. 
The lowest frequency of unconfirmed psychology disorder is in 2011, with a percentage of 
1.64% occurrence within the entire population and the highest frequency is in 2015, with a 
percentage of 2.26% of the total database population.  
The diagnosis trend shows an initial decrease in patient numbers but followed by a steady 
increase in frequency rate for this diagnosis. The forecast predicts an increase in frequency rate 







Table LD53 and Chart LD53, summarise the total number of patients diagnosed with vascular 
dementia per year (from 2008 – 2015). The total number of diagnoses per year are shown 
against the total database population per year.  
Chart LD53: Longitudinal Data (2008 – 2015): Vascular Dementia 
 






Longitudinal Data (2008 – 2015): Vascular Dementia 
Diagnosis Year Total Patients Total DP 
Vascular dementia 2008 525 2,092,183 
Vascular dementia 2009 461 2,192,129 
Vascular dementia 2010 504 2,434,220 
Vascular dementia 2011 558 2,581,043 
Vascular dementia 2012 554 2,711,594 
Vascular dementia 2013 568 2,822,416 
Vascular dementia 2014 701 2,923,433 
Vascular dementia 2015 387 2,984,103 
The results are as follows: 
a. 2008 
In 2008, 525 patients were diagnosed as suffering from vascular dementia. This is the total 
number of diagnoses, includes both male and female patients. The ratio of male to female 
patients will be discussed in Section II: Gender Focus databases.  
The total database population in 2008 is 2 092 183 people and this number is the sum of all 
medical claimants on the dataset. Vascular dementia as a diagnosis is one of 27 mental illness 
disorders, as classified for this specific database. Refer to Table X for a summary of disorders 
specified in this dataset. 
525 out of 2 092 183 patients diagnosed with vascular dementia, translates to 0.03% of the total 




b. 2009  
In 2009, 461 patients were diagnosed as suffering from vascular dementia. This value is 64 less 
patients than in 2008 and translates to a 12.19% decrease in diagnosis of vascular dementia, 
when compared to 2008.  
The total database population in 2009 is 2 192 129 people. This is 99 946 more claimants than 
in 2008 and translates to a 4.6% growth in claimant population in one year. 
461 out of 2 192 129 patients diagnosed with vascular dementia, translates to 0.02% of the total 
claimant population.  
c. 2010 
In 2010, 504 patients were diagnosed as suffering from vascular dementia. This value is 43 
more patients than in 2009 and translates to an 8.53% increase in diagnosis of vascular 
dementia, when compared to 2009.  
The total database population in 2010 is 2 434 220 people. This is 242 091 more claimants than 
in 2009 and translates to a 9.9% growth in claimant population in one year. 
504 out of 2 434 220 patients diagnosed with vascular dementia, translates to 0.02% of the total 
claimant population.  
d. 2011 
In 2011, 558 patients were diagnosed as suffering from vascular dementia. This value is 54 




when compared to 2010.  
The total database population in 2011 is 2 581 043 people. This is 146 823 more claimants than 
in 2010 and translates to a 7.76% growth in claimant population in one year. 
558 out of 2 581 043 patients diagnosed with vascular dementia, translates to 0.02% of the total 
claimant population.  
e. 2012 
In 2012, 554 patients were diagnosed as suffering from vascular dementia. This value is 4 less 
patients than in 2011 and translates to a 0.72% decrease in diagnosis of vascular dementia, 
when compared to 2011.  
The total database population in 2012 is 2 711 594 people. This is 130 551 more claimants than 
in 2011 and translates to a 4.8% growth in claimant population in one year. 
554 out of 2 711 594 patients diagnosed with vascular dementia translates to 0.02% of the total 
claimant population.  
f. 2013 
In 2013, 568 patients were diagnosed as suffering from vascular dementia. This value is 14 
more patients than in 2012 and translates to a 2.46% increase in diagnosis of vascular dementia, 
when compared to 2012.  
The total database population in 2013 is 2 822 416 people. This is 110 822 more claimants than 




568 out of 2 822 416 patients diagnosed with vascular dementia, translates to 0.02% of the total 
claimant population.  
g. 2014 
In 2014, 701 patients were diagnosed as suffering from vascular dementia. This value is 133 
more patients than in 2013 and translates to a 18.97% increase in diagnosis of vascular 
dementia, when compared to 2013.  
The total database population in 2014 is 2 923 433 people. This is 101 017 more claimants than 
in 2013 and translates to a 15.86% growth in claimant population in one year. 
701 out of 2 923 433 patients diagnosed with vascular dementia, translates to 0.02% of the total 
claimant population.  
h. 2015 
From January to June of 2015, 387 patients were diagnosed as suffering from vascular 
dementia. By mid-year 2014, the number of patients is 355 (according to Table: 
Database_2008_2015_ Vascular Dementia). By June 2015, 32 more patients are recorded when 
compared to the half-year sum for 2014. This translates to an 8.27% increase in patient 
diagnosis. Therefore the 8.27% increase is extrapolated for the remaining (unrecorded) 
subsequent 6 months, to give an estimated patient number of 767 for 2015.  
The database population for 2015 is 2 984 103 people. The average growth between 2014 and 
2013 (at 3.5% and 3.9% respectively) is 3.7%. This translates to a projected total database 




767 out of 3 031 600 patients diagnosed with vascular dementia, translates to 0.03% of the total 
claimant population.  
Table LD54 
Results summary: Vascular Dementia 
Year Diagnosis % 
Increase/Decrease 
% Diagnosis within Population 
2008 N/A 0.03% 
2009 12.19% decrease 0.02% 
2010 8.53% increase 0.02% 
2011 9.68% increase 0.02% 
2012 0.72% decrease 0.02% 
2013 2.46% increase 0.02% 
2014 18.97% increase 0.02% 
2015 8.27% increase 0.02% 
Chart LD54: Disorder Trend: Vascular Dementia 
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Summary of Table LD54 and Chart LD54. This summary table shows a year-on-year increase 
or decrease (when compared to the previous year), in the percentage of patients diagnosed with 
the disorder, with the adjacent column displaying the overall percentage frequency, year on 
year, within the entire database population. The half year values provided for 2015, were 
extrapolated to present a full year. The disorder trend chart shows the fluctuating pattern of the 
frequency increase or decrease of diagnosis over time. This chart includes a single period 
forecast on the diagnosis frequency going forward. Patient numbers for 2015, were excluded 
from this chart, because these numbers are representative of half a year (January to June). 
Including this in the trend chart would have erroneously skewed the trend result. 
Factoring in the increase in database population size year on year, the average percentage of 
patients diagnosed with vascular dementia is 0.02%, within the entire database. The highest 
frequency of vascular dementia is in 2008, with a percentage of 0.03% occurrence within the 
entire population and the remaining years have a frequency rate of 0.02% of the total database 
population.  
The diagnosis trend shows patient numbers show a constancy until the end of 2011, where after 
there is a steep increase in patient numbers across time. The forecast predicts a steep increase in 






Chapter 3: Results 
Section II: Gender Focus 
The aim of the results discussion on gender focus data is to provide the analysis to determine 
whether a bias exists towards a specific gender, with regards to certain mental illnesses. Should 
a bias exist, the question then is, to what extent is there a propensity for a specific illness to 
favour a gender? And is there an increase or decrease in this bias over time? Or perhaps, has 
there been a shift in bias from male to female (or vice versa), regarding certain mental 
illnesses? 
Source for Gender Focus (GF) charts: Discovery Health Database 
Results: Abuse, Dependence and Overdose of Opioids 
Table GF31  
Gender Focus: Abuse, Dependence and Overdose of Opioids 
DIAGNOSIS DATABASE: GENDER FOCUS      ABUSE, DEPENDENCE 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Abuse, dependence, overdose of opioids 2008 99 154 1062296 1029887 
Abuse, dependence, overdose of opioids 2009 80 151 1116307 1075822 
Abuse, dependence, overdose of opioids 2010 121 204 1245149 1189071 
Abuse, dependence, overdose of opioids 2011 122 215 1320350 1260693 
Abuse, dependence, overdose of opioids 2012 118 266 1389025 1322569 
Abuse, dependence, overdose of opioids 2013 145 257 1444105 1378311 
Abuse, dependence, overdose of opioids 2014 139 233 1498868 1424565 
Abuse, dependence, overdose of opioids 2015 84 153 1533223 1450880 
 




From Table GF1 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with abuse/dependence/overdose of 
opioids is 99:154, which is a ratio of 1:2 (rounded off). This means that for every female patient 
diagnosed with abuse/dependence/overdose of opioid, 2 males are diagnosed with the same 
disorder. 
2009: The ratio of female to male patients diagnosed with abuse/dependence/overdose of 
opioids is 80:151, which is a ratio of 1:2 (rounded off). This means that for every female patient 
diagnosed with abuse/dependence/overdose of opioid, 2 males are diagnosed with the same 
disorder. 
2010: The ratio of female to male patients diagnosed with abuse/dependence/overdose of 
opioids is 121:204, which is a ratio of 1:2 (rounded off). This means that for every female 
patient diagnosed with abuse/dependence/overdose of opioids, 2 males are diagnosed with the 
same disorder. 
2011: The ratio of female to male patients diagnosed with abuse/dependence/overdose of 
opioids is 122:219, which is a ratio of 1:2 (rounded off). This means that for every female 
patient diagnosed with abuse/dependence/overdose of opioids, 2 males are diagnosed with the 
same disorder. 
2012: The ratio of female to male patients diagnosed with abuse/dependence/overdose of opioid 
is 118:266, which is a ratio of 1:2 (rounded off). This means that for every female patient 





2013: The ratio of female to male patients diagnosed with abuse/dependence/overdose of 
opioids is 145:257, which is a ratio of 1:2 (rounded off). This means that for every female 
patient diagnosed with abuse/dependence/overdose of opioids, 2 males are diagnosed with the 
same disorder. 
2014: The ratio of female to male patients diagnosed with abuse/dependence/overdose of 
opioids is 139:233, which is a ratio of 1:2 (rounded off). This means that for every female 
patient diagnosed with abuse/dependence/overdose of opioids, 2 males are diagnosed with the 
same disorder. 
2015: The ratio of female to male patients diagnosed with abuse/dependence/overdose of 
opioids is 84:153, which is a ratio of 1:2 (rounded off). This means that for every female patient 
diagnosed with abuse/dependence/overdose of opioid, 2 males are diagnosed with the same 
disorder. 
The longitudinal data shows that consistently, there are twice as many males, than female 





Chart GF1: Gender Focus: Abuse, Dependence and Overdose of Opioids 
 
Chart GF1 above, is a summary of gender representation for abuse/dependence/overdose of 
opioids between and including 2008 to June 2015. The ratio presented provides an average over 
7 years of male to female demographics for this disorder. For abuse/dependence/overdose of 
opioid, the ratio is 64:36%, which translates to 64 males will be diagnosed over 36 females for 






Table GF2  
Gender Focus: Alcoholism 
DIAGNOSIS DATABASE: GENDER FOCUS      ALCOHOLISM 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Alcoholism 2008 664 1110 1062296 1029887 
Alcoholism 2009 832 1537 1116307 1075822 
Alcoholism 2010 832 1487 1245149 1189071 
Alcoholism 2011 990 1815 1320350 1260693 
Alcoholism 2012 1063 1883 1389025 1322569 
Alcoholism 2013 1188 1848 1444105 1378311 
Alcoholism 2014 1290 2060 1498868 1424565 
Alcoholism 2015 714 1122 1533223 1450880 
From Table GF2 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with alcoholism is 664:1110, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with alcoholism, 
2 males are diagnosed with the same disorder. 
2009: The ratio of female to male patients diagnosed with alcoholism is 832:1537, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with alcoholism, 
2 males are diagnosed with the same disorder. 
2010: The ratio of female to male patients diagnosed with alcoholism is 832:1487, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with alcoholism, 




2011: The ratio of female to male patients diagnosed with alcoholism is 990:1815, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with alcoholism, 
2 males are diagnosed with the same disorder. 
2012: The ratio of female to male patients diagnosed with alcoholism is 1063:1883, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with alcoholism, 
2 males are diagnosed with the same disorder. 
2013: The ratio of female to male patients diagnosed with alcoholism is 1188:1848, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with alcoholism, 
2 males are diagnosed with the same disorder. 
2014: The ratio of female to male patients diagnosed with alcoholism is 1290:2060, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with alcoholism, 
2 males are diagnosed with the same disorder. 
2015: The ratio of female to male patients diagnosed with alcoholism is 714:1122, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with alcoholism, 
2 males are diagnosed with the same disorder. 
The longitudinal data shows that consistently, there are twice as many males, than female 





Chart GF2  
Gender Focus: Alcoholism 
 
Chart GF2 above, is a summary of gender representation for alcoholism between and including 
2008 to June 2015. The ratio presented provides an average over 7 years, of male to female 
demographics for this disorder. For alcoholism, the ratio is 63:37%, which translates to 63 
males will be diagnosed over 37 females for every 100 patients, or more simply 17 males for 





Results: Anxiety Disorder 
Table GF3  
Gender Focus: Anxiety Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS      ANXIETY DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Anxiety disorder 2008 32578 18151 1062296 1029887 
Anxiety disorder 2009 31435 17920 1116307 1075822 
Anxiety disorder 2010 32748 18785 1245149 1189071 
Anxiety disorder 2011 34090 19647 1320350 1260693 
Anxiety disorder 2012 36173 20644 1389025 1322569 
Anxiety disorder 2013 37328 21582 1444105 1378311 
Anxiety disorder 2014 39386 23323 1498868 1424565 
Anxiety disorder 2015 23160 13020 1533223 1450880 
From Table GF3 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with anxiety disorder is 32 576:18 151, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
anxiety disorder, 2 females are diagnosed with the same disorder. 
2009: The ratio of female to male patients diagnosed with anxiety disorder is 31 435:17 920, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
anxiety disorder, 2 females are diagnosed with the same disorder. 
2010: The ratio of female to male patients diagnosed with anxiety disorder is 32 748:18 785, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 




2011: The ratio of female to male patients diagnosed with anxiety disorder is 34 090:19 647, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
anxiety disorder, 2 females are diagnosed with the same disorder. 
2012: The ratio of female to male patients diagnosed with anxiety disorder is 36 317:20 644, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
anxiety disorder, 2 females are diagnosed with the same disorder. 
2013: The ratio of female to male patients diagnosed with anxiety disorder is 37 326:21 582, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
anxiety disorder, 2 females are diagnosed with the same disorder. 
2014: The ratio of female to male patients diagnosed with anxiety disorder is 39 386:23 323, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
anxiety disorder, 2 females are diagnosed with the same disorder. 
2015: The ratio of female to male patients diagnosed with anxiety disorder is 23 160:13 020, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
anxiety disorder, 2 females are diagnosed with the same disorder. 
The longitudinal data shows that consistently, there are twice as many females, than male 





Chart GF3  
Gender Focus: Anxiety Disorder 
 
Chart GF3 above, is a summary of gender representation for anxiety disorder between and 
including 2008 to June 2015. The ratio presented provides an average over 7 years, of male to 
female demographics for this disorder. For anxiety disorder, the ratio is 36:64%, which 
translates to 36 males will be diagnosed over 64 females for every 100 patients, or more simply 





Results: Attention Deficit Hyperactivity Disorder 
Table GF4:  
Gender Focus: Attention Deficit Hyperactivity Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS   ATTENTION DEFICIT HYPERACTIVITY DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Attention deficit hyperactivity disorder 2008 19853 49451 1062296 1029887 
Attention deficit hyperactivity disorder 2009 26868 65554 1116307 1075822 
Attention deficit hyperactivity disorder 2010 33756 80508 1245149 1189071 
Attention deficit hyperactivity disorder 2011 41076 94827 1320350 1260693 
Attention deficit hyperactivity disorder 2012 47945 109130 1389025 1322569 
Attention deficit hyperactivity disorder 2013 55978 122866 1444105 1378311 
Attention deficit hyperactivity disorder 2014 62282 132436 1498868 1424565 
Attention deficit hyperactivity disorder 2015 34888 72572 1533223 1450880 
From Table GF4 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with attention deficit hyperactivity 
disorder is 19 853:49 451, which is a ratio of 1:2.5 (rounded off). This means that for every 
female patient diagnosed with attention deficit hyperactivity disorder, 2.5 males are diagnosed 
with the same disorder. This translates to two females diagnosed for every five males diagnosed 
with the disorder. 
2009: The ratio of female to male patients diagnosed with attention deficit hyperactivity 
disorder is 26 868:65 554, which is a ratio of 1:2.4 (rounded off). This means that for every 




with the same disorder. This translates to ten females diagnosed for every twenty-four males 
diagnosed with the disorder. 
2010: The ratio of female to male patients diagnosed with attention deficit hyperactivity 
disorder is 33 756:80 508, which is a ratio of 1:2.4 (rounded off). This means that for every 
female patient diagnosed with attention deficit hyperactivity disorder, 2.4 males are diagnosed 
with the same disorder. This translates to ten females diagnosed for every twenty-four males 
diagnosed with the disorder.  
2011: The ratio of female to male patients diagnosed with attention deficit hyperactivity 
disorder is 41 076:94 827, which is a ratio of 1:2.3 (rounded off). This means that for every 
female patient diagnosed with attention deficit hyperactivity disorder, 2.3 males are diagnosed 
with the same disorder. This translates to ten females diagnosed for every twenty-three males 
diagnosed with the disorder. 
2012: The ratio of female to male patients diagnosed with attention deficit hyperactivity 
disorder is 47 945:109 130, which is a ratio of 1:2.3 (rounded off). This means that for every 
female patient diagnosed with attention deficit hyperactivity disorder, 2.3 males are diagnosed 
with the same disorder. This translates to ten females diagnosed for every twenty-three males 
diagnosed with the disorder. 
2013: The ratio of female to male patients diagnosed with attention deficit hyperactivity 
disorder is 55 978:122 866, which is a ratio of 1:2.2 (rounded off). This means that for every 
female patient diagnosed with attention deficit hyperactivity disorder, 2.2 males are diagnosed 
with the same disorder. This translates to five females diagnosed for every eleven males 




2014: The ratio of female to male patients diagnosed with attention deficit hyperactivity 
disorder is 62 282:132 436, which is a ratio of 1:2.1 (rounded off). This means that for every 
female patient diagnosed with attention deficit hyperactivity disorder, 2.1 males are diagnosed 
with the same disorder. This translates to ten females diagnosed for every twenty-one males 
diagnosed with the disorder. 
2015: The ratio of female to male patients diagnosed with attention deficit hyperactivity 
disorder is 34 686:72 542, which is a ratio of 1:2.1 (rounded off). This means that for every 
female patient diagnosed with attention deficit hyperactivity disorder, 2.1 males are diagnosed 
with the same disorder. This translates to ten females diagnosed for every twenty-one males 
diagnosed with the disorder. 
The longitudinal data shows that consistently, there are more than twice as many males, than 
female patients diagnosed with attention deficit hyperactivity disorder. Interestingly, there is a 
steady decrease in the numbers of male patients, relative to female patients from 2008 – 2015. 
The decrease shows a trend that was approaching a ratio of 1 female for every 3 male patients 
in 2008, to approaching a ratio of 1 female for every 2 male patients. This translates to a steady 






Chart GF4  
Gender Focus: Attention Deficit Hyperactivity Disorder 
 
Chart GF4 above, is a summary of gender representation for attention deficit hyperactivity 
disorder between and including 2008 to June 2015. The ratio presented provides an average 
over 7 years, of male to female demographics for this disorder. For attention deficit 
hyperactivity disorder, the ratio is 69:31%, which translates to 69 males will be diagnosed over 





Results: Behavioural Disorder 
Table GF5  
Gender Focus: Behavioural Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS     BEHAVIOURAL DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Behavioural Disorder 2008 721 511 1062296 1029887 
Behavioural Disorder 2009 1047 718 1116307 1075822 
Behavioural Disorder 2010 1178 758 1245149 1189071 
Behavioural Disorder 2011 1233 793 1320350 1260693 
Behavioural Disorder 2012 1454 915 1389025 1322569 
Behavioural Disorder 2013 1504 985 1444105 1378311 
Behavioural Disorder 2014 1584 1228 1498868 1424565 
Behavioural Disorder 2015 934 737 1533223 1450880 
From Table GF5 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with behavioural disorder is 721:611, 
which is a ratio of 1.2:1 (rounded off). This means that for every male patient diagnosed with 
behavioural disorder, 1.2 females are diagnosed with the same disorder. This translates to six 
female patients for every five males. 
2009: The ratio of female to male patients diagnosed with behavioural disorder is 1 047:718, 
which is a ratio of 1.5:1 (rounded off). This means that for every male patient diagnosed with 
behavioural disorder, 1.5 females are diagnosed with the same disorder. This translates to three 




2010: The ratio of female to male patients diagnosed with behavioural disorder is 1 178:758, 
which is a ratio of 1.6:1 (rounded off). This means that for every male patient diagnosed with 
behavioural disorder, 1.6 females are diagnosed with the same disorder. This translates to eight 
female patients for every five males. 
2011: The ratio of female to male patients diagnosed with behavioural disorder is 1 233:793, 
which is a ratio of 1.6:1 (rounded off). This means that for every male patient diagnosed with 
behavioural disorder, 1.6 females are diagnosed with the same disorder. This translates to eight 
female patients for every five males. 
2012: The ratio of female to male patients diagnosed with behavioural disorder is 1 454:915, 
which is a ratio of 1.6:1 (rounded off). This means that for every male patient diagnosed with 
behavioural disorder, 1.6 females are diagnosed with the same disorder. This translates to eight 
female patients for every five males. 
2013: The ratio of female to male patients diagnosed with behavioural disorder is 1 504:985, 
which is a ratio of 1.5:1 (rounded off). This means that for every male patient diagnosed with 
behavioural disorder, 1.5 females are diagnosed with the same disorder. This translates to three 
female patients for every two males. 
2014: The ratio of female to male patients diagnosed with behavioural disorder is 1 584:1 228, 
which is a ratio of 1.3:1 (rounded off). This means that for every male patient diagnosed with 
behavioural disorder, 1.3 females are diagnosed with the same disorder. This translates to 




2015: The ratio of female to male patients diagnosed with behavioural disorder is 934:737, 
which is a ratio of 1.3:1 (rounded off). This means that for every male patient diagnosed with 
behavioural disorder, 1.3 females are diagnosed with the same disorder. This translates to 
thirteen female patients for every ten males. 
The longitudinal data shows fluctuating ratios of male:female representation between 2008 – 
2015, however within that fluctuation, female numbers are always higher than male diagnosis 
numbers. Consistency is shown from 2010 – 2012, with a ratio of eight females diagnosed with 
behavioural disorder, for every five males diagnosed.  
Chart GF5  
Gender Focus: Behavioural Disorder 
 
Chart GF5 above, is a summary of gender representation for behavioural disorder between and 
including 2008 to June 2015. The ratio presented provides an average over 7 years, of male to 
female demographics for this disorder. For behavioural disorder, the ratio is 41:59%, which 
translates to 41 males will be diagnosed over 59 females for every 100 patients, or more simply 




Results: Bipolar Mood Disorder 
Table GF6 
Gender Focus: Bipolar Mood Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS     BIPOLAR MOOD DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Bipolar mood disorder 2008 53023 24386 1062296 1029887 
Bipolar mood disorder 2009 69094 31945 1116307 1075822 
Bipolar mood disorder 2010 90334 40705 1245149 1189071 
Bipolar mood disorder 2011 112560 51152 1320350 1260693 
Bipolar mood disorder 2012 133088 60560 1389025 1322569 
Bipolar mood disorder 2013 150189 69021 1444105 1378311 
Bipolar mood disorder 2014 162166 76870 1498868 1424565 
Bipolar mood disorder 2015 86138 41090 1533223 1450880 
From Table GF6 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with bipolar mood disorder is 53 023:24 
386, which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed 
with bipolar mood disorder, 2 females are diagnosed with the same disorder. 
2009: The ratio of female to male patients diagnosed with bipolar mood disorder is 69 094:31 
945, which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed 
with bipolar mood disorder, 2 females are diagnosed with the same disorder. 
2010: The ratio of female to male patients diagnosed with bipolar mood disorder is 90 334:40 
705, which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed 




2011: The ratio of female to male patients diagnosed with bipolar mood disorder is 112 560:51 
152, which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed 
with bipolar mood disorder, 2 females are diagnosed with the same disorder. 
2012: The ratio of female to male patients diagnosed with bipolar mood disorder is 133 086:60 
560, which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed 
with bipolar mood disorder, 2 females are diagnosed with the same disorder. 
2013: The ratio of female to male patients diagnosed with bipolar mood disorder is 150 189:69 
021, which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed 
with bipolar mood disorder, 2 females are diagnosed with the same disorder. 
2014: The ratio of female to male patients diagnosed with bipolar mood disorder is 162 166:76 
870, which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed 
with bipolar mood disorder, 2 females are diagnosed with the same disorder. 
2015: The ratio of female to male patients diagnosed with bipolar mood disorder is 86 138:41 
090, which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed 
with bipolar mood disorder, 2 females are diagnosed with the same disorder. 
The longitudinal data shows that consistently, there are twice as many females, than male 





Chart GF6  
Gender Focus: Bipolar Mood Disorder 
 
Chart GF6 above, is a summary of gender representation for bipolar mood disorder between 
and including 2008 to June 2015. The ratio presented provides an average over 7 years, of male 
to female demographics for this disorder. For bipolar mood disorder, the ratio is 32:68%, which 
translates to 32 males will be diagnosed over 68 females for every 100 patients, or more simply 





Results: Delusional Disorder 
Table GF7 
Gender Focus: Delusional Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS      DELUSIONAL DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Delusional disorder 2008 173 149 1062296 1029887 
Delusional disorder 2009 191 131 1116307 1075822 
Delusional disorder 2010 202 90 1245149 1189071 
Delusional disorder 2011 180 135 1320350 1260693 
Delusional disorder 2012 123 141 1389025 1322569 
Delusional disorder 2013 202 157 1444105 1378311 
Delusional disorder 2014 219 148 1498868 1424565 
Delusional disorder 2015 84 99 1533223 1450880 
From Table GF7 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with delusional disorder is 173:149, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2009: The ratio of female to male patients diagnosed with delusional disorder is 191:131, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2010: The ratio of female to male patients diagnosed with delusional disorder is 202:90, which 
is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with Delusional 




2011: The ratio of female to male patients diagnosed with delusional disorder is 180:135, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2012: The ratio of female to male patients diagnosed with delusional disorder is 123:141, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2013: The ratio of female to male patients diagnosed with delusional disorder is 202:157, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2014: The ratio of female to male patients diagnosed with delusional disorder is 219:148, which 
is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with delusional 
disorder, 2 females are diagnosed with the same disorder. 
2015: The ratio of female to male patients diagnosed with Delusional Disorder is 84:99, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
Male and female patients diagnosed with delusional disorder, show equal representation for 
most years represented in this database. However, in 2010 and 2014, there are twice as many 






Gender Focus: Delusional Disorder 
 
Chart GF7 above, is a summary of gender representation for delusional disorder between and 
including 2008 to June 2015. The ratio presented provides an average over 7 years, of male to 
female demographics for this disorder. For delusional disorder, the ratio is 43:57%, which 
translates to 43 males will be diagnosed over 57 females for every 100 patients, or more simply 






Table GF8  
Gender Focus: Depression 
DIAGNOSIS DATABASE: GENDER FOCUS       DEPRESSION 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Depression 2008 222705 87612 1062296 1029887 
Depression 2009 309375 119734 1116307 1075822 
Depression 2010 380947 146930 1245149 1189071 
Depression 2011 439807 171424 1320350 1260693 
Depression 2012 490742 193448 1389025 1322569 
Depression 2013 544896 217123 1444105 1378311 
Depression 2014 596181 238600 1498868 1424565 
Depression 2015 323946 129880 1533223 1450880 
From Table GF8 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with depression is 222 705:87 612, which 
is a ratio of 3:1 (rounded off). This means that for every male patient diagnosed with 
depression, 3 female patients are diagnosed with the same disorder. 
2009: The ratio of female to male patients diagnosed with depression is 309 375:119 734, 
which is a ratio of 3:1 (rounded off). This means that for every male patient diagnosed with 
depression, 3 female patients are diagnosed with the same disorder. 
2010: The ratio of female to male patients diagnosed with depression is 380 947:146 930, 
which is a ratio of 3:1 (rounded off). This means that for every male patient diagnosed with 




2011: The ratio of female to male patients diagnosed with depression is 439 807:171 424, 
which is a ratio of 3:1 (rounded off). This means that for every male patient diagnosed with 
depression, 3 female patients are diagnosed with the same disorder. 
2012: The ratio of female to male patients diagnosed with depression is 490 742:193 448, 
which is a ratio of 3:1 (rounded off). This means that for every male patient diagnosed with 
depression, 3 female patients are diagnosed with the same disorder. 
2013: The ratio of female to male patients diagnosed with depression is 544 896:217 123, 
which is a ratio of 3:1 (rounded off). This means that for every male patient diagnosed with 
depression, 3 female patients are diagnosed with the same disorder. 
2014: The ratio of female to male patients diagnosed with depression is 596 181:238 600, 
which is a ratio of 3:1 (rounded off). This means that for every male patient diagnosed with 
depression, 3 female patients are diagnosed with the same disorder. 
2015: The ratio of female to male patients diagnosed with depression is 323 946:129 880, 
which is a ratio of 3:1 (rounded off). This means that for every male patient diagnosed with 
depression, 3 female patients are diagnosed with the same disorder. 
The longitudinal data shows that consistently, there are three times as many females, than male 





Chart GF8  
Gender Focus: Depression 
 
Chart GF8 above, is a summary of gender representation for depression between and including 
2008 to June 2015. The ratio presented provides an average over 7 years, of male to female 
demographics for this disorder. For depression, the ratio is 28:72%, which translates to 28 
males will be diagnosed over 72 females for every 100 patients, or more simply 10 males for 





Results: Developmental and Learning Disorder 
Table GF9  
Gender Focus: Developmental and Learning Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS   DEVELOPMENTAL AND LEARNING DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Developmental and learning disorder 2008 18603 30945 1062296 1029887 
Developmental and learning disorder 2009 20032 32456 1116307 1075822 
Developmental and learning disorder 2010 22119 35249 1245149 1189071 
Developmental and learning disorder 2011 24112 37685 1320350 1260693 
Developmental and learning disorder 2012 23784 38819 1389025 1322569 
Developmental and learning disorder 2013 25890 41918 1444105 1378311 
Developmental and learning disorder 2014 28248 47321 1498868 1424565 
Developmental and learning disorder 2015 15514 27226 1533223 1450880 
From Table GF9 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with developmental and learning disorder 
is 18 603:30 945, which is a ratio of 1:2 (rounded off). This means that for every female patient 
diagnosed with developmental and learning disorder, 2 male patients are diagnosed with the 
same disorder. 
2009: The ratio of female to male patients diagnosed with developmental and learning disorder 
is 20 032:32 456, which is a ratio of 1:2 (rounded off). This means that for every female patient 





2010: The ratio of female to male patients diagnosed with developmental and learning disorder 
is 22 119:35 249, which is a ratio of 1:2 (rounded off). This means that for every female patient 
diagnosed with developmental and learning disorder, 2 male patients are diagnosed with the 
same disorder. 
2011: The ratio of female to male patients diagnosed with developmental and learning disorder 
is 24 112:37 685, which is a ratio of 1:2 (rounded off). This means that for every female patient 
diagnosed with Developmental and Learning Disorder, 2 male patients are diagnosed with the 
same disorder. 
2012: The ratio of female to male patients diagnosed with developmental and learning disorder 
is 23 784:38 819, which is a ratio of 1:2 (rounded off). This means that for every female patient 
diagnosed with developmental and learning disorder, 2 male patients are diagnosed with the 
same disorder. 
2013: The ratio of female to male patients diagnosed with developmental and learning disorder 
is 25 690:41 918, which is a ratio of 1:2 (rounded off). This means that for every female patient 
diagnosed with developmental and learning disorder, 2 male patients are diagnosed with the 
same disorder. 
2014: The ratio of female to male patients diagnosed with developmental and learning disorder 
is 28 248:47 321, which is a ratio of 1:2 (rounded off). This means that for every female patient 





2015: The ratio of female to male patients diagnosed with developmental and learning disorder 
is 15 514:27 226, which is a ratio of 1:2 (rounded off). This means that for every female patient 
diagnosed with developmental and learning disorder, 2 male patients are diagnosed with the 
same disorder. 
The longitudinal data shows that consistently, there are twice as many males, than female 
patients diagnosed with developmental and learning disorder. 
Chart GF9 
Gender Focus: Developmental and Learning Disorder 
 
Chart GF9 above, is a summary of gender representation for developmental and learning 
disorder between and including 2008 to June 2015. The ratio presented provides an average 
over 7 years, of male to female demographics for this disorder. For developmental and learning 
disorder, the ratio is 62:38%, which translates to 62 males will be diagnosed over 38 females 





Results: Dissociative Disorder 
Table GF10  
Gender Focus: Dissociative Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS      DISSOCIATIVE DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Dissociative disorder 2008 179 178 1062296 1029887 
Dissociative disorder 2009 210 310 1116307 1075822 
Dissociative disorder 2010 257 219 1245149 1189071 
Dissociative disorder 2011 277 259 1320350 1260693 
Dissociative disorder 2012 318 275 1389025 1322569 
Dissociative disorder 2013 340 287 1444105 1378311 
Dissociative disorder 2014 322 330 1498868 1424565 
Dissociative disorder 2015 202 166 1533223 1450880 
From Table GF10 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with dissociative disorder is 179:178, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder. 
2009: The ratio of female to male patients diagnosed with dissociative disorder is 210:310, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder. 
2010: The ratio of female to male patients diagnosed with dissociative disorder is 257:219, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 




2011: The ratio of female to male patients diagnosed with dissociative disorder is 277:259, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder. 
2012: The ratio of female to male patients diagnosed with dissociative disorder is 318:275, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder. 
2013: The ratio of female to male patients diagnosed with dissociative disorder is 340:287, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder. 
2014: The ratio of female to male patients diagnosed with dissociative disorder is 322:330, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder. 
2015: The ratio of female to male patients diagnosed with dissociative disorder is 202:166, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder. 





Chart GF10  
Gender Focus: Dissociative Disorder 
 
Chart GF10 above, is a summary of gender representation for dissociative disorder between and 
including 2008 to June 2015. The ratio presented provides an average over 7 years, of male to 
female demographics for this disorder. For dissociative disorder, the ratio is 49:51%, which 
translates to 49 males will be diagnosed over 51 females for every 100 patients, or more simply 





Results: Eating Disorder 
Table GF11  
Gender Focus: Eating Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS      EATING DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Eating disorder 2008 2397 462 1062296 1029887 
Eating disorder 2009 2562 503 1116307 1075822 
Eating disorder 2010 2921 622 1245149 1189071 
Eating disorder 2011 3241 830 1320350 1260693 
Eating disorder 2012 3495 878 1389025 1322569 
Eating disorder 2013 3534 856 1444105 1378311 
Eating disorder 2014 3761 871 1498868 1424565 
Eating disorder 2015 2082 499 1533223 1450880 
From Table GF11 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with eating disorder is 2397:462, which is 
a ratio of 5:1 (rounded off). This means that for every male patient diagnosed with eating 
disorder, 5 female patients are diagnosed with the same disorder. 
2009: The ratio of female to male patients diagnosed with eating disorder is 2562:503, which is 
a ratio of 5:1 (rounded off). This means that for every male patient diagnosed with eating 
disorder, 5 female patients are diagnosed with the same disorder. 
2010: The ratio of female to male patients diagnosed with eating disorder is 2921:622, which is 
a ratio of 5:1 (rounded off). This means that for every male patient diagnosed with eating 




2011: The ratio of female to male patients diagnosed with eating disorder is 3241:830, which is 
a ratio of 4:1 (rounded off). This means that for every male patient diagnosed with eating 
disorder, 4 female patients are diagnosed with the same disorder. 
2012: The ratio of female to male patients diagnosed with eating disorder is 3495:878, which is 
a ratio of 4:1 (rounded off). This means that for every male patient diagnosed with eating 
eisorder, 4 female patients are diagnosed with the same disorder. 
2013: The ratio of female to male patients diagnosed with eating disorder is 3534:856, which is 
a ratio of 4:1 (rounded off). This means that for every male patient diagnosed with eating 
disorder, 4 female patients are diagnosed with the same disorder. 
2014: The ratio of female to male patients diagnosed with eating disorder is 3761:871, which is 
a ratio of 4:1 (rounded off). This means that for every male patient diagnosed with eating 
disorder, 4 female patients are diagnosed with the same disorder. 
2015: The ratio of female to male patients diagnosed with eating disorder is 2082:499, which is 
a ratio of 4:1 (rounded off). This means that for every male patient diagnosed with eating 
disorder, 4 female patients are diagnosed with the same disorder. 
The longitudinal data shows that up until the end of 2010, there are five times as many females, 
than male patients diagnosed with an eating disorder. Thereafter, consistently, there are four 
times as many females, than male patients. This is indicative of an increase in male patients 






Chart GF11  
Gender Focus: Eating Disorder 
 
Chart GF11 above, is a summary of gender representation for eating disorder between and 
including 2008 to June 2015. The ratio presented provides an average over 7 years, of male to 
female demographics for this disorder. For eating disorder, the ratio is 19:81%, which translates 
to 19 males will be diagnosed over 81 females for every 100 patients, or more simply 10 males 





Results: Impulse Control Disorder 
Table GF12 
Gender Focus: Impulse Control Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS     IMPULSE CONTROL DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Impulse control disorder 2008 1220 1629 1062296 1029887 
Impulse control disorder 2009 1434 1606 1116307 1075822 
Impulse control disorder 2010 1451 1622 1245149 1189071 
Impulse control disorder 2011 1322 1661 1320350 1260693 
Impulse control disorder 2012 1445 1833 1389025 1322569 
Impulse control disorder 2013 1567 2118 1444105 1378311 
Impulse control disorder 2014 1573 2374 1498868 1424565 
Impulse control disorder 2015 986 1382 1533223 1450880 
From Table GF12 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with impulse control disorder is 
1220:1629, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  
2009: The ratio of female to male patients diagnosed with impulse control disorder is 
1434:1606, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  
2010: The ratio of female to male patients diagnosed with impulse control disorder is 
1451:1622, which is a ratio of 1:1 (rounded off). This means that male and female patients 




2011: The ratio of female to male patients diagnosed with impulse control disorder is 
1322:1661, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  
2012: The ratio of female to male patients diagnosed with impulse control disorder is 
1445:1833, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  
2013: The ratio of female to male patients diagnosed with impulse control disorder is 
1567:2118, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  
2014: The ratio of female to male patients diagnosed with impulse control disorder is 
1573:2374, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  
2015: The ratio of female to male patients diagnosed with impulse control disorder is 986:1382, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
Male and female patients diagnosed with impulse control disorder, show equal representation 





Chart GF12  
Gender Focus: Impulse Control Disorder 
 
Chart GF12 above, is a summary of gender representation for impulse control disorder between 
and including 2008 to June 2015. The ratio presented provides an average over 7 years, of male 
to female demographics for this disorder. For impulse control disorder, the ratio is 56:44%, 
which translates to 56 males will be diagnosed over 44 females for every 100 patients, or more 





Results: Mental Retardation 
Table GF13  
Gender Focus: Mental Retardation 
DIAGNOSIS DATABASE: GENDER FOCUS      MENTAL RETARDATION 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Mental retardation 2008 221 170 1062296 1029887 
Mental retardation 2009 266 228 1116307 1075822 
Mental retardation 2010 258 266 1245149 1189071 
Mental retardation 2011 308 315 1320350 1260693 
Mental retardation 2012 278 318 1389025 1322569 
Mental retardation 2013 258 398 1444105 1378311 
Mental retardation 2014 288 335 1498868 1424565 
Mental retardation 2015 203 218 1533223 1450880 
From Table GF13 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with mental retardation is 221:170, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2009: The ratio of female to male patients diagnosed with mental retardation is 226:228, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2010: The ratio of female to male patients diagnosed with mental retardation is 258:266, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 




2011: The ratio of female to male patients diagnosed with mental retardation is 308:315, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2012: The ratio of female to male patients diagnosed with mental retardation is 278:318, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2013: The ratio of female to male patients diagnosed with mental retardation is 258:398, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2014: The ratio of female to male patients diagnosed with mental retardation is 288:335, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2015: The ratio of female to male patients diagnosed with mental retardation is 203:218, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  





Chart GF13  
Gender Focus: Mental Retardation 
 
Chart GF13 above, is a summary of gender representation for mental retardation between and 
including 2008 to June 2015. The ratio presented provides an average over 7 years, of male to 
female demographics for this disorder. For mental retardation, the ratio is 52:48%, which 
translates to 52 males will be diagnosed over 48 females for every 100 patients, or more simply 





Results: Non-specific Neuroses 
Table GF14  
Gender Focus: Non-specific Neuroses 
DIAGNOSIS DATABASE: GENDER FOCUS     NON-SPECIFIC NEUROSES 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Non-specific neuroses 2008 35456 23699 1062296 1029887 
Non-specific neuroses 2009 33216 22828 1116307 1075822 
Non-specific neuroses 2010 34953 23929 1245149 1189071 
Non-specific neuroses 2011 35753 25535 1320350 1260693 
Non-specific neuroses 2012 36735 26254 1389025 1322569 
Non-specific neuroses 2013 36900 26574 1444105 1378311 
Non-specific neuroses 2014 37926 26761 1498868 1424565 
Non-specific neuroses 2015 20330 14319 1533223 1450880 
From Table GF14 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with non-specific neuroses is 35 456:23 
699, which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed 
with non-specific neuroses, 2 females are diagnosed with the same disorder. 
2009: The ratio of female to male patients diagnosed with non-specific neuroses is 33 216:22 
828, which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed 
with non-specific neuroses, 2 females are diagnosed with the same disorder. 
2010: The ratio of female to male patients diagnosed with non-specific neuroses is 34 953:23 
929, which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed 




2011: The ratio of female to male patients diagnosed with non-specific neuroses is 35 753:25 
535, which is a ratio of 1.4:1 (rounded off). This means that for every male patient diagnosed 
with non-specific neuroses, 1.4 females are diagnosed with the same disorder. This translates to 
five males diagnosed for every seven females diagnosed with the disorder. 
2012: The ratio of female to male patients diagnosed with non-specific neuroses is 36 735:26 
254, which is a ratio of 1.4:1 (rounded off). This means that for every male patient diagnosed 
with non-specific neuroses, 1.4 females are diagnosed with the same disorder. This translates to 
five males diagnosed for every seven females diagnosed with the disorder. 
2013: The ratio of female to male patients diagnosed with non-specific neuroses is 36 900:26 
574, which is a ratio of 1.4:1 (rounded off). This means that for every male patient diagnosed 
with non-specific neuroses, 1.4 females are diagnosed with the same disorder. This translates to 
five males diagnosed for every seven females diagnosed with the disorder. 
2014: The ratio of female to male patients diagnosed with non-specific neuroses is 37 926:26 
761, which is a ratio of 1.4:1 (rounded off). This means that for every male patient diagnosed 
with non-specific neuroses, 1.4 females are diagnosed with the same disorder. This translates to 
five males diagnosed for every seven females diagnosed with the disorder. 
2015: The ratio of female to male patients diagnosed with non-specific neuroses is 20 330:14 
319an, which is a ratio of 1.4:1 (rounded off). This means that for every male patient diagnosed 
with non-specific neuroses, 1.4 females are diagnosed with the same disorder. This translates to 




The longitudinal data shows that from 2008 – 2010, there are more than twice as many females, 
than male patients diagnosed with non-specific neuroses. Thereafter, the ratio alters, and shows 
a constant ratio approaching a ratio of 1.4 females for every male patient. This translates to a 
decrease in the number of male patients diagnosed with Non-specific Neuroses from 2011 
onwards. 
Chart GF14  
Gender Focus: Non-specific Neuroses 
 
Chart GF14 above, is a summary of gender representation for non-specific neuroses between 
and including 2008 to June 2015. The ratio presented provides an average over 7 years, of male 
to female demographics for this disorder. For non-specific neuroses, the ratio is 41:59%, which 
translates to 41 males will be diagnosed over 59 females for every 100 patients, or more simply 





Results: Non-specific Psychoses 
Table GF15  
Gender Focus: Non-specific Psychoses 
DIAGNOSIS DATABASE: GENDER FOCUS     NON-SPECIFIC PSYCHOSES 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Non-specific psychoses 2008 198 219 1062296 1029887 
Non-specific psychoses 2009 237 207 1116307 1075822 
Non-specific psychoses 2010 201 194 1245149 1189071 
Non-specific psychoses 2011 159 217 1320350 1260693 
Non-specific psychoses 2012 195 210 1389025 1322569 
Non-specific psychoses 2013 259 241 1444105 1378311 
Non-specific psychoses 2014 179 311 1498868 1424565 
Non-specific psychoses 2015 127 151 1533223 1450880 
From Table GF15 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with non-specific psychoses is 198:219, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2009: The ratio of female to male patients diagnosed with non-specific psychoses is 237:207, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2010: The ratio of female to male patients diagnosed with non-specific psychoses is 201:194, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 




2011: The ratio of female to male patients diagnosed with non-specific psychoses is 159:217, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2012: The ratio of female to male patients diagnosed with non-specific psychoses is 195:210, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2013: The ratio of female to male patients diagnosed with non-specific psychoses is 259:241, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2014: The ratio of female to male patients diagnosed with non-specific psychoses is 179:311, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2015: The ratio of female to male patients diagnosed with non-specific psychoses is 127:151, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  






Gender Focus: Non-specific Psychoses 
 
Chart GF15 above, is a summary of gender representation for non-specific psychoses between 
and including 2008 to June 2015. The ratio presented provides an average over 7 years, of male 
to female demographics for this disorder. For non-specific psychoses, the ratio is 53:47%, 
which translates to 53 males will be diagnosed over 47 females for every 100 patients, or more 





Results: Obsessive Compulsive Disorder 
Table GF16  
Gender Focus: Obsessive Compulsive Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS    OBSESSIVE COMPULSIVE DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Obsessive compulsive disorder 2008 2285 2195 1062296 1029887 
Obsessive compulsive disorder 2009 2705 2531 1116307 1075822 
Obsessive compulsive disorder 2010 2775 2914 1245149 1189071 
Obsessive compulsive disorder 2011 3324 3415 1320350 1260693 
Obsessive compulsive disorder 2012 3656 3535 1389025 1322569 
Obsessive compulsive disorder 2013 4125 3825 1444105 1378311 
Obsessive compulsive disorder 2014 4114 3868 1498868 1424565 
Obsessive compulsive disorder 2015 2092 1885 1533223 1450880 
From Table GF16 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with obsessive compulsive disorder is 
2285:2195, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  
2009: The ratio of female to male patients diagnosed with obsessive compulsive disorder is 
2705:2531, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  
2010: The ratio of female to male patients diagnosed with obsessive compulsive disorder is 
2775:2914, which is a ratio of 1:1 (rounded off). This means that male and female patients 




2011: The ratio of female to male patients diagnosed with obsessive compulsive disorder is 
3324:3415, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  
2012: The ratio of female to male patients diagnosed with obsessive compulsive disorder is 
3656:3535, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  
2013: The ratio of female to male patients diagnosed with obsessive compulsive disorder is 
4125:3825, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  
2014: The ratio of female to male patients diagnosed with obsessive compulsive disorder is 
4114:3868, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  
2015: The ratio of female to male patients diagnosed with obsessive compulsive disorder is 
2092:1885, which is a ratio of 1:1 (rounded off). This means that male and female patients 
show equal representation with this disorder.  







Gender Focus: Obsessive Compulsive Disorder 
 
Chart GF16 above, is a summary of gender representation for obsessive compulsive disorder 
between and including 2008 to June 2015. The ratio presented provides an average over 7 
years, of male to female demographics for this disorder. For obsessive compulsive disorder, the 
ratio is 49:51%, which translates to 49 males will be diagnosed over 51 females for every 100 





Results: Parasomnia or Sleep Disorder 
Table GF17 
Gender Focus: Parasomnia or Sleep Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS    PARASOMNIA OR SLEEP DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Parasomnia or sleep disorder 2008 39815 26348 1062296 1029887 
Parasomnia or sleep disorder 2009 57669 36813 1116307 1075822 
Parasomnia or sleep disorder 2010 69814 45839 1245149 1189071 
Parasomnia or sleep disorder 2011 79466 52935 1320350 1260693 
Parasomnia or sleep disorder 2012 85623 58018 1389025 1322569 
Parasomnia or sleep disorder 2013 92978 64618 1444105 1378311 
Parasomnia or sleep disorder 2014 99807 71177 1498868 1424565 
Parasomnia or sleep disorder 2015 54248 39136 1533223 1450880 
From Table GF17 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with parasomnia or sleep disorder is 39 
815:26 348, which is a ratio of 1.5:1 (rounded off). This means that for every male patient 
diagnosed with parasomnia or sleep disorder, 1.5 females are diagnosed with the same disorder. 
This translates to two male patients for every three female patients diagnosed with the disorder. 
2009: The ratio of female to male patients diagnosed with parasomnia or sleep disorder is 57 
669:36 813, which is a ratio of 1.6:1 (rounded off). This means that for every male patient 
diagnosed with parasomnia or sleep disorder, 1.6 females are diagnosed with the same disorder. 




2010: The ratio of female to male patients diagnosed with parasomnia or sleep disorder is 69 
814:45 839, which is a ratio of 1.5:1 (rounded off). This means that for every male patient 
diagnosed with parasomnia or sleep disorder, 1.5 females are diagnosed with the same disorder. 
This translates to two male patients for every three female patients diagnosed with the disorder. 
2011: The ratio of female to male patients diagnosed with parasomnia or sleep disorder is 79 
466:52 935, which is a ratio of 1.5:1 (rounded off). This means that for every male patient 
diagnosed with parasomnia or sleep disorder, 1.5 females are diagnosed with the same disorder. 
This translates to two male patients for every three female patients diagnosed with the disorder. 
2012: The ratio of female to male patients diagnosed with parasomnia or sleep disorder is 85 
623:58 018, which is a ratio of 1.5:1 (rounded off). This means that for every male patient 
diagnosed with parasomnia or sleep disorder, 1.5 females are diagnosed with the same disorder. 
This translates to two male patients for every three female patients diagnosed with the disorder. 
2013: The ratio of female to male patients diagnosed with parasomnia or sleep disorder is 92 
978:64 618, which is a ratio of 1.4:1 (rounded off). This means that for every male patient 
diagnosed with parasomnia or sleep disorder, 1.4 females are diagnosed with the same disorder. 
This translates to two male patients for every three female patients diagnosed with the disorder. 
2014: The ratio of female to male patients diagnosed with parasomnia or sleep disorder is 99 
807:71 177, which is a ratio of 1.4:1 (rounded off). This means that for every male patient 
diagnosed with parasomnia or sleep disorder, 1.4 females are diagnosed with the same disorder. 





2015: The ratio of female to male patients diagnosed with parasomnia or sleep disorder is 54 
248:39 136, which is a ratio of 1.4:1 (rounded off). This means that for every male patient 
diagnosed with parasomnia or sleep disorder, 1.4 females are diagnosed with the same disorder. 
This translates to five male patients for every seven female patients diagnosed with the 
disorder. 
The longitudinal data shows that between 2008 and 2012, there are more female, than male 
patients diagnosed with parasomnia or sleep disorder, to the order of 3 female patients for every 
two male patients. Interestingly, the number of female patients diagnosed from 2008 to 2009 
increases by 30%. From 2013 to 2015, the trend is 1 male for every 1.4 female patients, which 
translates to five male patients for every seven female patients. This signifies a decrease in male 
patient numbers.  
Chart GF17  
Gender Focus: Parasomnia or Sleep Disorder 
 
Chart GF17 above, is a summary of gender representation for parasomnia or sleep disorder 




years, of male to female demographics for this disorder. For parasomnia or sleep disorder, the 
ratio is 41:59%, which translates to 41 males will be diagnosed over 59 females for every 100 
patients, or more simply 10 males for every 14 females. 
Results: Personality Disorder 
Table GF18  
Gender Focus: Personality Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS      PERSONALITY DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Personality disorder 2008 282 259 1062296 1029887 
Personality disorder 2009 313 286 1116307 1075822 
Personality disorder 2010 366 331 1245149 1189071 
Personality disorder 2011 376 382 1320350 1260693 
Personality disorder 2012 416 292 1389025 1322569 
Personality disorder 2013 366 302 1444105 1378311 
Personality disorder 2014 468 309 1498868 1424565 
Personality disorder 2015 293 185 1533223 1450880 
From Table GF18 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with personality disorder is 282:259, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2009: The ratio of female to male patients diagnosed with personality disorder is 313:286, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 




2010: The ratio of female to male patients diagnosed with personality disorder is 366:331, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2011: The ratio of female to male patients diagnosed with personality disorder is 376:382, 
which is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2012: The ratio of female to male patients diagnosed with personality disorder is 416:292, 
which is a ratio of 1.4:1 (rounded off). This means that for every male patient diagnosed with 
personality disorder, 1.4 females are diagnosed with the same disorder. This translates to five 
male patients for every seven female patients diagnosed with the disorder. 
2013: The ratio of female to male patients diagnosed with personality disorder is 366:302, 
which is a ratio of 1.2:1 (rounded off). This means that for every male patient diagnosed with 
personality disorder, 1.2 females are diagnosed with the same disorder. This translates to five 
male patients for every six female patients diagnosed with the disorder. 
2014: The ratio of female to male patients diagnosed with personality disorder is 468:309, 
which is a ratio of 1.5:1 (rounded off). This means that for every male patient diagnosed with 
personality disorder, 1.5 females are diagnosed with the same disorder. This translates to two 
male patients for every three female patients diagnosed with the disorder. 
2015: The ratio of female to male patients diagnosed with personality disorder is 293:185, 




personality disorder, 1.6 females are diagnosed with the same disorder. This translates to five 
male patients for every six female patients diagnosed with the disorder. 
The longitudinal data shows that between 2008 and 2011, there is equal representation between 
male and female patients diagnosed with personality disorder. Thereafter, the trend alters, and 
reveals a steady increase in the number of female patients relative to male patients. By 2015 the 
ratio is 1.6 to 1, which translates to eight female patients for every five male patients. 
Chart GF18  
Gender Focus: Personality Disorder 
 
Chart GF18 above, is a summary of gender representation for personality disorder between and 
including 2008 to June 2015. The ratio presented provides an average over 7 years, of male to 
female demographics for this disorder. For personality disorder, the ratio is 45:55%, which 
translates to 45 males will be diagnosed over 55 females for every 100 patients, or more simply 





Results: Psychosis General Medical Disorder 
Table GF19:  
Gender Focus: Psychosis General Medical Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS    PSYCHOSIS GENERAL MEDICAL DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Psychosis general medical disorder 2008 183 436 1062296 1029887 
Psychosis general medical disorder 2009 204 451 1116307 1075822 
Psychosis general medical disorder 2010 157 482 1245149 1189071 
Psychosis general medical disorder 2011 203 495 1320350 1260693 
Psychosis general medical disorder 2012 188 539 1389025 1322569 
Psychosis general medical disorder 2013 206 638 1444105 1378311 
Psychosis general medical disorder 2014 272 739 1498868 1424565 
Psychosis general medical disorder 2015 130 429 1533223 1450880 
From Table GF19 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with psychosis due to general medical 
disorder is 183:436, which is a ratio of 1:2 (rounded off). This means that for every female 
patient diagnosed with psychosis due to general medical disorder, two males are diagnosed with 
the same disorder. 
2009: The ratio of female to male patients diagnosed with psychosis due to general medical 
disorder is 204:451, which is a ratio of 1:2 (rounded off). This means that for every female 
patient diagnosed with psychosis due to general medical disorder, two males are diagnosed with 




2010: The ratio of female to male patients diagnosed with psychosis due to general medical 
disorder is 157:482, which is a ratio of 1:3 (rounded off). This means that for every female 
patient diagnosed with psychosis due to general medical disorder, three males are diagnosed 
with the same disorder. 
2011: The ratio of female to male patients diagnosed with psychosis due to general medical 
disorder is 203:495, which is a ratio of 1:2 (rounded off). This means that for every female 
patient diagnosed with psychosis due to general medical disorder, two males are diagnosed with 
the same disorder. 
2012: The ratio of female to male patients diagnosed with psychosis due to general medical 
disorder is 188:539, which is a ratio of 1:3 (rounded off). This means that for every female 
patient diagnosed with psychosis due to general medical disorder, three males are diagnosed 
with the same disorder. 
2013: The ratio of female to male patients diagnosed with psychosis due to general medical 
disorder is 206:638, which is a ratio of 1:3 (rounded off). This means that for every female 
patient diagnosed with psychosis due to general medical disorder, three males are diagnosed 
with the same disorder. 
2014: The ratio of female to male patients diagnosed with psychosis due to general medical 
disorder is 272:739, which is a ratio of 1:3 (rounded off). This means that for every female 
patient diagnosed with psychosis due to general medical disorder, three males are diagnosed 




2015: The ratio of female to male patients diagnosed with psychosis due to general medical 
disorder is 130:429, which is a ratio of 1:3 (rounded off). This means that for every female 
patient diagnosed with psychosis due to general medical disorder, three males are diagnosed 
with the same disorder. 
The longitudinal data shows that for five of the eight years reflective of the database, there are 
three times as many males, than female patients diagnosed with psychosis due to general 
medical disorder. In 2008, 2009 and 2011, the ratio discrepancy is lower, and reflects a ratio of 
two male patients for every female patient. These ratio’s present a significantly higher number 
of male patients with this disorder, than female patients. 
Chart GF19 
Gender Focus: Psychosis General Medical Disorder 
 
Chart GF19 above, is a summary of gender representation for psychosis due to general medical 
disorder between and including 2008 to June 2015. The ratio presented provides an average 




medical disorder, the ratio is 73:27%, which translates to 73 males will be diagnosed over 27 
females for every 100 patients, or more simply 27 males for every 10 females. 
Results: Psycho-Social Disorder of Childhood 
Table GF20 
Gender Focus: Psycho-Social Disorder of Childhood 
DIAGNOSIS DATABASE: GENDER FOCUS   PSYCHO-SOCIAL DISORDER OF CHILDHOOD 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Psycho-social disorder of childhood 2008 3455 4401 1062296 1029887 
Psycho-social disorder of childhood 2009 3779 4430 1116307 1075822 
Psycho-social disorder of childhood 2010 3815 4360 1245149 1189071 
Psycho-social disorder of childhood 2011 3993 4656 1320350 1260693 
Psycho-social disorder of childhood 2012 3798 4562 1389025 1322569 
Psycho-social disorder of childhood 2013 3641 4724 1444105 1378311 
Psycho-social disorder of childhood 2014 3706 4455 1498868 1424565 
Psycho-social disorder of childhood 2015 2272 2786 1533223 1450880 
From Table GF20 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with psycho-social disorder of childhood 
is 3455:4401, which is a ratio of 1:1.2 (rounded off). This means that for every female patient 
diagnosed with psycho-social disorder of childhood, 1.2 males are diagnosed with the same 
disorder. This translates to 6 male patients for every 5 female patients. 
2009: The ratio of female to male patients diagnosed with psycho-social disorder of childhood 




diagnosed with psycho-social disorder of childhood, 1.2 males are diagnosed with the same 
disorder. This translates to 6 male patients for every 5 female patients. 
2010: The ratio of female to male patients diagnosed with psycho-social disorder of childhood 
is 3815:4360, which is a ratio of 1:1.2 (rounded off). This means that for every female patient 
diagnosed with psycho-social disorder of childhood, 1.2 males are diagnosed with the same 
disorder. This translates to 6 male patients for every 5 female patients. 
2011: The ratio of female to male patients diagnosed with psycho-social disorder of childhood 
is 3993:4656, which is a ratio of 1:1.2 (rounded off). This means that for every female patient 
diagnosed with psycho-social disorder of childhood, 1.2 males are diagnosed with the same 
disorder. This translates to 6 male patients for every 5 female patients. 
2012: The ratio of female to male patients diagnosed with psycho-social disorder of childhood 
is 3798:4562, which is a ratio of 1:1.2 (rounded off). This means that for every female patient 
diagnosed with psycho-social disorder of childhood, 1.2 males are diagnosed with the same 
disorder. This translates to 6 male patients for every 5 female patients. 
2013: The ratio of female to male patients diagnosed with psycho-social disorder of childhood 
is 3641:4724, which is a ratio of 1:1.2 (rounded off). This means that for every female patient 
diagnosed with psycho-social disorder of childhood, 1.2 males are diagnosed with the same 
disorder. This translates to 6 male patients for every 5 female patients. 
2014: The ratio of female to male patients diagnosed with psycho-social disorder of childhood 




diagnosed with psycho-social disorder of childhood, 1.2 males are diagnosed with the same 
disorder. This translates to 6 male patients for every 5 female patients. 
2015: The ratio of female to male patients diagnosed with psycho-social disorder of childhood 
is 2272:2786, which is a ratio of 1:1.2 (rounded off). This means that for every female patient 
diagnosed with psycho-social disorder of childhood, 1.2 males are diagnosed with the same 
disorder. This translates to 6 male patients for every 5 female patients. 
The longitudinal data shows that consistently, there are slightly more male, than female patients 
diagnosed with psycho-social disorder of childhood. The ratio of 1.2 males for every 1 female 
patient, translates to a ratio of 6 male patients for every 5 female patients. 
Chart GF20  
Gender Focus: Psycho-Social Disorder of Childhood 
 
Chart GF20 above, is a summary of gender representation for psycho-social disorder of 
childhood between and including 2008 to June 2015. The ratio presented provides an average 




childhood, the ratio is 55:45%, which translates to 55 males will be diagnosed over 45 females 
for every 100 patients, or more simply 12 males for every 10 females. 
Results: Schizophrenia 
Table GF21:  
Gender Focus: Schizophrenia 
DIAGNOSIS DATABASE: GENDER FOCUS      SCHIZOPHRENIA 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Schizophrenia 2008 6123 5755 1062296 1029887 
Schizophrenia 2009 6463 6180 1116307 1075822 
Schizophrenia 2010 6817 6718 1245149 1189071 
Schizophrenia 2011 7724 7391 1320350 1260693 
Schizophrenia 2012 8227 7719 1389025 1322569 
Schizophrenia 2013 8419 8048 1444105 1378311 
Schizophrenia 2014 8798 8383 1498868 1424565 
Schizophrenia 2015 4642 4341 1533223 1450880 
From Table GF21 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with schizophrenia is 6123:5755, which is 
a ratio of 1:1 (rounded off). This means that male and female patients show equal representation 
with this disorder.  
2009: The ratio of female to male patients diagnosed with schizophrenia is 6463:6180, which is 
a ratio of 1:1 (rounded off). This means that male and female patients show equal representation 




2010: The ratio of female to male patients diagnosed with schizophrenia is 6817:6718, which is 
a ratio of 1:1 (rounded off). This means that male and female patients show equal representation 
with this disorder.  
2011: The ratio of female to male patients diagnosed with schizophrenia is 7724:7391, which is 
a ratio of 1:1 (rounded off). This means that male and female patients show equal representation 
with this disorder.  
2012: The ratio of female to male patients diagnosed with schizophrenia is 8227:7719, which is 
a ratio of 1:1 (rounded off). This means that male and female patients show equal representation 
with this disorder.  
2013: The ratio of female to male patients diagnosed with schizophrenia is 8419:8048, which is 
a ratio of 1:1 (rounded off). This means that male and female patients show equal representation 
with this disorder.  
2014: The ratio of female to male patients diagnosed with schizophrenia is 8798:8383, which is 
a ratio of 1:1 (rounded off). This means that male and female patients show equal representation 
with this disorder.  
2015: The ratio of female to male patients diagnosed with schizophrenia is 4642:4341, which is 
a ratio of 1:1 (rounded off). This means that male and female patients show equal representation 
with this disorder.  





Chart GF21  
Gender Focus: Schizophrenia 
 
Chart GF21 above, is a summary of gender representation for schizophrenia between and 
including 2008 to June 2015. The ratio presented provides an average over 7 years, of male to 
female demographics for this disorder. For schizophrenia, the ratio is 49:51%, which translates 
to 49 males will be diagnosed over 51 females for every 100 patients, or more simply 1 male 





Results: Sexual and Gender Identity Disorder 
Table GF22 
Gender Focus: Sexual and Gender Identity Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS    SEXUAL AND GENDER IDENTITY DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Sexual and gender identity disorder 2008 481 1815 1062296 1029887 
Sexual and gender identity disorder 2009 915 2583 1116307 1075822 
Sexual and gender identity disorder 2010 1212 3081 1245149 1189071 
Sexual and gender identity disorder 2011 1345 3768 1320350 1260693 
Sexual and gender identity disorder 2012 1349 4113 1389025 1322569 
Sexual and gender identity disorder 2013 1281 4569 1444105 1378311 
Sexual and gender identity disorder 2014 1353 4834 1498868 1424565 
Sexual and gender identity disorder 2015 729 2638 1533223 1450880 
From Table GF22 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with sexual and gender identity disorder is 
481:1815, which is a ratio of 1:4 (rounded off). This means that for every female patient 
diagnosed with sexual and gender identity disorder, four males are diagnosed with the same 
disorder. 
2009: The ratio of female to male patients diagnosed with sexual and gender identity disorder is 
915:2583, which is a ratio of 1:3 (rounded off). This means that for every female patient 





2010: The ratio of female to male patients diagnosed with sexual and gender identity disorder is 
1212:3081, which is a ratio of 1:3 (rounded off). This means that for every female patient 
diagnosed with sexual and gender identity disorder, three males are diagnosed with the same 
disorder. 
2011: The ratio of female to male patients diagnosed with sexual and gender identity disorder is 
1345:3768, which is a ratio of 1:3 (rounded off). This means that for every female patient 
diagnosed with sexual and gender identity disorder, three males are diagnosed with the same 
disorder. 
2012: The ratio of female to male patients diagnosed with sexual and gender identity disorder is 
1349:4113, which is a ratio of 1:3 (rounded off). This means that for every female patient 
diagnosed with sexual and gender identity disorder, three males are diagnosed with the same 
disorder. 
2013: The ratio of female to male patients diagnosed with sexual and gender identity disorder is 
1281:4569, which is a ratio of 1:4 (rounded off). This means that for every female patient 
diagnosed with sexual and gender identity disorder, four males are diagnosed with the same 
disorder. 
2014: The ratio of female to male patients diagnosed with sexual and gender identity disorder is 
1353:4834, which is a ratio of 1:4 (rounded off). This means that for every female patient 





2015: The ratio of female to male patients diagnosed with sexual and gender identity disorder is 
729:2638, which is a ratio of 1:4 (rounded off). This means that for every female patient 
diagnosed with sexual and gender identity disorder, four males are diagnosed with the same 
disorder. 
The longitudinal data shows that for four of the eight years reflective of the database, there are 
four times as many males, than female patients diagnosed with sexual and gender identity 
disorder. In 2009 - 2012, the ratio discrepancy is lower, and reflects a ratio of three male 
patients for every female patient. These ratio’s present a significantly higher number of male 
patients with this disorder, than female patients. 
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Chart GF22 above, is a summary of gender representation for sexual and gender identity 
disorder between and including 2008 to June 2015. The ratio presented provides an average 




disorder, the ratio is 76:24%, which translates to 76 males will be diagnosed over 24 females 
for every 100 patients, or more simply 32 males for every 10 females. 
Results: Somatoform Disorder 
Table GF23  
Gender Focus: Somatoform Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS     SOMATOFORM DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Somatoform disorder 2008 2432 1355 1062296 1029887 
Somatoform disorder 2009 2187 1294 1116307 1075822 
Somatoform disorder 2010 2429 1375 1245149 1189071 
Somatoform disorder 2011 2671 1456 1320350 1260693 
Somatoform disorder 2012 2756 1459 1389025 1322569 
Somatoform disorder 2013 3005 1568 1444105 1378311 
Somatoform disorder 2014 3128 1639 1498868 1424565 
Somatoform disorder 2015 1694 824 1533223 1450880 
From Table GF23 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with somatoform disorder is 2432:1355, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
somatoform disorder, two females are diagnosed with the same disorder. 
2009: The ratio of female to male patients diagnosed with somatoform disorder is 2187:1294, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 




2010: The ratio of female to male patients diagnosed with somatoform disorder is 2429:1375, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
somatoform disorder, two females are diagnosed with the same disorder. 
2011: The ratio of female to male patients diagnosed with somatoform disorder is 2671:1456, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
somatoform disorder, two females are diagnosed with the same disorder. 
2012: The ratio of female to male patients diagnosed with somatoform disorder is 2756:1459, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
somatoform disorder, two females are diagnosed with the same disorder. 
2013: The ratio of female to male patients diagnosed with somatoform disorder is 3005:1368, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
somatoform disorder, two females are diagnosed with the same disorder. 
2014: The ratio of female to male patients diagnosed with somatoform disorder is 3128:1639, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
somatoform disorder, two females are diagnosed with the same disorder. 
2015: The ratio of female to male patients diagnosed with somatoform disorder is 1694:824, 
which is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with 
somatoform disorder, two females are diagnosed with the same disorder. 
The longitudinal data shows that consistently, there are twice as many females, than male 




Chart GF23  
Gender Focus: Somatoform Disorder 
 
Chart GF23 above, is a summary of gender representation for somatoform disorder between and 
including 2008 to June 2015. The ratio presented provides an average over 7 years, of male to 
female demographics for this disorder. For somatoform disorder, the ratio is 35:65%, which 
translates to 35 males will be diagnosed over 65 females for every 100 patients, or more simply 





Results: Substance Abuse or Dependence Behaviour 
Table GF24 
Gender Focus: Substance Abuse or Dependence Behaviour 
DIAGNOSIS DATABASE: GENDER FOCUS   SUBSTANCE ABUSE OR DEPENDENCE BEHAVIOUR 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Substance abuse or dependence behaviour  2008 991 1259 1062296 1029887 
Substance abuse or dependence behaviour  2009 1053 1389 1116307 1075822 
Substance abuse or dependence behaviour  2010 1024 1532 1245149 1189071 
Substance abuse or dependence behaviour  2011 1320 2251 1320350 1260693 
Substance abuse or dependence behaviour  2012 1900 2873 1389025 1322569 
Substance abuse or dependence behaviour  2013 1646 2840 1444105 1378311 
Substance abuse or dependence behaviour  2014 1686 2926 1498868 1424565 
Substance abuse or dependence behaviour  2015 761 1471 1533223 1450880 
From Table GF24 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with substance abuse or dependence 
behaviour is 991:1259, which is a ratio of 1:1.3 (rounded off). This means that for every female 
patient diagnosed with substance abuse or dependence behaviour, 1.3 males are diagnosed with 
the same disorder. This translates to ten females diagnosed with substance abuse or dependence 
behaviour, for every thirteen males diagnosed. 
2009: The ratio of female to male patients diagnosed with substance abuse or dependence 
behaviour is 1053:1389, which is a ratio of 1:1.3 (rounded off). This means that for every 
female patient diagnosed with substance abuse or dependence behaviour, 1.3 males are 
diagnosed with the same disorder. This translates to ten females diagnosed with substance 




2010: The ratio of female to male patients diagnosed with substance abuse or dependence 
behaviour is 1024:1532, which is a ratio of 1:1.5 (rounded off). This means that for every 
female patient diagnosed with substance abuse or dependence behaviour, 1.5 males are 
diagnosed with the same disorder. This translates to two females diagnosed with substance 
abuse or dependence behaviour, for every three males diagnosed. 
2011: The ratio of female to male patients diagnosed with substance abuse or dependence 
behaviour is 1320:2251, which is a ratio of 1:1.7 (rounded off). This means that for every 
female patient diagnosed with substance abuse or dependence behaviour, 1.7 males are 
diagnosed with the same disorder. This translates to ten females diagnosed with substance 
abuse or dependence behaviour, for every seventeen males diagnosed. 
2012: The ratio of female to male patients diagnosed with substance abuse or dependence 
behaviour is 1900:2873, which is a ratio of 1:1.5 (rounded off). This translates to two females 
diagnosed with substance abuse or dependence behaviour, for every three males diagnosed. 
2013: The ratio of female to male patients diagnosed with substance abuse or dependence 
behaviour is 1646:2840, which is a ratio of 1:1.7 (rounded off). This means that for every 
female patient diagnosed with substance abuse or dependence behaviour, 1.7 males are 
diagnosed with the same disorder. This translates to ten females diagnosed with substance 
abuse or dependence behaviour, for every seventeen males diagnosed. 
2014: The ratio of female to male patients diagnosed with substance abuse or dependence 
behaviour is 1686:2926, which is a ratio of 1:1.7 (rounded off). This means that for every 




diagnosed with the same disorder. This translates to ten females diagnosed with substance 
abuse or dependence behaviour, for every seventeen males diagnosed. 
2015: The ratio of female to male patients diagnosed with substance abuse or dependence 
behaviour is 761:1471, which is a ratio of 1:2 (rounded off). This means that for every female 
patient diagnosed with substance abuse or dependence behaviour, 2 males are diagnosed with 
the same disorder. 
The longitudinal data shows that the number of male patients is consistently higher than female 
patient numbers. From 2010 onwards, the pattern is consistent with incrementally increasing 
numbers of males, than female patients diagnosed with the disorder. 
Chart GF24  
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Chart GF24 above, is a summary of gender representation for substance abuse or dependence 
behaviour between and including 2008 to June 2015. The ratio presented provides an average 




dependence behaviour, the ratio is 61:39%, which translates to 61 males will be diagnosed over 
39 females for every 100 patients, or more simply 16 males for every 10 females. 
Results: Tic Disorder 
Table GF25 
Gender Focus: Tic Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS      TIC DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Tic disorder 2008 58 227 1062296 1029887 
Tic disorder 2009 91 284 1116307 1075822 
Tic disorder 2010 110 267 1245149 1189071 
Tic disorder 2011 147 344 1320350 1260693 
Tic disorder 2012 176 389 1389025 1322569 
Tic disorder 2013 161 356 1444105 1378311 
Tic disorder 2014 168 341 1498868 1424565 
Tic disorder 2015 68 190 1533223 1450880 
From Table GF25 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with tic disorder is 58:227, which is a ratio 
of 1:4 (rounded off). This means that for every female patient diagnosed with tic disorder, four 
males are diagnosed with the same disorder. 
2009: The ratio of female to male patients diagnosed with tic disorder is 91:284, which is a ratio 
of 1:3 (rounded off). This means that for every female patient diagnosed with tic disorder, three 




2010: The ratio of female to male patients diagnosed with tic disorder is 110:267, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with tic disorder, 
two males are diagnosed with the same disorder. 
2011: The ratio of female to male patients diagnosed with tic disorder is 147:344, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with tic disorder, 
two males are diagnosed with the same disorder. 
2012: The ratio of female to male patients diagnosed with tic disorder is 176:389, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with tic disorder, 
two males are diagnosed with the same disorder. 
2013: The ratio of female to male patients diagnosed with tic disorder is 161:356, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with tic disorder, 
two males are diagnosed with the same disorder. 
2014: The ratio of female to male patients diagnosed with tic disorder is 168:341, which is a 
ratio of 1:2 (rounded off). This means that for every female patient diagnosed with tic disorder, 
two males are diagnosed with the same disorder. 
2015: The ratio of female to male patients diagnosed with tic disorder is 68:190, which is a ratio 
of 1:2 (rounded off). This means that for every female patient diagnosed with tic disorder, two 
males are diagnosed with the same disorder. 
The ratio of 1:4 in 2008, shows a significant disproportion in female:male diagnosis numbers, 
with one female patient for every four males diagnosed with the disorder. In 2009 there is a 




1 in 3. Thereafter, the ratio remains at one female for every two males diagnosed with the 
disorder.  
Chart GF25  
Gender Focus: Tic Disorder 
 
Chart GF25 above, is a summary of gender representation for tic disorder between and 
including 2008 to June 2015. The ratio presented provides an average over 7 years, of male to 
female demographics for this disorder. For tic disorder, the ratio is 71:29%, which translates to 
71 males will be diagnosed over 29 females for every 100 patients, or more simply 24 males for 






Results: Unconfirmed Psychology Disorder 
Table GF26  
Gender Focus: Unconfirmed Psychology Disorder 
DIAGNOSIS DATABASE: GENDER FOCUS    UNCONFIRMED PSYCHOLOGY DISORDER 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Unconfirmed psychology disorder 2008 24511 15872 1062296 1029887 
Unconfirmed psychology disorder 2009 22568 14907 1116307 1075822 
Unconfirmed psychology disorder 2010 24402 15935 1245149 1189071 
Unconfirmed psychology disorder 2011 25083 16491 1320350 1260693 
Unconfirmed psychology disorder 2012 27314 17637 1389025 1322569 
Unconfirmed psychology disorder 2013 29495 19157 1444105 1378311 
Unconfirmed psychology disorder 2014 32195 21176 1498868 1424565 
Unconfirmed psychology disorder 2015 22185 14483 1533223 1450880 
From Table GF26 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with unconfirmed psychology disorder is 
24 511:15 872, which is a ratio of 1.5:1 (rounded off). This means that for every male patient 
diagnosed with unconfirmed psychology disorder, 1.5 females are diagnosed with the same 
disorder. This translates to three female patients for every two male patients. 
2009: The ratio of female to male patients diagnosed with unconfirmed psychology disorder is 
22 568:14 907, which is a ratio of 1.5:1 (rounded off). This means that for every male patient 
diagnosed with unconfirmed psychology disorder, 1.5 females are diagnosed with the same 




2010: The ratio of female to male patients diagnosed with unconfirmed psychology disorder is 
24 402:15 935, which is a ratio of 1.5:1 (rounded off). This means that for every male patient 
diagnosed with unconfirmed psychology disorder, 1.5 females are diagnosed with the same 
disorder. This translates to three female patients for every two male patients. 
2011: The ratio of female to male patients diagnosed with unconfirmed psychology disorder is 
25 083:16 491, which is a ratio of 1.5:1 (rounded off). This means that for every male patient 
diagnosed with unconfirmed psychology disorder, 1.5 females are diagnosed with the same 
disorder. This translates to three female patients for every two male patients. 
2012: The ratio of female to male patients diagnosed with unconfirmed psychology disorder is 
27 314:17 637, which is a ratio of 1.5:1 (rounded off). This means that for every male patient 
diagnosed with unconfirmed psychology disorder, 1.5 females are diagnosed with the same 
disorder. This translates to three female patients for every two male patients. 
2013: The ratio of female to male patients diagnosed with unconfirmed psychology disorder is 
29 495:19 157, which is a ratio of 1.5:1 (rounded off). This means that for every male patient 
diagnosed with unconfirmed psychology disorder, 1.5 females are diagnosed with the same 
disorder. This translates to three female patients for every two male patients. 
2014: The ratio of female to male patients diagnosed with unconfirmed psychology disorder is 
32 195:21 176, which is a ratio of 1.5:1 (rounded off). This means that for every male patient 
diagnosed with unconfirmed psychology disorder, 1.5 females are diagnosed with the same 




2015: The ratio of female to male patients diagnosed with unconfirmed psychology disorder is 
22 185:14 483, which is a ratio of 1.5:1 (rounded off). This means that for every male patient 
diagnosed with unconfirmed psychology disorder, 1.5 females are diagnosed with the same 
disorder. This translates to three female patients for every two male patients. 
The ratio of males to females for unconfirmed psychology disorder is consistently 1:1.5, 
translating to three female patients for every two male patients. 
Chart GF26  
Gender Focus: Unconfirmed Psychology Disorder 
 
Chart GF26 above, is a summary of gender representation for unconfirmed psychology disorder 
between and including 2008 to June 2015. The ratio presented provides an average over 7 
years, of male to female demographics for this disorder. For unconfirmed psychology disorder, 
the ratio is 40:60%, which translates to 40 males will be diagnosed over 60 females for every 





Results: Vascular Dementia 
Table GF27  
Gender Focus: Vascular Dementia 
DIAGNOSIS DATABASE: GENDER FOCUS      VASCULAR DEMENTIA 
DIAGNOSIS YEAR  DATABASE POPULATION (DP) 
  FEMALE MALE FEMALE MALE 
  TOTAL TOTAL TOTAL TOTAL 
Vascular dementia 2008 277 245 1062296 1029887 
Vascular dementia 2009 228 231 1116307 1075822 
Vascular dementia 2010 259 241 1245149 1189071 
Vascular dementia 2011 337 221 1320350 1260693 
Vascular dementia 2012 332 219 1389025 1322569 
Vascular dementia 2013 288 280 1444105 1378311 
Vascular dementia 2014 447 254 1498868 1424565 
Vascular dementia 2015 221 166 1533223 1450880 
From Table GF27 above, the following is deduced: 
2008: The ratio of female to male patients diagnosed with vascular dementia is 227:245, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2009: The ratio of female to male patients diagnosed with vascular dementia is 228:231, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2010: The ratio of female to male patients diagnosed with vascular dementia is 259:241, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 




2011: The ratio of female to male patients diagnosed with vascular dementia is 337:221, which 
is a ratio of 1.5:1 (rounded off). This means that for every male patient diagnosed with vascular 
dementia, 1.5 females are diagnosed with the same disorder. This translates to two male 
patients for every three females. 
2012: The ratio of female to male patients diagnosed with vascular dementia is 337:221, which 
is a ratio of 1.5:1 (rounded off). This means that for every male patient diagnosed with vascular 
dementia, 1.5 females are diagnosed with the same disorder. This translates to two male 
patients for every three females. 
2013: The ratio of female to male patients diagnosed with vascular dementia is 288:280, which 
is a ratio of 1:1 (rounded off). This means that male and female patients show equal 
representation with this disorder.  
2014: The ratio of female to male patients diagnosed with vascular dementia is 447:254, which 
is a ratio of 2:1 (rounded off). This means that for every male patient diagnosed with vascular 
dementia, 2 females are diagnosed with the same disorder.  
2015: The ratio of female to male patients diagnosed with vascular dementia is 221:166, which 
is a ratio of 1.3:1 (rounded off). This means that for every male patient diagnosed with vascular 
dementia, 1.3 females are diagnosed with the same disorder. This translates to ten male patients 
for every thirteen females. 
From 2008 – 2010 the number of males to females diagnosed with vascular dementia, is equal. 
In 2011 – 2012, there is an increase of female patients over male patients, in the ratio of 1.5:1, 




fluctuate, ranging from equal (2013), to double the number of females over males (2014), to 
1.3:1 female to males in 2015, which translates to thirteen female patients for every 10 male 
patients.  
Chart GF27 
Gender Focus: Vascular Dementia 
 
Chart GF27 above, is a summary of gender representation for vascular dementia between and 
including 2008 to June 2015. The ratio presented provides an average over 7 years, of male to 
female demographics for this disorder. For vascular dementia, the ratio is 44:56%, which 
translates to 44 males will be diagnosed over 56 females for every 100 patients, or more simply 






Chapter 3: Results 
Section III: Data analysis: Patient numbers, gender analysis, disorder frequency and 
comparison. 
 
What follows below is an over-arching graphic analysis of the study database, showing trends 
in mental disorders, split by gender as well as mode of treatment (inpatient or outpatient). The 
trends highlight the key differences at gender and treatment levels. An additional objective of 
the analysis is to establish any correlations that may be apparent at mental disorder, gender 




Chart A1: Graphic representation of the study database, showing total number of patients per mental disorder (A = Analysis) 
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From Chart A1 above, the five mental disorder frequencies, listed below, make up 84% of the 
volume of mentally ill patients in the study database. These are:  
1. Depression: 46%  
2. Bipolar mood disorder: 13%  
3. Attention deficit and hyperactivity disorder: 10%  
4. Parasomnia or sleep disorder: 10%  
5. Developmental and learning disorder: 5%  
Table A1 below, displays of the frequency of a diagnosis, expressed as a percentage of 






Frequency of a diagnosis, expressed as a percentage of occurrence across all mental illnesses 
Mental Disorder Patients as % of Database Population 
Depression 23.71% 
Bipolar mood disorder 6.42% 
Attention deficit and hyperactivity disorder 5.27% 
Parasomnia or sleep disorder 5.01% 
Developmental and learning disorder 2.44% 
Non-specific neuroses 2.47% 
Anxiety disorder 2.21% 
Unconfirmed psychology disorder 1.84% 
Schizophrenia 0.60% 
Psycho-social disorder of childhood 0.34% 
Obsessive compulsive disorder 0.26% 
Sexual and gender identity disorder 0.18% 
Somatoform disorder 0.17% 
Eating disorder 0.15% 
Substance abuse or dependence behaviour 0.15% 
Impulse control disorder 0.13% 
Alcoholism 0.12% 
Behavioural disorder 0.08% 
Psychosis due to a general medical disorder 0.03% 
Personality disorder 0.03% 
Mental retardation 0.02% 
Vascular dementia 0.02% 




Chart A2 displays the total number of patients, per mental disorder, that were treated in hospital between 2008 to 2015. IH denotes in-
hospital treatment.  
Chart A2: In-patient mental disorder frequencies  
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Chart A3 displays the total number of patients, per mental disorder, that were treated as out-patients between 2008 to 2015.  
Chart A3: Out-patient mental disorder frequencies  
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From Chart A2, the top five most common mental disorders that are treated in hospital are listed 
below. The accompanying percentage denotes the frequency of that diagnosis, relative to the 
other disorders on the database. They are: 
1. Depression: 43%  
2. Bipolar mood disorder: 18%  
3. Parasomnia or sleep disorder: 13%  
4. Unconfirmed psychology disorder: 10%  
5. Alcoholism: 5%  
From Chart A3, the top five most common mental disorders that are treated as an out-patient 
option are listed below. The accompanying percentage denotes the frequency of that diagnosis, 
relative to the other disorders on the database. They are: 
1. Depression: 46%  
2. Bipolar mood disorder: 13%  
3. Attention deficit and hyperactivity disorder: 11%  
4. Parasomnia or sleep disorder: 10%  




Chart A4: Female: Mental disorder frequencies  
Source: Discovery Health Database   




Chart A5: Male: Mental disorder frequencies  
Source: Discovery Health Database 
Male: Mental disorder frequencies  
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From Chart A4, the top five most commonly occurring female mental disorder diagnoses. The 
accompanying percentage denotes the frequency of that diagnosis, relative to the other disorders 
on the database. They are:  
Table A2 
Top 5 female mental disorders  
Disorder % Female patients 
Depression 53% 
Bipolar mood disorder 14% 
Attention deficit and hyperactivity disorder 5% 
Parasomnia or sleep disorder 9% 
Non-specific neuroses 4% 
From Chart A5, the top five most commonly occurring male mental disorder diagnoses. The 
accompanying percentage denotes the frequency of that diagnosis, relative to the other disorders 
on the database. They are: 
Table A3  
Top 5 male mental disorders   
Disorder % Male patients 
Depression 34% 
Bipolar mood disorder 10% 
Attention deficit and hyperactivity disorder 19% 
Parasomnia or sleep disorder 10% 




Chart A6, presents an overview of selected mental disorders that display increasing frequency rates year-on-year. 
Chart A6: Mental disorders with increasing frequency rates over time  
Source: Discovery Health Database 
Mental disorders showing increased frequency over time 
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From Chart A6, the top four highest ranking mental disorders in terms of dominance, are the 
same mental disorders depicting the greatest increase of frequency year-on-year. The following 
four mental disorders almost doubled in terms of frequency (patient numbers) from 2008 to 
2014: 
1. Depression 
2. Bipolar mood disorder 
3. Attention deficit and hyperactivity disorder 




Chart A7: Female: Mental disorders with increasing frequencies over time 
Source: Discovery Health Database   





Chart A8: Male: Mental disorders with increasing frequencies over time 
Source: Discovery Health Database 
 




Table A4  
Table showing degrees of correlation between mental disorders 
Source: Discovery Health Database  
  




















Anxiety disorder 0.74 1.00
Attention deficit and hyperactivity disorder0.82 0.82 1.00
Behavioural disorder 0.74 0.70 0.84 1.00
Bipolar mood disorder 0.79 0.64 0.90 0.84 1.00
Depression 0.82 0.68 0.93 0.85 0.99 1.00
Developmental and learning disorder 0.64 0.86 0.84 0.66 0.60 0.64 1.00
Dissociative disorder 0.53 0.49 0.57 0.54 0.47 0.51 0.58 1.00
Eating disorder 0.76 0.71 0.82 0.65 0.78 0.81 0.57 0.37 1.00
Impulse control disorder 0.65 0.89 0.80 0.70 0.62 0.65 0.88 0.55 0.56 1.00
Mental retardation 0.59 0.64 0.78 0.55 0.68 0.72 0.63 0.41 0.71 0.60 1.00
Non-specific neuroses 0.56 0.87 0.65 0.44 0.34 0.40 0.84 0.38 0.56 0.76 0.51
Obsessive compulsive disorder 0.81 0.68 0.93 0.77 0.95 0.97 0.65 0.49 0.84 0.63 0.73
Parasomnia or sleep disorder 0.83 0.70 0.94 0.84 0.98 1.00 0.67 0.54 0.82 0.66 0.74
Personality disorder 0.34 0.32 0.30 0.13 0.15 0.22 0.32 0.16 0.45 0.23 0.32
Psychosis due to a general medical disorder0.60 0.77 0.71 0.63 0.64 0.66 0.72 0.48 0.52 0.76 0.55
Psycho-social disorder of childhood 0.32 0.68 0.43 0.20 0.06 0.13 0.74 0.38 0.32 0.64 0.41
Schizophrenia 0.80 0.65 0.91 0.82 0.98 0.98 0.62 0.49 0.81 0.62 0.70
Sexual and gender identity disorder 0.82 0.66 0.91 0.80 0.97 0.98 0.62 0.53 0.81 0.62 0.73
Somatoform disorder 0.68 0.81 0.72 0.61 0.54 0.58 0.72 0.39 0.61 0.76 0.54
Substance abuse or dependence behaviour0.81 0.72 0.86 0.74 0.88 0.89 0.61 0.44 0.85 0.63 0.67
Unconfirmed psychology disorder 0.73 0.95 0.81 0.75 0.66 0.68 0.83 0.42 0.67 0.87 0.62




Table A5:  
Table showing degrees of correlation between mental disorders.  
Source: Discovery Health Database 
All correlations were found to be significant (p<0.05). The value in each cell is the correlation coefficient. Key to Tables A4 and A5 
(Correlation Tables) (Bakan, 1966).  
1. Yellow cells (.9-1): Very strong correlation  
2. Green cells (0.8-0.9): Strong correlation 






















Obsessive compulsive disorder 0.46 1.00
Parasomnia or sleep disorder 0.44 0.97 1.00
Personality disorder 0.36 0.30 0.27 1.00
Psychosis due to a general medical disorder 0.61 0.63 0.67 0.15 1.00
Psycho-social disorder of childhood 0.89 0.20 0.18 0.36 0.47 1.00
Schizophrenia 0.38 0.96 0.98 0.23 0.61 0.11 1.00
Sexual and gender identity disorder 0.40 0.96 0.98 0.25 0.63 0.15 0.97 1.00
Somatoform disorder 0.74 0.57 0.60 0.36 0.60 0.58 0.56 0.57
Substance abuse or dependence behaviour 0.53 0.89 0.89 0.20 0.64 0.27 0.88 0.90
Unconfirmed psychology disorder 0.82 0.65 0.69 0.23 0.74 0.61 0.65 0.64












Chapter 4: Discussion 
The discussion chapter begins with detailing the composition of the mental health landscape 
of the study database. Composition is examined from a gender perspective as well as actual 
numbers of sufferers against the total database population. What follows is an analysis of the 
trends observed in mental disorder frequencies, split by gender as well as mode of treatment. 
An additional aim of the discussion chapter is to elaborate on correlations apparent in the 
database.  
Thereafter the discussion will centre on the comparison of these findings against the broader 
South African and even broader global mental health context. 
Finally, the question of mental illness incorporated within the confines of a cost-effective 
equation is discussed in the concluding section. 
A summary of the South African mental health landscape 
This study is a cross-section of an aspect of South African society, which concerns mental 
health. The Discovery Medical Aid Scheme database used in this study comprises its full 
population of members from 2008 to midway through 2015. For this study, the focus was on 
those members diagnosed with one of the 27 mental disorders listed in the database. The 
percentage of the database population diagnosed with each mental disorder is significant for 
this discussion, when looked at against the landscape of the high numbers of sufferers of 
mental disorders in South Africa. The South African Stress and Health (SASH) Study of 
2009 (Herman, Stein, Seedat, Heeringa, Moomal & Williams, 2009; Stein, Williams & 
Kessler, 2009) presents an analysis of mental disorders in South Africa that provides a solid 




In South Africa, approximately 4.5 to 5 million people suffer from a mental disorder (Ngui, 
Khasakhala, Ndetei & Roberts, 2010). If alcohol and drug abuse are included in the 
classification of mental disorders, the number of sufferers’ spikes to a staggering 15 million 
people (Robinson & Adinoff, 2016). This means that 16.5% of adults in South Africa suffer 
from a mental disorder, ranking mental disorders as third in their contribution to the burden 
of disease, after HIV, AIDS and other infectious diseases (Lund, Stein, Corrigall, Bradshaw, 
Schneider & Flisher, 2008).  
The sections that follow, discuss the findings in the results chapter (Chapter 3) with the aim 
of providing a composition of the mental health landscape of private (medical aid) patients in 
the Discovery Health Medical Aid Scheme database. Thereafter the discussion will centre on 
the comparison of these findings against the broader South African and even broader global 
mental health context.  
Approximately 15% of the South African population belong to a medical aid scheme, with 
Discovery Health Medical Aid Scheme being the largest open medical aid scheme in South 
Africa (with 2 819 139 beneficiaries and a current market share of 56.6% of the open market) 
(Discovery Integrated Annual Report, 2018). The dominance of the medical aid allows for 
frequencies of disorders within the database to be extrapolated and compared to the broader 
South African context. This means comparing the mental health statistics in this dissertation 
(that represent private health care figures), against the South African mental health landscape 
and even global statistics.  
Discussion on Discovery Health Medical Aid Scheme database 
The results on gender focus show significant differences at gender level regarding certain 




specific illness to favour a gender is shown. The results also show if there was an increase or 
decrease in bias over time.  
There are significant differences at gender level regarding certain mental disorders: 
• Depression is the most prevalent mental disorder in both genders but the prevalence 
rates of depression among females is almost three times that of male sufferers.  
• More males are diagnosed with attention deficit and hyperactivity disorder than 
females, but interestingly the growth in numbers of females diagnosed with the 
disorder is higher among females than males. 
• The number of female patients diagnosed with bipolar mood disorder is more than 
double the number of males; however, growth in the number of males diagnosed with 
the disorder over time is higher in males than females.  
• Sexuality and gender identity disorder as well as substance abuse or dependent 
behaviour is significantly higher among males than females.  
• Growth in male patient numbers over for time, for those diagnosed with substance 
abuse or dependent behaviour is more than double that of female numbers over time.  
Analysis of gender specific longitudinal data for each diagnosis reveals seven distinct groups. 
They are: 
1. Twice as many males than females for certain disorders. 
2. Twice as many females than males for certain disorders. 
3. Fluctuating ratios across time, but always with higher female numbers for certain 
disorders.  





5. Significantly higher female numbers for certain disorders.   
6. Significantly higher male numbers for certain disorders.   
7. Equal representation of male and female numbers for certain disorders.    
Gender bias, and the extent to which there is a propensity for a specific illness to favour a 
gender has clear implications for developing or modifying medical policies and services, to 
ensure that they are gender sensitive. Incorporating gender sensitivity into medical and 
hospital policy is crucial for adequate provision. Adequate provision begins with the 
fundamentals of enough beds and accommodation to gender and culturally sensitive 
practitioners. Studies have shown that, on average, men receive less psychiatric treatment 
than women (Lee, Kim, Lee, Jeong, Lim, Lee & Rhee, 1998; Kim, 2000), which may be 
related to gender bias for different mental disorders. For example, women tend to have a 
higher frequency of mood and/or anxiety disorders that are more likely to respond to 
psychiatric treatment than men (Rhodes, Goering & Williams, 2002; Hauenstein, Petterson, 
Merwin, Rovnyak, Heise & Wagner, 2006). However, a study in the United States reported 
that men had higher rates of hospitalisation than women for alcohol and drug disorders 
(Mark, Levit, Buck, Coffey & Vandivort-Warren, 2007).  
The diagnoses in this study are categorised into the following seven groups:  
1. Twice as many males than females for the following disorders:   
a. Abuse, dependence and/or overdose of opioids 
b. Alcoholism  
c. Attention deficit and hyperactivity disorder 





2. Twice as many females than males for the following disorders:   
a. Anxiety disorder 
b. Bipolar mood disorder 
c. Somatoform disorder 
3. Fluctuating ratios across time, but always with higher female numbers for the 
following disorders: 
a. Behavioural disorder 
b. Eating disorder 
c. Non-specific neuroses 
d. Parasomnia or sleep disorder 
e. Personality disorder 
f. Vascular dementia  
4. Fluctuating ratios across time, but always with higher male numbers for the 
following disorders: 
a. Psychosis due to general medical disorder 
b. Tic disorder 
5. Significantly higher female numbers for the following disorders:   
a. Depression 
b. Unconfirmed psychology disorder 
6. Significantly higher male numbers for the following disorders:   
a. Sexual and gender identity disorder 




7. Equal representation of male and female numbers for the following disorders: 
a. Delusional disorder  
b. Dissociative disorder 
c. Impulse control disorder 
d. Mental retardation 
e. Non-specific psychoses 
f. Obsessive compulsive disorder 
g. Psycho-social disorder of childhood 
h. Schizophrenia 
Discussion around diagnoses per group: 
Twice as many males than females for the following disorders: 
Abuse Dependence and or overdose of opioids 
By 2015, the Discovery Health Medical Aid Scheme database listed 414 patients out of a 
total population of 3 031 600 members diagnosed with abuse, dependence and or overdose of 
opioids. This translates to 0.014% of the total database population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with abuse/dependence, and/or overdose of opioid is 0.013%, within the 
entire database. The lowest frequency of abuse/dependence, and/or overdose of opioids is in 
2009, with a percentage of 0.011% occurrence within the entire population and the highest 






By 2015, the Discovery Health Medical Aid Scheme database listed 3702 patients out of a 
total population of 3 031 600 members diagnosed with alcoholism. This translates to 0.122% 
of the total database population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with alcoholism is 0.107%, within the entire database. The lowest 
frequency of alcoholism is in 2008, with a percentage of 0.086% occurrence within the entire 
population and the highest frequency is in 2015, with a percentage of 0.122% of the total 
database population.  
Attention Deficit and Hyperactivity Disorder  
By 2015, the Discovery Health Medical Aid Scheme database listed 207 149 patients out of a 
total population of 3 031 600 members diagnosed with attention deficit hyperactivity 
disorder. This translates to 6.83% of the total database population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with attention deficit and hyperactivity disorder is 5.44%, within the entire 
database. The lowest frequency of attention deficit and hyperactivity disorder is in 2008, with 
a percentage of 3.36% occurrence within the entire population and the highest frequency is in 
2015, with a percentage of 6.83% of the total database population.  
Developmental and Learning Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 83 483 patients out of a 
total population of 3 031 600 members diagnosed with developmental and learning disorder. 




Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with development and learning disorder is 2.47%, within the entire 
database. The lowest frequency of development and learning disorder is in 2012, with a 
percentage of 2.33% occurrence within the entire population and the highest frequency is in 
2015, with a percentage of 2.75% of the total database population.  
Twice as many females than males for the following disorders: 
Anxiety 
By 2015, the Discovery Health Medical Aid Scheme database listed 69 916 patients out of a 
total population of 3 031 600 members diagnosed with anxiety disorder. This translates to 
2.31% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with anxiety disorder is 2.2%, within the entire database. The lowest 
frequency of anxiety disorder is in 2011, with a percentage of 2.01% occurrence within the 
entire population and the highest frequency is in 2015, with a percentage of 2.46% of the total 
database population.  
Bipolar Mood disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 256 943 patients out of a 
total population of 3 031 600 members diagnosed with bipolar mood disorder. This translates 
to 8.48% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with bipolar mood disorder is 6.49%, within the entire database. The 




within the entire population and the highest frequency is in 2015, with a percentage of 8.48% 
of the total database population.  
Somatoform Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 4 912 patients out of a 
total population of 3 031 600 members diagnosed with somatoform disorder. This translates 
to 0.16% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with somatoform disorder is 0.16%, within the entire database. The 
highest frequency of somatoform disorder is in 2008, with a percentage of 0.18% occurrence 
within the entire population and the remaining years have a frequency rate of 0.16% of the 
total database population.  
Fluctuating ratios across time, but always with higher female numbers for the following 
disorders: 
Behavioural Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 3232 patients out of a 
total population of 3 031 600 members diagnosed with behavioural disorder. This translates 
to 0.107% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with behavioural disorder is 0.09%, within the entire database. The lowest 
frequency of behavioural disorder is in 2008, with a percentage of 0.064% occurrence within 
the entire population and the highest frequency is in 2015, with a percentage of 0.107% of the 





By 2015, the Discovery Health Medical Aid Scheme database listed 5008 patients out of a 
total population of 3 031 600 members diagnosed with eating disorder. This translates to 
0.165% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with eating disorder is 0.154%, within the entire database. The lowest 
frequency of eating disorder is in 2008, with a percentage of 0.139% occurrence within the 
entire population and the highest frequency is in 2015, with a percentage of 0.165% of the 
total database population.  
Non-specific Neuroses 
By 2015, the Discovery Health Medical Aid Scheme database listed 64 978 patients out of a 
total population of 3 031 600 members diagnosed with non-specific neuroses. This translates 
to 2.143% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with non-specific neuroses is 2.413%, within the entire database. The 
lowest frequency of non-specific neuroses is in 2015, with a percentage of 2.143% 
occurrence within the entire population and the highest frequency is in 2008, with a 
percentage of 2.87% of the total database population.  
Parasomnia or Sleep Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 163 910 patients out of a 
total population of 3 031 600 members diagnosed with parasomnia or sleep disorder. This 




Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with parasomnia or sleep disorder is 4.93%, within the entire database. 
The lowest frequency of parasomnia or sleep disorder is in 2008, with a percentage of 3.19% 
occurrence within the entire population and the highest frequency is in 2014, with a 
percentage of 5.87% of the total database population.  
Personality Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 907 patients out of a 
total population of 3 031 600 members diagnosed with personality disorder. This translates to 
0.03% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with personality disorder is 0.03%, within the entire database. The lowest 
frequency of personality disorder is in 2013, with a percentage of 0.03% occurrence within 
the entire population and the remaining years have a frequency rate of 0.03% of the total 
database population.  
Vascular Dementia 
By 2015, the Discovery Health Medical Aid Scheme database listed 767 patients out of a 
total population of 3 031 600 members diagnosed with vascular dementia. This translates to 
0.03% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with vascular dementia is 0.02%, within the entire database. The highest 
frequency of vascular dementia is in 2008, with a percentage of 0.03% occurrence within the 
entire population and the remaining years have a frequency rate of 0.02% of the total 




Fluctuating ratios across time, but always with higher male numbers for the following 
disorders: 
Psychosis due to General Medical Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 1 078 patients out of a 
total population of 3 031 600 member diagnosed with psychosis due to a general medical 
disorder. This translates to 0.04% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with psychosis due to general medical disorder is 0.03%, within the entire 
database. The highest frequency of psychosis due to general medical disorder is in 2015, with 
a percentage of 0.04% occurrence within the entire population and the remaining years have a 
frequency rate of 0.03% of the total database population.  
Tic Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 492 patients out of a 
total population of 3 031 600 members diagnosed with tic disorder. This translates to 0.02% 
of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with tic disorder is 0.02%, within the entire database. The lowest 
frequency of tic disorder is in 2008, with a percentage of 0.01% occurrence within the entire 






Significantly higher female numbers for the following disorders: 
Depression 
By 2015, the Discovery Health Medical Aid Scheme database listed 898 402 patients out of a 
total population of 3 031 600 members diagnosed with depression. This translates to 29.63% 
of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with depression is 23.91%, within the entire database. The lowest 
frequency of depression is in 2008, with a percentage of 14.95% occurrence within the entire 
population and the highest frequency is in 2015, with a percentage of 29.63% of the total 
database population.  
Unconfirmed Psychology Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 68 623 patients out of a 
total population of 3 031 600 members diagnosed with unconfirmed psychology disorder. 
This translates to 2.26% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with unconfirmed psychology disorder is 1.83%, within the entire 
database. The lowest frequency of unconfirmed psychology disorder is in 2011, with a 
percentage of 1.64% occurrence within the entire population and the highest frequency is in 





Significantly higher male numbers for the following disorders: 
Sexual and Gender Identity Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 6 593 patients out of a 
total population of 3 031 600 members diagnosed with sexual and gender identity disorder. 
This translates to 0.22% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with sexual and gender identity disorder is 0.19%, within the entire 
database. The lowest frequency of sexual and gender identity disorder is in 2008, with a 
percentage of 0.11% occurrence within the entire population and the highest frequency is in 
2015, with a percentage of 0.22% of the total database population.   
Substance Abuse or Dependence Behaviour 
By 2015, the Discovery Health Medical Aid Scheme database listed 4 066 patients out of a 
total population of 3 031 600 members diagnosed with substance abuse or dependence 
behaviour. This translates to 0.13% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with substance abuse or dependence behaviour is 0.14%, within the entire 
database. The lowest frequencies of substance abuse or dependence behaviour are in 2008, 
2009 and 2010, with a percentage of 0.11% occurrence within the entire population and the 





Equal representation for male and female numbers for the following disorders: 
Delusional Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 333 patients out of a 
total population of 3 031 600 members diagnosed with delusional disorder. This translates to 
0.011% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with delusional Disorder is 0.013%, within the entire database. The lowest 
frequency of delusional disorder is in 2012, with a percentage of 0.010% occurrence within 
the entire population and the highest frequencies are in 2008 and 2009, with a percentage of 
0.015% of the total database population.  
Dissociative Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 732 patients out of a 
total population of 3 031 600 members diagnosed with dissociative disorder. This translates 
to 0.024% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with dissociative disorder is 0.022%, within the entire database. The 
lowest frequency of dissociative disorder is in 2008, with a percentage of 0.017% occurrence 
within the entire population and the highest frequencies are in 2009 and 2015, with a 
percentage of 0.024% of the total database population.  
Impulse Control Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 4237 patients out of a 




translates to 0.140% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with impulse control disorder is 0.131%, within the entire database. The 
lowest frequency of impulse control disorder is in 2011, with a percentage of 0.117% 
occurrence within the entire population and the highest frequency is in 2009, with a 
percentage of 0.141% of the total database population.  
Mental Retardation 
By 2015, the Discovery Health Medical Aid Scheme database listed 855 patients out of a 
total population of 3 031 600 members diagnosed with mental retardation. This translates to 
0.028% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with mental retardation is 0.023%, within the entire database. The lowest 
frequency of mental retardation is in 2008, with a percentage of 0.019% occurrence within 
the entire population and the highest frequency is in 2015, with a percentage of 0.028% of the 
total database population.  
Non-specific Psychoses 
By 2015, the Discovery Health Medical Aid Scheme database listed 540 patients out of a 
total population of 3 031 600 members diagnosed with non-specific psychoses. This 
translates to 0.018% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with non-specific psychoses is 0.018%, within the entire database. The 




0.015% occurrence within the entire population and the highest frequencies are in 2008 and 
2009, with a percentage of 0.021% of the total database population.  
Obsessive Compulsive Disorder 
By 2015, the Discovery Health Medical Aid Scheme database listed 7700 patients out of a 
total of 3 031 600 members diagnosed with obsessive compulsive disorder. This translates to 
0.254% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with obsessive compulsive disorder is 0.018%, within the entire database. 
The lowest frequencies of obsessive-compulsive disorder are in 2011 and 2012, with a 
percentage of 0.015% occurrence within the entire population and the highest frequencies are 
in 2008 and 2009, with a percentage of 0.021% of the total database population.  
Psycho-social Disorder of Childhood 
By 2015, the Discovery Health Medical aid scheme database listed 9 386 patients out of a 
total population of 3 031 600 members diagnosed with psycho-social disorder of childhood. 
This translates to 0.31% of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with psycho-social disorder of childhood is 0.33%, within the entire 
database. The lowest frequency of psycho-social disorder of childhood is in 2014, with a 
percentage of 0.28% occurrence within the entire population and the highest frequencies are 






By 2015, the Discovery Health Medical Aid Scheme database listed 18 057 patients out of a 
total population of 3 031 600 members diagnosed with schizophrenia. This translates to 0.6% 
of the total claimant population.  
Factoring in the increase in database population size year-on-year, the average percentage of 
patients diagnosed with schizophrenia is 0.58%, within the entire database. The lowest 
frequency of schizophrenia is in 2008, with a percentage of 0.57% occurrence within the 
entire population and the highest frequency is in 2015, with a percentage of 0.6% of the total 





Table 2  
Prevalence of disorder within database population 
Mental disorder % Prevalence in population  
Abuse, dependence/overdose of opioids  0.013 
Alcoholism 0.107 
Anxiety disorder 2.2 
Attention deficit and hyperactivity disorder 5.44 
Behavioural disorder 0.09 
Bipolar mood disorder 6.49 
Delusional disorder 0.013 
Depression 23.91 
Developmental and learning disorder 2.47 
Dissociative disorder 0.022 
Eating disorder 0.154 
Impulse control disorder 0.131 
Mental retardation 0.023 
Non-specific neuroses 2.413 
Non-specific psychosis 0.018 
Obsessive compulsive disorder 0.018 
Parasomnia or sleep disorder 4.93 
Personality disorder 0.03 
Psychosis due to a general medical disorder 0.03 
Psycho-social disorder of childhood 0.33 
Schizophrenia 0.58 
Sexual and gender identity disorder 0.19 
Somatoform disorder 0.16 
Substance abuse or dependence behaviour 0.14 
Tic disorder 0.02 
Unconfirmed psychology disorder 1.83 






Discussion around data analysis 
Section III (in Chapter 3: Results) is a graphic analysis of the study database. Trends are 
observed in mental disorder frequencies, split by gender as well as mode of treatment (in-
patient or out-patient), highlighting key differences at gender and treatment levels. An 
additional objective of the analysis is to establish any correlations that may be apparent at 
mental disorder, gender and/or treatment level. 
From Chart A1, the five mental disorders, listed below, make up 84% of the volume of 
mentally ill patients in the study database. These are:  
1. Depression: 46%  
2. Bipolar mood disorder: 13%  
3. Attention deficit and hyperactivity disorder: 10%  
4. Parasomnia or sleep disorder: 10%  
5. Developmental and learning disorder: 5%  
Chart A2 displays the total number of patients, per mental disorder, that were treated in 
hospital and Chart A3 displays the total number of patients, per mental disorder, that were 
treated as out-patients. From this analysis, the majority (98%) of patients are treated as out-
patients, with in-hospital treatment administered to approximately 2% of patients. 
From Chart A2, the top five most common mental disorders that are treated in hospital are 
listed below. The accompanying percentage denotes the frequency of that diagnosis, relative 
to the other disorders on the database. They are: 
1. Depression: 43%  
2. Bipolar mood disorder: 18%  




4. Unconfirmed psychology disorder: 10%  
5. Alcoholism: 5%  
From Chart A3, the top five most common mental disorders that are treated as an out-patient 
option are listed below. The accompanying percentage denotes the frequency of that 
diagnosis, relative to the other disorders on the database. They are: 
1. Depression: 46%  
2. Bipolar mood disorder: 13%  
3. Attention deficit and hyperactivity disorder: 11%  
4. Parasomnia or sleep disorder: 10%  
5. Developmental and learning disorder: 5%  
Chart A4 displays the top five most commonly occurring female mental disorder diagnoses. 
The accompanying percentage denotes the frequency of that diagnosis, relative to the other 
disorders on the database. They are: 
1. Depression: 53%  
2. Bipolar mood disorder: 14%  
3. Attention deficit and hyperactivity disorder: 5%  
4. Parasomnia or sleep disorder: 9%  
5. Non-specific neuroses: 4%  
Chart A5 displays the top five most commonly occurring male mental disorder diagnoses. 
The accompanying percentage denotes the frequency of that diagnosis, relative to the other 
disorders on the database. They are: 
1. Depression: 34%  




3. Attention deficit and hyperactivity disorder: 19%  
4. Parasomnia or sleep disorder: 10%  
5. Developmental and learning disorder: 8%  
Female patients are dominant with 62% of total mental disorder diagnoses with male patients 
comprise the remaining 38% of patients diagnosed with a mental disorder.  
Chart A6, presents an overview of selected mental disorders that show increasing frequency 
rates year-on-year. What is displayed is the top four highest-ranking mental disorders in 
terms of dominance. These are the same mental disorders showing the greatest increase in 
frequency year-on-year. The following four mental disorders almost doubled in frequency 
(patient numbers) from 2008 to 2014: 
1. Depression 
2. Bipolar mood disorder 
3. Attention deficit and hyperactivity disorder 
4. Parasomnia or sleep disorder 
Depression is the most prevalent mental illness for both genders but the prevalence rate of 
depression among female patients is more than double that of male patients: 33% (female) 
compared to 14% (male). 
More than double the number of male patients are diagnosed with attention deficit and 
hyperactivity disorder compared to female patients, but the increase in frequency of diagnosis 
is higher in females than males.  
More than double the number of females are diagnosed with bipolar mood disorder than 




The order of 2nd, 3rd and 4th most prevalent mental disorders along with prevalent and growth 
in frequency rates are shown below:  
The four most common mental disorders, in terms of patient numbers and patient number 
growth rate are listed below. They are:  
1. Depression: 88% growth in prevalence from 2008 to 2014. 
2. Bipolar mood disorder: 118% growth in prevalence from 2008 to 2014. 
3. Attention deficit and hyperactivity disorder: 123% growth in prevalence from 2008 to 
2014. 
4. Parasomnia or sleep disorder: 78% growth in prevalence from 2008 to 2014. 
Analysis shows that there is a significantly high prevalence growth rate in patients diagnosed 
with sexual and gender identity disorder, substance abuse or dependence behaviour and 
behavioural disorder. The prevalence of sexual and gender identity disorder in 2014, is 
approximately double that of its frequency in 2008. The list below shows these mental 
disorders, that although they contain lower patient numbers, reveal high growth rates. The 
percentages indicate the rate of growth of patient numbers across time:  
1. Substance abuse or dependence behaviour: 30% (2008 to 2014). 
2. Behavioural disorder: 56% (2008 to 2014). 
Rank 
Male Female 


























3. Sexual and gender identity disorder: 100% (2008 to 2014). 
The remaining mental disorders show a constancy in frequency rates, which implies no 
significant increase in patient numbers. From Chart A6, these diagnoses have remained either 
constant or fluctuated fractionally across seven years. 
Chart A7 (Female: Mental disorders with increasing frequencies over time) shows that mental 
disorder trends for female patients correspond to overall mental disorder trends. The mental 
disorders that have the highest numbers of female patients, together with the greatest year-on-
year growth rates, are also the mental disorders with the highest growth rates and patient 
numbers overall (Refer to Chart A6). 
Mental disorders showing significant increases in male patient numbers (Chart A8) 
correspond to female and overall patient numbers, apart from a difference in the order of 
ranking of the highest four mental illnesses. With female patients, the disorders showing the 
greatest patient increases across time are:  
1. Depression. Then,  
2. Bipolar mood disorder. Followed by  
3. Parasomnia or sleep disorder. And lastly,  
4. Attention deficit and hyperactivity disorder.  
With male patients, the disorders showing the greatest patient increases across time are:  
1. Depression. Then,  
2. Attention deficit and hyperactivity disorder. Followed by 
3. Parasomnia or sleep disorder. And lastly  




The range of correlations depicted in tables A4 and A5 is based on the foundational work of 
Bakan (1966). All correlations are found to be significant (p<0.05). From Table A4 (p.407) 
and Table A5 (p.408), a significant correlation exists between bipolar mood disorder and the 
following five mental disorders (listed in descending degree of correlation):  
1. Depression: 0.99  
2. Parasomnia or sleep disorder: 0.98 
3. Schizophrenia: 0.98 
4. Sexual and gender identity disorder: 0.97 
5. Obsessive compulsive disorder: 0.95 
Discussion around correlation between mental illnesses 
Table A4 (p.407) and Table A5 (p.408), show degrees of correlation between specific mental 
illnesses. The correlations that exist are shown either to be a very strong correlation, a strong 
correlation or a mild to no correlation. The statistical term ‘correlation’ is translated as (from 
a psychology perspective) to the probability of a comorbidity existing between mental 
illnesses. A strong correlation then, points to a high probability for a comorbidity of illnesses 
manifest in a patient. A mild, to no correlation points to a specific mental illness presenting in 
isolation. From Tables A4 and A5, the following correlation patterns were revealed: 
Very strong correlation 
1. Bipolar mood disorder and Attention deficit and hyperactivity disorder  
2. Depression and Attention deficit and hyperactivity disorder 
3. Obsessive-compulsive disorder and Attention deficit and hyperactivity disorder 
4. Parasomnia or sleep disorder and Attention deficit and hyperactivity disorder  




6. Sexual and gender identity disorder and Attention deficit and hyperactivity disorder 
7. Unconfirmed psychology disorder and Anxiety 
8. Depression and Bipolar mood disorder 
9. Obsessive-compulsive disorder and Bipolar mood disorder 
10. Parasomnia or sleep disorder and Bipolar mood disorder 
11. Schizophrenia and Bipolar mood disorder 
12. Sexual and gender identity disorder and Bipolar mood disorder 
13. Obsessive-compulsive disorder and Depression 
14. Parasomnia or sleep disorder and Depression 
15. Schizophrenia and Depression 
16. Sexual and gender identity disorder and Depression 
17. Parasomnia or sleep disorder and Obsessive-compulsive disorder 
18. Schizophrenia and Obsessive-compulsive disorder 
19. Sexual and gender identity disorder and Obsessive-compulsive disorder 
20. Schizophrenia and Parasomnia or sleep disorder 
21. Sexual and gender identity disorder and Parasomnia or sleep disorder 
22. Sexual and gender identity disorder and Schizophrenia 
Strong correlation 
1. Attention deficit and hyperactivity disorder and Alcoholism 
2. Depression and Alcoholism 
3. Obsessive-compulsive disorder and Alcoholism 
4. Parasomnia or sleep disorder and Alcoholism 
5. Sexual and gender identity disorder and Alcoholism 




7. Attention deficit and hyperactivity disorder and Anxiety disorder 
8. Developmental and learning disorder and Anxiety disorder 
9. Impulse control disorder and Anxiety disorder 
10. Non-specific neuroses and Anxiety disorder 
11. Somatoform disorder and Anxiety disorder 
12. Behavioural disorder and Attention deficit and hyperactivity disorder 
13. Developmental and learning disorder and Attention deficit and hyperactivity disorder 
14. Eating disorder and Attention deficit and hyperactivity disorder 
15. Substance abuse or dependence disorder and Attention deficit and hyperactivity 
disorder 
16. Unconfirmed psychology disorder and Attention deficit and hyperactivity disorder 
17. Bipolar mood disorder and Behavioural disorder  
18. Depression and Behavioural disorder 
19. Parasomnia or sleep disorder and Behavioural disorder 
20. Schizophrenia and Behavioural disorder 
21. Sexual and gender identity disorder and Behavioural disorder 
22. Substance abuse or dependence disorder and Bipolar mood disorder 
23. Eating disorder and Depression 
24. Substance abuse or dependence disorder and Depression 
25. Impulse control disorder and Developmental and learning disorder 
26. Non-specific neuroses and Developmental and learning disorder 
27. Unconfirmed psychology disorder and Developmental and learning disorder 
28. Obsessive-compulsive disorder and Eating disorder 
29. Parasomnia or sleep disorder and Eating disorder 




31. Sexual and gender identity disorder and Eating disorder 
32. Substance abuse or dependence disorder and Eating disorder 
33. Unconfirmed psychology disorder and Impulse control disorder 
34. Psycho-social disorder of childhood and Non-specific neuroses 
35. Unconfirmed psychology disorder and Non-specific neuroses 
36. Substance abuse or dependence disorder and Obsessive-compulsive disorder 
37. Substance abuse or dependence disorder and Parasomnia or sleeping disorder 
38. Substance abuse or dependence disorder and Schizophrenia  
39. Substance abuse or dependence disorder and Sexual and gender identity disorder 
No correlation 
1. Abuse, dependence/overdose of opioids  
2. Alcoholism 
3. Anxiety disorder 
4. Delusional disorder 
5. Dissociative disorder 
6. Mental retardation 
7. Non-specific psychosis 
8. Personality disorder 
9. Psychosis due to a general medical disorder 
10. Psycho-social disorder of childhood 
11. Tic disorder 






Comorbidity, from the perspective of mental illness, means the co-occurrence of one or more 
disorders in an individual. Each presenting disorder is defined in terms of its characteristic 
symptoms rather than the underlying cause (Ollendick & King, 1994; Kessler, 1995). 
Comorbidity exhibits in different patterns, from mental disorders co-occurring with each 
other, as well as with substance abuse disorders, with anxiety disorders commonly co-
occurring, but also with affective (mood) disorders for example.  
Heterotypic comorbidity is defined as comorbidity between different classes of mental 
disorders. A general example would be the co-occurrence of substance use and other mental 
disorders (Angold, Costello & Erkanli, 1999).  
Homotypic comorbidity is defined as comorbidity between different members of a general 
class of mental disorder. Examples would be the co-occurrence of phobia and generalised 
anxiety disorder, or between alcohol and other drug abuse disorders. Interestingly, Kendler 
(1996) established that generalised anxiety and depression share a genetic vulnerability.    
Concurrent comorbidity is two or more disorders present at the same time. A typical 
example would be schizophrenia and alcoholism (Hall, 1998).  
Successive comorbidity is disorders present at different times in an individual, in ways that 
may or may not be causally related to each other (Hall, 1998). 
Why focus on comorbidity? 
1. The occurrence of comorbidity in an individual patient is more common than a single 
diagnosis. This is shown in Figure 3 below, where the total incidence of comorbidity 




individual. Furthermore, several studies support this finding (Hall, 1996; Merikangas, 
Mehta & Molnar, 1998; Andrews, Hall, Teesson, & Henderson, 1999; Valderas, 
Starfield, Sibbald, Salisbury & Roland, 2009). 
2. Comorbidity must be considered when studying individual mental disorders, since the 
attributes of the disorder under study, may instead be the features of the comorbid 
condition (Kessler, 1995; Valderas et al., 2009). 
3. Understanding why disorders co-occur can provide vital insight for prevention 
approaches.  
4. Understanding which disorders co-occur can provide vital insight for treatment 
approaches. 
 




The causes of comorbidity 
A main criticism in the classification of mental disorders as defined in the Diagnostic and 
Statistical Manual or the WHO’s International Classification of Diseases, is that there are no 
clear breaks in the symptom distributions for most mental disorders. Andrews et al. (1999) 
show that there is no distinguishable discontinuity in the symptom distributions of anxiety, 
affective or substance abuse disorders. What this means is that comorbidity may simply be 
the result of the indiscriminate division of disorders and that mental disorders are not always 
mutually exclusive illnesses. If diagnoses have been splintered into separate diagnoses, then 
our thinking around comorbidity may be an artefact, requiring change (Caron and Rutter, 
1991; Andrews et al., 1990). 
That the classification of mental disorders may be result (in some instances) of an artificial 
subdivision, is a plausible explanation for the occurrence of comorbidity in homotypic 
comorbidity. It explains comorbidity between different anxiety disorders, and perhaps 
between certain anxiety and affective disorders.  
Artificial illness classification, however, is not a catch-all explanation for comorbidity, 
because it cannot explain comorbidity between substance abuse disorders and anxiety and 
affective disorders for example. If the comorbidity between substance abuse and anxiety and 
affective disorders is not an artefact, the following arguments may provide explanation 
(Kessler, 1995; Kessler, Berglund, Demler, Jin, Merikangas & Walters, 2005):  
Argument 1: One mental disorder may directly cause another. Certain substance abuse 
disorders can directly induce other mental disorders. For example, heavy amphetamine use 
can produce a schizophreniform psychosis, which differs from schizophrenia (Angrist, 1983; 




alcohol-induced depression in alcoholics (Raimo & Schuckit, 1998; Kuria, Ndetei, Obot, 
Khasakhala, Bagaka, Mbugua & Kamau, 2012).  
Argument 2: One mental disorder may indirectly increase the risk of a substance use 
disorder. For example, individuals with anxiety and affective disorders may use alcohol and 
other drugs to self-medicate (Kessler, 1995; Turner, Mota, Bolton & Sareen, 2018). 
Similarly, it is common for children diagnosed with conduct disorders to initiate alcohol and 
other drug use earlier than their peers (Kandel, Davies, Karus & Yamaguchi, 1986; Vaillant, 
1995; Kendall, Flannery-Schroeder, Panichelli-Mindel & Southam-Gerow, 1997; Masroor, 
Patel, Bhimanadham, Raveendran, Ahmad, Queeneth, Pankaj & Mansuri, 2019). This is so 
prevalent that Kessler (1995) showed that almost 60% of those with a lifetime diagnosis of 
conduct disorder also had at least one lifetime diagnosis of an addictive disorder. Several 
studies have shown that symptoms of anxiety commonly precede and are risk factors for 
depressive disorders (Angst, Vollrath, Merikangas & Ernst, 1990; Hagnell & Graesbeck, 
1990; Cole, Peeke, Martin, Truglio & Seroczynski, 1998; Kessler et al.,2005). 
As discussed, comorbidities are found within members of the same class (category) as well as 
across categories. The axis classification system was removed in the DSM-5 but is now of 
historical significance. On May 18, 2013 the DSM-5 was published, superseding the DSM-
IV-TR, which was published in 2000 (American Psychiatric Association, 2013). Because the 
study database was populated between 2008 – 2015, the criteria for categorising mental 
disorders was modelled on the DSM-IV-TR. For this reason, the mental disorders listed in the 
database, were assigned to a relevant category adopted from the main categories of disorders 




Implications for health policy 
Comorbidities have important repercussions for treatment and prevention. Patients with 
comorbidities have a poorer treatment response and a greater chance of a negative outcome 
than those diagnosed with a single disorder (Kessler, 1995; Drake, Mueser, Clark & Wallach, 
1996; Worthington, Fava, Agustin, Alpert, Nierenberg, Pava & Rosenbaum, 1996; Pedrelli, 
Nyer, Yeung, Zulauf & Wilens, 2015). This has been verified in schizophrenia (Drake et al., 
1996), but also in comorbid depression and anxiety (Kranzler, Del Boca & Rousaville, 1996). 
This could be because comorbid disorders are not diagnosed and treated and/or because 
patients with more than one mental disorder are more difficult to treat.  
Substance abuse disorders in schizophrenics are a markedly serious concern (Bartels, Drake, 
& McHugo, 1992; Volkow, 2009), as well as the comorbidity of substance abuse disorders 
with anxiety, mood and other substance abuse disorders (Hall, Lynskey & Teesson, 2001; 
Brady, Haynes, Hartwell & Killeen, 2013). These comorbidities are common and therefore 
have significant medical aid, health insurance and public health implications as well as 
consequences for the individual. 
Comorbidity can only be treated effectively with an integrated, person-centred approach to 
health policy and services (Zulman, Asch, Martins, Kerr, Hoffman & Goldstein, 2014). 
Integrating health services improves the success of adherence to treatment and overall health 
outcomes. There is strong evidence for the effectiveness of collaborative care in the 
management of common mental health conditions (Hall et al., 2001; Goodrich, Kilbourne, 
Nord & Bauer, 2013). This calls for a rework of current medical aid healthcare policy, where 
outcome is measured only by a reduction in symptoms. An integrated, person-centred 




integration back into the day-to-day happenings in community and society. This means work, 







DSM-IV categories of disorder, with the mental disorders listed in the database, assigned to the relevant category. 
DSM-IV Group Mental disorders listed in study database 
Developmental disorders Mental retardation, Attention deficit & hyperactivity disorder, 
Developmental and learning disorder, Psycho-social disorder of childhood, 
Behavioural disorder, Tic disorder 
Cognitive disorders Vascular dementia 
Mental disorders due to a general medical condition Psychosis due to a general medical disorder 
Substance-related disorders Alcoholism, Abuse, dependence/overdose of opioids, Substance abuse or 
dependence behaviour 
Schizophrenia and other psychotic disorders Delusional disorder, Non-specific psychosis, Schizophrenia 
Mood disorders Depression, Bipolar mood disorder 
Anxiety disorders Anxiety disorder, Obsessive compulsive disorder, Non-specific neuroses 
Somatoform disorders Somatoform disorder 
Factitious disorders None specified in database 
Dissociative disorders Dissociative disorder 
Sexual and gender identity disorders Sexual and gender identity disorder 
Eating disorders Eating disorder 
Sleep disorders Parasomnia or sleep disorder 
Impulse control disorders Impulse control disorder 
Adjustment disorders None specified in database 





Table 4  
List of mental disorders with associated comorbid disorders 













































































































































Comparing findings with the broader mental health landscape 
The Discovery Health Medical Aid Scheme database represents a cross-section of the South 
African population. That 15% (1 in 6) South Africans belong to a medical aid scheme and 
that Discovery Medical Aid Scheme retains 56.6% of the open market share) (Discovery 
Integrated Annual Report, 2018), means that the database reflects 8.3% of the South African 
population. The medical aid scheme is inclusive of those individuals that afford the 
membership fees on a personal level, those that are members by virtue of employment 
benefits, or those that are members by virtue of being a dependent. Regardless, membership 
is determined by payment. Medical aid schemes in South Africa may not (Erasmus, 2016): 
1. Turn down an application. 
2. Refuse to admit a dependent. 
3. Cancel membership. 
4. Force the use of network hospitals or doctors (designated service providers). 
5. Change benefits or contributions in the middle of the year. 
6. Give pensioners a contribution discount. 
7. Load a contribution if a member is a high claimer. 
8. Not pay for Prescribed Minimum Benefits. 
9. Pay out medical savings accounts in cash. 
10. Wait more than 30 days to pay out a claim. 




section of South African society. This means that the prevalence of illnesses recorded in the 
database should be reflective of prevalence rates in South Africa. Extending this further, for 
global epidemiological studies, prevalence rates for specific illnesses are calculated using 
extensive datasets. That there may be differing prevalence’s in different geographical regions, 
is equalised by the calculation of a global average for the prevalence of specific mental 
illnesses. 
Because of the calculation of these averages, it is statistically improbable that South Africa, 
with its small population, relative to the rest of the global population, should exhibit illness 
prevalence rates exponentially higher or lower than global or national averages. Should such 
outlying values be apparent, it is important to provide possible reasons or arguments for this.  
The discussion below groups examples of mental illnesses that veer significantly away from 
national or global prevalence rates. The two groups are those illnesses that are significantly 
under-represented or those that are significantly over-represented when compared to national 
or international prevalence rates. The discussion that follows, argues for possible reasons for 
such out-lying values.  
Examples of significantly under-represented mental disorders in the database compared 
to national/international percentages 
Abuse of substances  
According to Discovery Health Medical Aid Scheme (Refer to Table 2), from 2008 – 2015, 
the average percentage of the total population diagnosed with abuse, dependence/overdose of 
opioids is 0.013%. Substance abuse or dependence behaviour averages at 0.14% of the total 





According to Discovery Health Medical Aid Scheme, from 2008 – 2015 (Refer to Table 2), 
the average percentage of the total population diagnosed with alcoholism is 0.107%. 
If the prevalence of abuse, dependence/overdose of opioids, substance abuse or dependence 
behaviour and alcoholism are added together, it equates to 0.26% of the population on 
Discovery health medical aid scheme with a substance abuse disorder.  
South Africa ranks among the top 10 drug and alcohol abusers in the world, with a degree of 
sufferers that are double the global average. According to him, at least 15% of South Africans 
have a drug abuse problem, with this percentage predicted to increase further (Health24, 
2017). According to Meyers (Health24, 2013), 11% (5.7million people) of the South African 
population suffer from an addiction disorder.  
Erring on the side of caution, if the result of Meyers is used, then the prevalence rate of 
0.26% in the database shows a 98% gross under-representation of substance disorders when 
compared to the realities of the South African landscape.  
The prevalence rates in the database, are under-represented even further if the conclusions 
presented by Van Heerden, Grimsrud, Seedat, Myer, Williams & Stein (2009), on substance 
abuse in South Africa are considered. Van Heerden et al. (2009) present an estimate for 
alcohol abuse at 38.7%, cannabis use at 8.4%, other drug use at 2.0% and extra-medical 
psychoactive drug use at 19.3%.  
There is no ‘quick-fix’ solution to treating substance abuse disorders. Treatments involve 
intensive rehabilitation programmes (Substance Abuse and Mental Health Services 
Administration (US), Office of the Surgeon General (US), 2016). These programmes offer a 




and group therapy sessions, specialised sessions, family meetings, after-care support, medical 
intervention and behavioural therapies.  
Mental retardation 
Learning difficulties are a common mental disorder, with incidences of severe mental 
retardation calculated at approximately 3.5 per 1000 people in wealthier countries and 
between 3 and 22 per 1000 in impoverished countries (Institute of Medicine Neurological, 
Psychiatric, and Developmental Disorders, 2001). Inferring from the mix of both the 
wealthier and impoverished facets of South Africa, the mean for the prevalence of mental 
retardation for South Africa would be approximately 1.28% of the population.  
According to Discovery Health Medical Aid Scheme, from 2008 – 2015 (Refer to Table 2), 
the average percentage of the total population diagnosed with mental retardation is 0.023%. 
This prevalence reflects only 1.8% of national figures and is therefore a 98% gross under-
representation of the occurrence of mental retardation when compared to the realities of the 
South African landscape.  
There is no standard treatment for mental retardation, except that for all treatment regimes, 
there is no instant solution (Blacher, 2001). Treatment plans will depend on the identification 
of the cause and takes place over a long period, allowing the patient to reach their highest 
possible level of function. Treatment may involve therapy, family therapy, medication, 
learning support systems, appropriate individualised education and skills training, social 
programs, early intervention agendas and training in independent living. Moderate to 
profoundly retarded persons usually require supervised community living in a group home or 





Vascular dementia is a common type of dementia caused by reduced blood flow to the brain 
and for which there is no cure (Venkat, Chopp & Chen, 2015). The resultant brain damage is 
irreversable, but treatment can help prevent further damage to the brain and may slow down 
its progression. Treatment agendas involve drug and non-drug treatment, support and 
activities (Venkat et al., 2015: NHS., 2017). 
The treatment for vascular dementia is largely centred on non-drug approaches that involve 
identifying areas that require assistance, such as social interaction, support in the form of a 
carer or whether a nursing home is a better option (Brooke, 2016). The treatment of vascular 
dementia continues throughout the duration of the illness. There is no short-term treatment 
option, but rather an investment in the patient to slow down the progression of the disease.  
It has been shown that progressive biological diseases of the brain (such as dementia) affect 
approximately 5% of people over 65 years of age in certain Asian and Latin American 
countries, while significantly lower rates of between 1% and 3% (average = 2%) have been 
reported in India and Sub-Saharan Africa (Kalaria, Maestre, Arizaga, Friedland, Galasko, 
Hall, Luchsinger, Ogunniyi, Perry, Potocnik, Prince, Stewart, Wimo, Zhang & Antuono, 
2008).  
According to Discovery Health Medical Aid Scheme, from 2008 – 2015 (Refer to Table 2), 
the average percentage of the total population diagnosed with vascular dementia is 0.02%. 
This prevalence represents 1% of the average of national figures and is therefore a 99% gross 
under-representation of vascular dementia when compared to the realities of the South 





Anxiety disorders are ranked sixth (3.4%) by the World Health Organisation, as contributors 
to disability on a worldwide scale (Mughal, Devadas, Ardman, Levis, Go & Gaynes, 2020). 
The total estimated global number of people living with anxiety disorders is 264 million, 
which translated in 2015 to approximately 3.6% of people world-wide (Alonso, Liu, Evans-
Lacko, Sadikova, Sampson, Chatterji, Abdulmalik, Aguilar-Gaxiola, Al-Hamzawi, Andrade, 
Bruffaerts, Cardoso, Cia, Florescu, de Girolamo, Gureje, Haro, He, de Jonge & Karam, 
2018). South Africa presents with an extraordinarily high number of sufferers of anxiety 
disorders, where the Medical Research Council estimates 15.8% of South Africans suffer 
from an anxiety disorder (Herman et al., 2009). This value is used for comparison with the 
study database because of the South African context. 
By 2015, the Discovery Health Medical Aid Scheme database listed 69 916 patients out of a 
total population of 3 031 600 members diagnosed with anxiety disorder. This translates to 
2.31% of the total claimant population. The database then only reflects 15% of the national 
prevalence rate for anxiety disorders and is therefore an 85% gross under-representation of 
anxiety disorders when compared to the realities of the South African landscape. 
When initiating treatment for anxiety disorders, many patients can experience meaningful 
symptom relief and improvement in their quality of life, but treatment success varies. Some 
people respond to treatment after a few weeks or months while others may take longer. If 
people have more than one anxiety disorder or if they suffer from other co-existing 
conditions, treatment may take longer (ADAA, 2017).  
A well-established and highly effective treatment is Cognitive-Behavioural Therapy (CBT). 
Benefits are usually seen in 12 to 16 weeks, depending on the individual. Additional therapies 




a. Exposure therapy 
b. Acceptance and commitment therapy (ACT) 
c. Dialectical behavioural therapy (DBT) 
d. Interpersonal therapy (IPT) 
e. Eye movement desensitisation and reprocessing (EMDR) 
Four classes of medications used in the treatment of anxiety disorders are (ADAA, 2017): 
a. Selective serotonin reuptake inhibitors (SSRI’s) 
b. Serotonin-norepinephrine reuptake inhibitors (SNRI’s) 
c. Benzodiazepines 
d. Tricyclic antidepressants 
The course of treatment is time intensive, and for meaningful recovery, does involve a 
multidisciplinary approach. 
Schizophrenia 
Schizophrenia is a severe and chronic mental disorder, affecting about 25 million people 
worldwide (about one out of every 285) (Myers, 2010). According to the Diagnostic and 
Statistic Manual of Mental Disorders (1994) and Bhugra (2005), approximately 1% of the 
global population is diagnosed with schizophrenia.  
According to Discovery Health Medical Aid Scheme, from 2008 – 2015 (Refer to Table 2), 
the average percentage of the total population diagnosed with schizophrenia is 0.58%. The 
database prevalence rate reflects 58% of global figures and is therefore a 42% under-
representation of schizophrenia when compared to the global landscape.  




rate (>70%) (Diagnostic and Statistical Manual of Mental Disorders.4th ed., 1994).  
There are different treatment strategies for patients at different stages of the illness. The use 
of antipsychotics alone does not manage the frequently occurring negative symptoms and 
cognitive impairments (Patel, Cherian, Gohil & Atkinson, 2014). Best practice recommends 
combination of treatment modalities that can meet the complex health needs of people with 
schizophrenia. This multifaceted illness management would include different combinations of 
physical, psychological, social interventions and rehabilitation in the later stages of the illness 
(Bilder, 1997; Jablensky, 2000; Pfammatter, Junghan & Brenner, 2006; Chien & Yip, 2013). 
Behavioural disorder 
An expanding literature base indicates the incidence and prevalence of emotional/behavioural 
problems in young children is increasing (Brauner & Stephens, 2006). Prevalence rates of 
behavioural and emotional problems (8.3% for pre-schoolers, 12.2% for pre-adolescents and 
15.0% for adolescents) have been reported as a global overview (Ginige, Tennakoon, 
Wijesinghe, Liyanage, Herath & Bandara, 2014). Because the database does not distinguish 
between age cohorts, the average between pre-schoolers, pre-adolescents and adolescents is 
calculated at 11.8%. This percentage is used as the comparison value with the Discovery 
Health Medical Aid Scheme database.  
According to Discovery Health Medical Aid Scheme, from 2008 – 2015 (Refer to Table 2), 
the average percentage of the total population diagnosed with behavioural disorder is 0.09%. 
The database prevalence rate reflects 0.8% of global figures and is therefore a gross 99.2% 
under-representation of behavioural disorder when compared to the global landscape. 
Cognitive behavioural therapy treatment (CBT) is the most commonly used modality for 




administered in hour-long sessions by a single therapist who will engage the patient on a deep 
level (Butler, Chapman, Forman & Beck, 2006). In addition, behavioural treatment through 
parent management training and family therapy can be remarkably effective for managing 
behavioural disorders, with medication used as treatment for underlying or co-occurring 
disorders (SickKids staff, 2018). 
The treatment options for behavioural disorder all involve intensive therapy, and time-
intensive dedication to the choice of therapy, provides hope for effective recovery. 
Obsessive compulsive disorder  
Epidemiological studies show that obsessive compulsive disorder (OCD) is a common mental 
illness (Jaisoorya, Janardhan Reddy, Nair, Rani, Menon, Revamma, Jeevan, Radhakrishnan, 
Jose & Thennarasu, 2017). Prevalence estimates vary slightly between major studies, with 
Karno, Golding, Sorenson & Burnam (1998) reporting a lifetime prevalence of between 
1.9%–3.3% (2.6% average), the Cross-National Collaborative Group reporting a 12-month 
prevalence of 1.1%–1.8%, (Weissman, Bland, Canino, Greenwald, Hwu, Lee, Newman, 
Oakley-Browne, Rubio-Stipec & Wickramaratne, 1994) and the National Comorbidity 
Survey Replication reporting a lifetime prevalence of 2.3% (Ruscio, Stein, Chiu & Kessler, 
2010; Jaisoorya, et al., 2017). If the lifetime prevalence study values (above) of 2.6% 
(average) and 2.3% are considered, the average prevalence rate between these two studies is 
2.5%. This value is used for comparison with the study database. 
The database in this study does not specify whether the diagnosis of obsessive-compulsive 
disorder is a lifetime or 12-month prevalence, and so erring on the side of caution, I have 
assumed a lifetime prevalence rate.  




the average percentage of the total population diagnosed with obsessive-compulsive disorder 
is 0.018%. The database prevalence rate reflects 0.7% of standard figures and is therefore a 
gross 99.3% gross under-representation of obsessive-compulsive disorder when compared to 
the average of peer-reviewed studies. 
Obsessive compulsive disorder is characterised by the presentation of obsessions and 
compulsions. Obsessions are repetitive, unwanted, intrusive thoughts, images or urges that 
cause extreme distress or anxiety (Brock & Hany, 2020). The compulsions (rituals) that 
follow, in response to the obsessions are repetitive behaviours or mental acts that are 
performed to reduce anxiety/distress or prevent a dreaded consequence (Foa, Kozak, 
Goodman, Hollander, Jenike & Rasmussen, 1995). Interestingly, the displays of obsessive 
compulsive disorder are significantly similar across cultures and geographic locations 
(Janardhan Reddy, Sundar, Narayanaswamy & Math, 2017). 
Obsessive compulsive disorder is often comorbid with other psychiatric disorders (Kessler et 
al., 2005; Pallanti, Grassi, Sarrecchia, Cantisani & Pellegrini, 2011). Depression and anxiety 
disorders are present in over 50% of patients being treated for obsessive compulsive disorder, 
with those with onset in childhood presenting with high rates of attention deficit hyperactivity 
disorder, oppositional defiant disorder and tic disorders (Murphy, Timpano, Wheaton, 
Greenberg & Miguel, 2010). While obsessive compulsive disorder is equally present in males 
and females in adulthood, the disorder is predominantly male in patients that are children 
(Geller, 2006). 
The most effective treatment for obsessive-compulsive disorder, in both adults and children, 
that is superior to medications alone (and supported by numerous clinical trials), is cognitive-
behavioural therapy (Foa, Steketee, Grayson, Turner & Latimer, 1984; Abramowitz, Franklin 




there are excessively high relapse rates when treated with medications alone. 
Eating disorders 
Eating disorders describe illnesses that are characterised by severe disturbances in eating 
habits and extreme anxiety or apprehension about body weight or shape (American 
Psychiatric Association, 2017). A minority of people are treated in mental healthcare for 
eating disorders (particularly bulimia nervosa) (Hoek, 2006; Hart, Granillo, Jorm & Paxton, 
2011; Smink & van Hoeken, 2012). For those that receive treatment, the evidence-based 
treatments listed below have been found to be effective for eating disorders (National Eating 
Disorders Collaboration, 2018): 
a. Cognitive behavioural therapy (CBT) 
b. Dialectical behavioural therapy (DBT) 
c. Family based psychotherapies 
d. Self-help approaches 
e. Nutritional management 
Medication based approaches are introduced in conjunction with the above treatment options, 
when a patient presents with co-morbidity (such as depression, anxiety or insomnia) 
(National Eating Disorders Collaboration, 2018). 
Approximately 1 to 4.2% of women suffer from anorexia nervosa in their lifetime (The 
Renfrew Center Foundation for Eating Disorders, 2003). The average prevalence rate 
calculated at 2.6%. Anorexia nervosa has the highest fatality rate of any mental illness 
(Sullivan, 1995; Arcelus, Mitchell, Wales & Nielsen, 2011), where shockingly, 4% of 
anorexic individuals die from complications of the disease (Crow, Peterson, Swanson, 




It is estimated that up to 4% of females in the United States will have bulimia during their 
lifetime (The National Institute of Mental Health [Eating Disorders], 2002) and the disorder 
will be fatal for 3.9% of those diagnosed (Crow et al., 2009). On a global scale, between 
1.1% and 4.6% of females will develop bulimia (Stice, Marti, Shaw & Jaconis, 2009), with 
the average then calculated at 2.85%. Disturbingly, 13.5% of athletes suffering from sub-
clinical to clinical eating disorders (Sundgot-Borgen & Torstveit, 2004). 
The Discovery Health Medical Aid Scheme database does not distinguish between anorexia 
nervosa and bulimia nervosa, and so the average between the two global prevalence’s (2.6% 
and 2.85%) from the references above are calculated at 2.72%. The dire percentage of 
athletes with eating disorders is not included, because it would skew average prevalence rates 
because for this study there is no way to determine whether patients are athletes or not.  
According to Discovery Health Medical Aid Scheme, from 2008 – 2015 (Refer to Table 2), 
the average percentage of the total population diagnosed with eating disorder is 0.154%. The 
database prevalence rate reflects 5.7% of global figures and is therefore a 94.3% under-
representation of eating disorders when compared to the global landscape. 
Developmental and learning disorders 
Learning disorders rate among the most commonly diagnosed developmental disorders in 
childhood (Moll, Kunze, Neuhoff, Bruder & Schulte-Körne, 2014). They are not pure 
syndromes but are developmental disorders that are characteristically multi-dimensional 
(John, 2010 (a)), coupled with a high degree of co-morbidity with disorders such as attention 
deficit and hyperactivity disorder and obsessive-compulsive/obsessive spectrum disorder 
(Philip, 2003). 




strengths, compensate for weaknesses and can impart effective coping mechanisms (National 
Institute of Neurological Disorders and Stroke, 2017). Leaving learning disorders untreated, 
may lead to low self-esteem and other problems (Learning Disabilities Association of 
America, 2018). 
The most effective treatment programmes for developmental disorders are those that are 
individualised and include a team of multidisciplinary medical professionals. The plan is 
centres around the severity of the disability and must involve the patient, family and medical 
professionals, taking into account both the immediate needs as well as the long-term 
prognosis for development (My Child without Limits, 2018). 
The evidence-based treatments listed below have been found to assistant developmental 
disorders and differ depending on the nature and scope of the disability. (Institute of 
Medicine (US). Committee on Nervous System Disorders in Developing Countries. 
Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the 
Developing World, 2001); My Child without Limits, 2018): 
a. Cognitive behavioural therapy (CBT) 
b. Dialectical behavioural therapy (DBT) 
c. Physical therapy 
d. Speech therapy 
e. Occupational therapy 
f. Medication therapy 
A study in India, with over five thousand children assessed for poor school performance 
revealed that 12.8% of them were ‘positive cases.’ A positive case means that the child in 
question was diagnosed with either dyslexia, dyscalculia, dysgraphia or mixed learning 




Epidemiological studies present prevalence rates of between 4 and 9% for deficits in reading 
and between 3 and 7% for deficits in mathematics (American Psychiatric Association, 2013; 
Moll et al., 2014). Furthermore, studies show that children experiencing challenges in one 
learning area commonly show deficits in other areas (Lewis, Hitch & Walker, 1994; Dirks, 
Spyer, van Lieshout & de Sonneville, 2008; Landerl & Moll, 2010).  
The average prevalence rate for reading deficits based on the epidemiological studies above 
is 6.5%, and the average for deficits in mathematics is 5%. The Discovery Health Medical 
Aid Scheme database does not distinguish between learning and developmental disorder 
types, and so the average between the two average prevalence’s cited above, as well as 
considering the large Indian cohort study is 9.3%. 
According to Discovery Health Medical Aid Scheme, from 2008 – 2015 (Refer to Table 2), 
the average percentage of the total population diagnosed with developmental and learning 
disorders is 2.47%. The database prevalence rate reflects 26.6% of average figures and is 
therefore a 73.4% under-representation of developmental and learning disorders when 
compared to the average of extensive prevalence studies. 
Attention deficit and hyperactivity disorder 
Analyses provide an estimate of global attention deficit and hyperactivity disorder prevalence 
at between 5.29% (Polanczyk, de Lima & Horta, 2007) and 7.1% (Willcutt, 2012). The 
average for the studies above was calculated at 6.2% as the global middling for the 
prevalence of attention deficit and hyperactivity disorder.  
Compiling the findings in 86 studies in children and adolescents, 11 studies in adults, and a 
methodical examination of 102 global studies found no significant differences between 




2007; Willcutt, 2012; Polanczyk, Willcutt & Salum, 2014). Therefore, it was concluded that 
attention deficit and hyperactivity disorder is not a cultural paradigm bounded by a specific 
geographical location.  
According to Discovery Health Medical Aid Scheme, from 2008 – 2015 (Refer to Table 2), 
the average percentage of the total population diagnosed with attention deficit and 
hyperactivity disorder is 5.44%. The database prevalence rate reflects 87.74% of average 
figures and is therefore a 12.26% under-representation of attention deficit and hyperactivity 
disorder when compared to global prevalence’s.  
South Africa has one of the highest rates globally of prescribing medication for attention 
deficit and hyperactivity disorder (Schoeman & de Klerk, 2017). Up until recently, 
medication was the only intervention approach adopted for attention deficit and hyperactivity 
disorder, but international trends now reveal a distinct change to this approach. 
Internationally, there is far greater emphasis on investigating the symptoms of attention 
deficit and hyperactivity disorder, uncovering the reasons behind behaviours and providing 
treatments that may not include medication (Health 24, 2017).  
The active ingredient, a central nervous system stimulant, used to medically treat attention 
deficit and hyperactivity disorder is Methylphenidate. This is sold under several trade names, 
with Ritalin being one of the most commonly known (Markowitz, Straughn & Patrick, 2003). 
A prescription for Ritalin in South Africa can be as low as R355.82 per month (South African 





Examples of significantly over-represented mental disorders in the database compared 
to national/international percentages 
Depression 
Globally, the number of people suffering from depression in 2015, was estimated to surpass 
300 million (translating to 4.4% of the world’s population) (WHO., 2018(a)). Depression is 
ranked globally as the single largest contributor to disability (7.5% in 2015) and is also a 
major contributor to suicide deaths, which approach 800 000 per annum (Greden, 2001; 
WHO., 2018(a); WHO., 2018(b)). 
The frequency of depression fluctuates by region, from, for example, 2.6% among males in 
the Western Pacific to 5.9% among females in Africa and when viewed globally, is more 
common among females (5.1%) than males (3.6%) (Kessler & Bromet, 2013; WHO., 
2018(a)). 
According to Discovery Health Medical Aid Scheme, from 2008 – 2015 (Refer to Table 2), 
the average percentage of the total population diagnosed depression is 23.91%. This 
prevalence is an 82% over-representation of average global figures and reveals a gross over-
depiction of depression when compared to the realities of the world.  
Mild and moderate depression and anxiety can be treated effectively with behavioural 
therapies, but only with intensive supervision (Clark, 2011). Developing countries do not 
have enough human resources to provide this level supervision against the number of 
sufferers (Gureje & Alem, 2000). On average a primary care centre of 10 000 people will 
present with 100 patients with psychosis, 300 with severe depression and 300 with epilepsy, 
of whom at least half of these serious illnesses listed would need active rehabilitation 




Antidepressants are prescribed extensively to treat depression, along with psychological 
support through, for example, cognitive behavioural or interpersonal therapies (Cipriani, 
Furukawa & Salanti, 2018; NHS [National Institute for Health Research], 2018).  
In direct contradiction to the practice of prescribing antidepressants for effective treatment of 
depression, studies show a mounting uncertainty about the efficacy of antidepressants. Their 
chemical action is poorly understood, and enhancement in mood is inclined to a modest result 
(Cipriani et al., 2018; NHS [National Institute for Health Research], 2018; Parikh & 
Kennedy, 2018). The comment by Chris Williams, Emeritus Professor of Psychosocial 
Psychiatry and President of the British Association for Behavioural and Cognitive 
Psychotherapies (NHS [National Institute for Health Research], 2018) summarises this stance 
by saying that medication does not directly tackle important external or internal challenges. 
Talking therapies can be effective, but not if they are not adhered to. Maximal response is 
likely to be individualised, selecting appropriate psychological, biological and social 
interventions that the individual wishes to use, and which lead to recovery. 
Bipolar mood disorder 
Bipolar mood disorder affects about 60 million people worldwide. Estimates of the lifetime 
prevalence of bipolar II (BP-II) disorder reported a median lifetime prevalence of 1.2% 
(Bauer & Pfennig, 2005). However, a recent international review, supporting the original 
finding, of both DSM-IV bipolar I and II disorders in population studies yielded an aggregate 
cross-study lifetime prevalence estimate of 1.2%, ranging from 0.1% in Nigeria to 3.3% in 
the U.S. (Grant, Stinson & Hasin, 2005; Gureje, Lasebikan, Kola & Makanjuola, 2006; 
Merikangas & Pato, 2009). 
According to Discovery Health Medical Aid Scheme, from 2008 – 2015 (Refer to Table 2), 




6.49%. This prevalence is an 82% over-representation of the average global figures and is 
therefore a gross over-representation of bipolar mood disorder when compared to the realities 
of the world. 
Relapse of bipolar mood disorder is avoidable with the use of by lithium, but this needs 
regular monitoring of drug levels in the blood and is therefore not available in primary care 
(Goodwin, Haddad, Ferrier, Aronson, Barnes, Cipriani, Coghill, Fazel, Geddes, Grunze, 
Holmes, Howes, Hudson, Hunt, Jones, Macmillan, McAllister-Williams, Miklowitz, Morriss, 
Munafò & Young, 2016). What this translates to, is rather than focusing on the provision of 
newer more costly medications, it would be of greater value in developing countries, to 
establish regular continuing professional development (CPD) for primary and secondary care 
practitioners, to efficiently and effectively deliver existing medications and psychological 
therapies (Ranis, Stewart & Samman, 2005).  
Parasomnia or sleep disorder 
Parasomnias have been reported in approximately 4% of the adult population (Avidan & 
Kaplish, 2013). Epidemiological studies show that up to 50% of children experience sleep 
problem (Owens, Spirito, McGuinn & Nobile, 2000; Liu, Liu, Owens & Kaplan, 2005; Pagel, 
Forister & Kwiatkowki, 2007), with approximately 4% of these, diagnosed with a formal 
sleep disorder (Meltzer, Johnson, Crosette, Ramos & Mindell, 2010).  
According to Discovery Health Medical Aid Scheme, from 2008 – 2015 (Refer to Table 2), 
the average percentage of the total population diagnosed with parasomnia is 4.93%. The 
database prevalence rate reflects 81.13% of average figures and is therefore an 18.87% over-
representation of parasomnia when compared to the global prevalence averages. 




(Pagel & Parnes, 2001). The general aim of drug treatment is to prevent arousal out of sleep 
or to suppress REM sleep (Sharma, 2018). Benzodiazepines are available at significantly low 





Summary of examples of under/overrepresented disorders in the study database, when compared to global/South African prevalence rates.  
Mental disorder Global/National 
prevalence rate 
Database 
prevalence rate  
Percentage of under/over representation 
within database (compared to 
global/national percentages) 
Examples of under-represented disorders in the study database 
Abuse of substances  11% 0.26% 98% 
Anxiety disorder 15.8% 2.3% 85% 
Attention deficit and behavioural disorder 6.2% 5.44% 12.26% 
Behavioural disorder 11.8% 0.09% 99.2% 
Developmental and learning disorder 9.3% 2.47% 73.4% 
Eating disorder 2.72% 0.154% 94.3% 
Mental retardation 1.28% 0.023% 98% 
Obsessive compulsive disorder 2.5% 0.7% 99.3% 
Schizophrenia 1% 0.58% 42% 





Examples of over-represented disorders in the study database 
Bipolar mood disorder 1.2% 6.49% 82% 
Depression 4.4% 23.91% 82% 








The diagnosis of mental illness as a cost-effective equation 
Mental illness in society is clouded by ignorance and judgement. The mentally ill are 
stigmatised in their communities. Such ignorance is partly due to a fear of what we cannot see. 
A broken arm is visible, but not a broken chain of neurotransmitters. 
Actively trying to destigmatise illness and create an awareness of different mental illnesses will 
go a long way to ease the daily assault faced by the mentally ill. However, this is not what this 
thesis is about: Instead, discussion centres on investigating the actuals within a database owned 
by a medical aid scheme. The database is examined to find clues that could build a picture of 
the mental illness landscape for medical aid paying South Africans. It is found that: 
1. There are changes in prevalence rates of mental disorders over time. 
2. The values of the fluctuations in prevalence rates of mental disorders over time are 
given in the results chapter. 
3. These fluctuation trends are attributed to an economic factor within medical aid 
scheme cost-driven policy.  
4. The predicted effect of this is discussed below. 
The primary obligation of a medical aid provider is to allow for the provision of adequate 
treatment of the member. For those members (diagnosed or incorrectly diagnosed with a mental 
disorder), this is not the case. 
The effective treatment of mental disorders is usually intensive and prolonged (Carey & Carey, 




treatment means that the individual gets to perform an active and productive role in society, but, 
of course, such treatment is costly.  
One assumes that medical aid cover will be an adequate support, regardless of the illness 
because the individual pays for it. However, diagnoses of disorders are in part, determined by 
economic structures rather than being clinically objective and neutral, the result is that medical 
support is inadequate (Cartwright, Lasser & Gottlieb, 2017).  
A mandate of a medical aid provider is to minimise the outlay of costs in the treatment of its 
members. How then, do medical aid providers circumvent paying for these costly treatment 
programmes? From the results and discussion in this study, costs for mental illness treatment 
programmes are curtailed in three ways: 
1. By radically under-diagnosing various mental illnesses: Costs for treatment are curtailed 
by keeping patient numbers significantly low.  
2. By radically over-diagnosing certain mental illnesses: Illnesses in the database with 
numbers exponentially exceeding global norms still fit within the cost-effective 
framework because they are treated with comparably cheaper pharmaceuticals. Long-
term intervention is bypassed this way. Since long-term intervention is costly, bypassing 
it then allows the cost-effective framework to be upheld.  
3. By drastically curbing time spent in a mental health facility: The standard for high 
paying members for treatment in a private facility is limited to 21 days per year. This 




Any health system must include interventions that not only change the symptoms of the 
disorders but also allow sufferers to move more easily back into community life (Andrews, 
Peters & Teesson, 1994). Outcome is not just a reduction in symptoms.  
What are the implications of this? This means that some members of the medical aid scheme 
have been deliberately misdiagnosed. Alternatively, those, correctly diagnosed, do not receive 
the treatment required of such an illness. The scenario then is of thousands of mentally ill 
people, who are not treated successfully. They will not live lives free of the symptoms that 
cause suffering, distress and isolation.  
Are there factors influencing psychiatric diagnosis? If so, what are these factors and what is the 
potential impact on the mental health landscape and sufferers of mental illness? 
Among patients on this medical aid scheme, examples of an under representation of patients 
(relative to global averages) are observed for the following disorders:  
a. Abuse, dependence and/or overdose of opioids 
b. Alcoholism 
c. Anxiety disorder 
d. Attention deficit and hyperactivity disorder  
e. Behavioural disorder 
f. Developmental and learning disorder 
g. Mental retardation 
h. Obsessive compulsive disorder 
i. Schizophrenia 




k. Vascular dementia 
Among patients on this medical aid scheme, examples of an over representation of patients 
(relative to global averages) are observed for the following disorders:  
a. Bipolar mood disorder 
b. Depression 
c. Parasomnia 
Medical aids and health insurance have substantially and artificially influenced the mental 
health arena, to the point where Rappo (2002) summarises this influence as the management of 
health cost rather than health care. Medical aid guidelines determine whether, or the extent to 
which the expertise of clinicians and therapists are reimbursable (Kirk & Kutchins, 1988; 
Hohenshil & Singh, 1997; Glosoff, 1998; Mead, Murphy, DeBernardo & Shoemaker, 1998; 
Danzinger & Welfel, 2001). When patients cannot afford to personally cover costs, inaccurate 
mental disorder diagnoses that are reimbursable may be submitted for patients to receive a 
modicum of care. Wylie (1995) refers to this practice as ‘diagnosing for dollars.’ 
The Medical Schemes Act of 1998 (Regulation 8), requires schemes to pay for the diagnosis, 
treatment and care of Prescribed Minimum Benefits (PMBs), in full, regardless of which benefit 
option the member belongs to. PMBs include a wide range of 270 conditions (such as HIV, 
diabetes, various cancers cardiac treatment, and medical emergencies) and 27 chronic illnesses 
(such as schizophrenia and epilepsy).  
According to Allan Sweidan (CEO of Akeso Clinics & Psychologist in Johannesburg), Bipolar 




excluded. This means that patients are then falsely coded as having bipolar mood disorder. 
South African Psychiatrist Dora Wynchank sees this as one of the ways psychiatric patients are 
discriminated against (Egbe, Brooke-Sumner, Kathree, Selohilwe, Thornicroft & Petersen, 
2014), and where fundamentally, they are denied the correct treatment for their illnesses 
because of the dictates of cost. Weight is added to this argument when one considers that 
depression is not listed as a PMB and yet, 20% of woman and up to 12% of men suffer from it 
(Sloan & Sandt, 2006; Egbe et al., 2014). That this study reveals an 82% over-representation of 
the average global figures of bipolar mood disorder, attests to this deliberate misdiagnosis by 
medical practitioners, who are forced to operate within the narrow confines of medical aid 
guidelines, but are at the same time compelled in whatever way to provide a measure of care to 
patients. This is an example of where the type of health care system influences the provision of 
psychiatric services (D’Agostino & Stephens, 1986; Brown, 2001; National Academies of 
Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care 
Services; Committee on Health Care Utilization and Adults with Disabilities, 2018).  
Medical spending on psychiatric hospitalisation imposes a significant cost in medical aid 
scheme reimbursement claims. Dementia, mental retardation and schizophrenia, are reported to 
be the largest contributor to psychiatric health care costs (Tzeng, Lian, Chang, Yang, Lee, Pan 
& Lung, 2007; KMGL: Medical Care Law, 2010), with schizophrenia being one of the most 
expensive psychiatric disorders across the adult lifespan (Freiman, Cunningham & Cornelius, 
1994; Guest & Cookson 1999; Kaskie, Wallace, Kang & Bloom, 2006). It is obvious then, that 
a primary objective in the design of medical aid policies is to limit these expenditures.  




2014, a case was submitted against the Minister of Health, arguing that although the minister 
may determine the list of conditions that comprise the PMBs, he has no authority to determine 
the scope of payment (Burger, Lubbe, Serfontein & Ellis, 2017). The result of this is that 
Discovery Health Medical Aid Scheme has limited the payment of services of 15 categories of 
health professionals, including psychologists. Psychologists now fall under the ‘allied health 
benefits’ category, that regulates limited annual cover for art therapists, chiropractors, 
homeopaths, podiatrists, social workers and speech therapists.  
Because clinical psychology is lumped into the same category as podiatry and homeopathy for 
example, undermines the status of psychology in the treatment of mental illness. Schizophrenia, 
for example, requires long-term and intense management – management that includes the 
expertise of a clinical psychologist. That Discovery Medical Aid Scheme, limits payment to 
these medical professions, translates to severely affecting the effectivity of mental-health 
treatment.  
Furthermore, two-thirds of people with psychosis experience a relapsing or deteriorating course 
of illness, unless adequately treated (Emsley, Chiliza, Asmal & Harvey, 2013; Fleischhacker, 
Arango, Arteel, Barnes, Carpenter, Duckworth, Galderisi, Halpern, Knapp, Marder, Moller, 
Sartorius & Woodruff, 2014). Because there is a scarcity of psychiatrists in South Africa (see 
pages 54, 55 and 56 of this study) and there are limitations imposed by medical aids to the full 
spectrum of treatment programmes (discussed in this section), the resultant will be psychiatric 
hospitals acquiring an accumulated number of chronically ill patients suffering from regressive, 
psychiatric disorders. Patients in psychiatric hospitals tend to stay 69% longer than patients at 




2009). In Korea, for example, the average length of hospital stay for psychiatric patients is 89.8 
days (OECD Health Data, 2007; Chung et al., 2009). Discovery Medical Aid Scheme limits 
psychiatric hospitalisation to 21 days per annum, regardless of the severity of the mental illness 
diagnosis. That a patient may relapse during a year, or require longer hospitalisation, is 
characteristic of mental illness, but this is not factored in medical aid scheme policy. The 
outcome of this equates to inadequate care for the mentally ill. Inadequate care, as a casualty of 
cost-driven health policy. 
Medical aid scheme policies dictate mental health care, mental health care providers and the 
course of treatment (Wineburgh, 1998), especially how managed health care has radically 
altered the counselling landscape (Stern, 1993; Cuffel, Snowden, Masland & Piccagli, 1996), 
having a dire impact on the effectivity of treatment of mental illness. For example, mental 
health benefits may be limited to 20 sessions and brief therapy may be limited to one to five 
sessions (Cuffel et al., 1996; Kiesler, 2000). What this does is restrict treatment to the narrow 
parameters of the benefit package (Austad & Hoyt, 1996). Studies show that most mental health 
counsellors admit that medical aid scheme and health insurance stipulations have a negative 
influence on their practices (Miller, 1996; Murphy et al., 1998; Danzinger & Welfel, 2001). For 
the patient and mental health practitioner, this tragically translates to adhering to treatment 
plans that comply with medical aid payment policy, rather than patient need. Medical aid 
policies create restrictions that diminish the independence of patient and counsellor in making 
mental health decisions that are in the best interest of the patient (Smith, Grost & Kashner, 




Imposing limitations can only but affect a medical professional’s practice style at psychiatric 
hospitals, but also the interrelation of medical policy and patient thought and behaviour when it 
comes to treatment. This suggests that patient diagnoses are affected by medical aid scheme 
policy, which then interrelates among patients, among medical professionals, or between 
patients and medical professionals within a psychiatric institution (Russo, 1974; Simon & 
Zusman, 1983; Bertakis, Callahan, Helms, Azari, Robbins & Miller, 1998; Hassan, McCabe & 
Priebe, 2007). According to Borch-Jacobsen (2001), an aspect of the symptoms of mental 
illness is the sum of a patient’s interaction with medical professionals and institutions. Patients 
will tend to conform to the language of the medical professional and the society to which they 
belong, to expedite the treatment they so desperately need (Grivois, 1992). Barrett (1996), by 
way of reinforcing this point, demonstrates how schizophrenic patients learn, during clinical 
interviews, to speak the doctor’s language. It seems then that medical aid policy has the 
capacity to radically change the appearance of the mental health landscape, creating a false 
reality of mental illness prevalence’s, and a thin veneer of treatment. What this does is to 
undermine what needs to be done to effectivity treat those that are mentally ill, firstly with the 
correct diagnosis and secondly with suitable treatment.  
Incorrect diagnoses, driven by medical aid scheme policy has resulted in increasing 
epidemiological inaccuracy (at national and global levels) as reflected in the mental health 
statistics documented by the World Health Organization (WHO), such as the intentional 
misdiagnosis using depression or generalised anxiety disorder codes instead of V-Code 




Tragically, members will continue to pay fees, paying under the illusion that medical cover 











Chapter 5: Critical Reflections 
Overview and critical reflections 
Civil liberties cannot be disputed if they ensure the dignity of human beings. Examples of such 
irrefutable rights would be the right to adequate shelter, the right to sanitation, clean water and 
protection from abuse. These fundamentals are what each human being deserves. Another 
fundamental, is surely the right to adequate medical care? All people should have the right to 
effective medical treatment, but instead, what is apparent, is a polarisation in the quality of 
medical care brought about by the introduction of medical aid schemes and health insurance 
(Abuosi, Domfeh & Abor, 2016). 
What this creates is a system of inequality, where those with medical aid can afford care in 
better-equipped hospitals and can opt for best-practice treatment options, compared to those on 
government care. The subdivision creates a stratification into the ‘have and have-nots’ and it is 
a tragedy.  
The clear-cut distinction into the ‘have’ and ‘have-nots’ is not quite so binary. While those 
without medical aid are most certainly receiving of inferior medical care, it seems, from the 
outcome of this study, that those with medical aid support are also subject to inadequate care. It 
can be deduced that people on medical aid, with a mental disorder, may not receive the 
prolonged and intensive treatment they require. Medical aid delivers, but only within the strict 
confines of the governance of cost. This provision is based on an equation of cost return, and 
for this equation to balance, intensive, multidisciplinary and (often-needed) prolonged treatment 




providers been solved? What are the implications for the mentally ill? These questions are 
discussed in the conclusion below. 
The present study quantitatively analysed a dataset for a South African medical aid scheme, 
between 2008 to June of 2015. The focus of analysis is an investigation around the mental 
illnesses listed in the dataset. Analysis concentrated on frequency distributions across and 
within diagnoses, gender, treatment options, time and compared these results against the dataset 
population and within the larger South African and/or global context. Analysis also determined 
any correlations between mental illnesses.  
An objective of this analysis is to determine whether mental illness prevalence rates in the 
dataset aligned with national and/or global prevalence rates for significant disorders. Should a 
misalignment be apparent, a further aim of the analysis is to argue for possible reasons behind 
these outliers. Medical aid schemes operate within clear policy parameters, and because the 
dataset is from an existing medical aid scheme, it is logical to apply reasons for possible 
outliers from this perspective. Importantly then, because this perspective is adopted, it is 
necessary to provide a background on the nature of medical aid schemes and the rules and 
objectives they are governed by.  
Before analysing data or constructing arguments, it is important to describe the backdrop within 
which the dataset resides. What is this backdrop? It is firstly the South African mental health 
arena, and overarching that, a global picture of mental disorder frequencies. To this end, the 
current mental health landscape in South Africa is described from the vantage point of 
significant mental disorder prevalence rates. In addition, it is critical to discuss the attainability 




need? Is the process involved in receiving treatment, easily navigated? If treatment is received, 
to what degree is the treatment approach effective? It is critical to examine best-practice 
treatment approaches for specific mental disorders and this is discussed in Chapter 4. 
The fluctuating nature of mental disorder frequency is presented in this study and possible 
contributing factors for this are examined. An underlying aspect in this study is the recognition 
that there are metamorphoses of mental disorders that may result in altered or overlapping 
symptoms (Salloum & Thase, 2000). The overlapping or transformation of symptoms is the 
factor that inadvertently supports increasingly constrained medical aid scheme policy because it 
creates a loophole to validate misdiagnosis: Because of overlapping symptoms, it is likely that 
the diagnoses of mental disorders may be prone to misdiagnosis (whether deliberately or 
erroneously).  
Study limitations 
The study database was limiting in the data fields provided. Detailed data, with more data 
fields, will further add to creating a more accurate picture of the mental health arena in South 
Africa. It would have been especially useful to be able to utilise such characteristics as: 
1. Patient age 
2. Pre-admission history  
3. Severity of psychiatric illness.  
4. The proportion of involuntary admissions 




Recommendations for future research 
It is of value to create a much-needed awareness of the impact, and prevalence of mental 
disorders in the South African context. Studies and statistics exist for certain mental disorders, 
but many are scantily documented.  
A study focusing on the concise characterisation of disorders, locality patterns and prevalence 
rates will serve to establish a clearer picture of mental illness in South Africa. 
Medical aid providers have digitised databases of their members, but the public sector has great 
gaps in the management of patient databases. A future study that combines both public and 
private statistics will be invaluable.  
A clear picture is essential to manage treatment, group outreach and focused communication. 
Conclusion 
The study quantitatively analysed a dataset of mental disorders for South Africa’s leading 
medical aid scheme. It is found that there are changes in prevalence rates of mental disorders 
over time and that these fluctuations are attributed to an economic factor within medical aid 
scheme cost-driven policy.  
The effect of cost-driven policy is that members diagnosed with a mental disorder may not be 





Costs for mental illness treatment programmes are curtailed by keeping patient numbers 
significantly low, by radically over-diagnosing certain mental illnesses treated with comparably 
cheaper pharmaceuticals or by drastically curbing time spent in a mental health facility.  
Some members of the medical aid scheme have been deliberately misdiagnosed. Alternatively, 
those, correctly diagnosed, do not receive the treatment required of such an illness. The 
scenario then is of thousands of mentally ill people, who are not treated effectively. 
Members continue to pay fees, paying under the illusion that medical cover ensures effective 
treatment. 
Personal conclusion 
In 2018, my curly-haired, wide-mouthed boy of 16 was diagnosed with schizophrenia. There is 
such a sense of sadness and loss attached to hearing this. Sadness, at knowing the suffering the 
illness brings. Loss, at mourning the end of carefree childhood. Nevertheless, at the same time, 
hearing the diagnosis brings with it a sense of gratitude for those professionals who devote their 
lives to assisting with and learning about the complexity of the illness. More importantly, the 
diagnosis comes coupled with a deep respect for the daily bravery and quiet heroism shown by 
those who endure such internal turmoil and suffering. Schizophrenics are truly exceptional and 
beautiful human beings.  
This brings me to my huge frustration: that in the 21st century, with the advancement of 
Artificial Intelligence, virtual reality, and the pioneering of genetic engineering, there still exists 
such ignorance around the nature of mental illness. It is almost a deliberate and stubborn 




For me, it is so simple – schizophrenia is a complex and serious illness of the brain that results 
in a myriad of symptoms. That it is manageable (especially with early diagnosis), makes it no 
different to any other serious, outwardly obvious illness that requires effective management. 
Why then the fear? The prejudice? The stigma? The misconceptions?  
Ignorance breeds intolerance and judgement. Therefore, it rests on us, those that understand, to 
destigmatise actively. Communication is essential. The symptoms of the illness need to be 
understood. The management of the illness needs to be understood. There is no place for our 
children, our parents or family members who have schizophrenia to endure the added pain that 
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